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ABSTRACT 
This thesis describes the development of the various methods available for the 
synthesis of deoxyoligoribOflUCleOtideS. The use of the 2,2-b/s 
(4-nitrophenyl)ethyl group was investigated, mainly as a 5'-hydroxyl protecting 
group on 2'-deoxyri bon uCleotideS. but also as a base protecting group for the 
04 -function of thvmidine and the N 6-exocyclic amine of adenosine. The 
deprotection conditions required for the removal of this group and its 
subsequent use in the synthesis of 2'-deoxyribOfluCleotideS utilising 
phosphoramidite methodology are described. An investigation, by 31 P n.m.r., of 
the coupling and oxidation steps of the synthesis of DNA is included as well as 
a brief study of the potential use of zinc iodide as an accelerating agent in the 
coupling of nucleotides by the phosphotriester method of synthesis. 
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1.1. HISTORY OF DNA SYNTHESIS 
The chemical synthesis of DNA has proved to be one of the most exciting 
challenges to organic chemists in recent times. The opportunity to investigate 
the molecules which hold the key to life by carrying the genetic code for each 
organism, and the chemical complexity of such compounds, has created 
considerable interest in this area of chemistry. 
The basic objective is to join a 5'-OH group on the deoxyribose ring of one 
nucleotide with the 3'-01 ­1 group on another nucleotide via a phosphoric acid 
function. A variety of protecting groups and activating groups have been 
developed to ensure the required reaction occurs whilst minimising unwanted 
side-reactions. 
The first synthesis of DNA by chemical methods was reported in the 1950s 
by Todd  who successfully made and isolated a dithymidine dinucleotide. 
Khorana then used and developed the phosphodiester approach for many years 
finally using it in the synthesis of a biologically active gene  in the late 1970s. 
During this time other chemists including Eckstein 3, Reese 4  and Letsinger 5 
began to explore the phosphotriester approach which, after modification by 
Cramer 6 and Narang 7, was also used to make biologically active genetic 
material 8. The phosphite approach, first used by Letsinger 9 
 in the mid 1970s, 
has been developed rapidly and with the introduction of solid phase synthesis, 
also proposed by Letsinger 5 , it is now possible to make routinely 
oligodeoxyribonucleOtides using an automated synthesizer. 
2 
1.2. DNA STRUCTURE 
1.2.1. Primary Structure 
The primary structure of DNA consists of a chain of 2'-deoxy-D - ribose 
rings linked by 3'-5' phosphodiesters with each of the sugars having a base 
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Fig.1.1 Primary Structure of DNA 
There are four different bases in DNA, all are heterocycles and are divided 
into the substituted purines, guanine and adenine, and the substituted 
pyrimidines, thymine and cytosine. The structure of RNA is similar to DNA, the 
differences being the occurrence of uracil in place of thvmine, and the sugar to 
which the bases are attached being D-ribose as opposed to 2'-deoxy-D-ribose 






Fig.1.2 Uridine, an RNA Nucleoside 
1.2.2. Secondary Structure 
The presence on three of the bases, adenine, guanine and cytosine, of 
exocyclic amino functions having the potential to form hydrogen-bonds make 
oligonucleotides soluble in aqueous rather than organic solvents. The property 
of hydrogen-bonding is also very important in the formation of the secondary 
structure of DNA where base pairs are formed between adenine and thymine, 
and between guanine and cytosine, by the formation of two and three 
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Fig.1.3 Base Pairing in DNA 
The natural form of DNA is an antiparallel duplex held together by 
hydrogen-bonds, fig.1.4. but unwanted secondary structures can 
	also 	occur 
such as 	hairpin loops, in which 	one part of the 
strand hydrogen-bonds to 
another part of the strand containing the complementary sequence of bases, 
see fig.1.5. 









Fig.1.5 A Hairpin Loop in DNA 
5 
1.3. USES OF SYNTHETIC DNA AND RNA 
1.3.1. Introduction 
When chemists first gained the knowledge and ability to make synthetic 
oligonucleotideS it was little realised what effect the availability of such 
compounds would have on the study of genetics and molecular biology. 
During the last twenty years such synthetic DNA and RNA has found a diverse, 
and ever increasing, variety of uses. 
One of the first problems it was instrumental in solving was the genetic 
code 10  relating the order of bases along the DNA to the primary structure of 
the protein produced. From this researchers in molecular biology began to 
explore the function of various sequences in genes including regulatory 
signals,8 specific probes 
11 and linkers, 12 and, with the information gained from 
such studies, used chemically synthesized oligodeoxyribOflucleOtide segments 
in the synthesis of a double stranded DNA corresponding to a gene. 
13,14 
Today recombinant DNA technology, in which a fragment of synthetic DNA 
is incorporated into a natural DNA molecule, is probably the major area of 
application for chemically synthesized DNA. By employing this technique it is 
possible to make Escherichia co/i produce a variety of proteins, including 
medically important ones such as insulin 
15 and human growth hormone. 6" 7 
Another application of synthetic DNA is in site-directed mutageneSiS in 
which a duplex is constructed containing either a mutation in both strands or 
in just one strand, the latter resulting in a base-pair mis-match. The mutant 
DNA is then inserted into a gene whose natural sequence has been 
deleted. 18,19,20 
In order to obtain the crystal structure of DNA relatively large amounts of 
Me 
the sequence to be studied are required. Isolation and purification from natural 
sources can be excessively time consuming and yields only small quantities of 
DNA so the use of synthetic material has proved invaluable in this area. 
21 
1.3.2. Recombinant DNA Technology 
The use of micro-organisms is not a recent innovation. Such organisms 
have been used by man for a long time in the production of food, e.g cheese, 
bread, beer and wine, but until recently such applications were restricted to the 
use of certain naturally occurring organisms. With the advent of recombinant 
DNA technology it is possible to genetically alter these, and other organisms, 
to produce a vast array of useful products, particularly in the areas of 
agriculture and medicine. 
The key to the utilisation of this technology is the cloning of DNA which 
occurs in three stages. First it is necessary to construct a molecule containing 
the recombinant DNA, i.e. the DNA to be copied. It is at this stage that the 
synthetic DNA is joined to a DNA vector which will then replicate autonomously 
in the chosen host cell. Suitable vectors for this application include plasmids, 
naturally occurring circles of DNA, and X phage, a virus, both of which will 
replicate in Escherichia co/i In the second stage the recombinant DNA must be 
introduced into the host cell either by cell takeup from the medium or by the 
use of infected virus particles assembled to harbour the recombinant DNA 
molecule. The last stage is the selection of cells which contain the 
recombinant DNA. Such cells may be identified if the plasmid vector confers 
antibiotic resistance, or alternatively, individual cells can be cultivated and then 
identified using a Southern blot, in which labelled, complementary probes 
determine the presence, or otherwise, of the required recombinant DNA. 
With the possibility of synthesizing and cloning genes there is great scope 
7 
for the production of proteins, which perform essential roles in the regulation 
of the metabolic processes, but which occur in such low concentrations in the 
body that isolation cannot provide enough material for the medical applications 
in which they are involved. Cloning can provide relatively large amounts of 
pure protein. 
The first synthesis of a functional polypeptide product from a gene of 
chemically synthesized origin was performed by K. ltakura et al.22 in 1977 with 
the production of the hormone Somatostatin. This hormone, containing 14 
amino acid residues, inhibits the secretion of other hormones including insulin 
and human growth hormone. 
The protein insulin is involved in the regulation of glucose levels in the 
blood and is normally produced in the pancreas, but in the instance of diabetes 
mellitus there is a deficiency of this hormone. In some cases it is necessary to 
treat the sufferer with injections of insulin which until recently have been 
derived from bovine or porcine pancreas. Since 1982, when the insulin gene 
was synthesized and inserted into Escher/chia co/i 1  human insulin has been 
produced on a large scale for the treatment of diabetes. 
Another important hormone to be produced in this way is human growth 
hormone, a 191 amino acid protein, a deficiency of which leads to dwarfism. 
This can be treated by replacement therapy. The usual source for such 
treatment has been human cadavers, but the alternative source now provided 
by cloning the recombinant DNA in Escherichia coI, 617  has meant that demand 
may be more readily met. 
For the control of pain the body produces peptides called endorphins which 
are non-addictive alternatives to opiates. Human -endorphin, a peptide of 31 
amino acid residues, has been successfully produced using a synthetic gene 
implanted into Escherichia co/i23  The bacteria selectively secrete the peptide 
into the culture medium from which it is then isolated. 
The action of proteins as hormones is only one function of this versatile 
group of compounds, which can also act as enzymes, catalysing most chemical 
reactions in the body. Many thousands of enzymes exist naturally but few are 
currently of industrial importance, those that are being mainly used in food 
production or for medical treatments. In order to increase the potential of 
enzymes it is possible to either construct them with synthetic genetic material, 
or modify existing enzymes by site-directed mutagenesis, both by using 
recombinant DNA methods. 
Protein engineering has benefitted greatly from the improved methods of 
making synthetic DNA. Molecular biologists are now able to alter precisely a 
protein by changing one or more of the bases in the DNA which codes for that 
particular protein. This technology allows the structure of natural and 
synthetically engineered enzymes and other proteins to be studied in more 
detail. 
Recombinant DNA technology also uses sections of DNA, e.g a gene, from 
one cell for transplant into another type of cell using a suitable vector. This 
method does not use synthetic DNA for the implant but may make use of such 
a compound in the process of cloning the DNA. 
1.3.3. Cloning DNA 
The cloning of DNA, whether it is of natural or synthetic origin, utilises 
various fragments of synthetic DNA which perform different functions in the 
process. 
One such function is that of primer in which a small piece of DNA or RNA 
of complementary sequence binds to the single stranded DNA to be copied and 
allows DNA polymerase to replicate the remainder of the strand A synthetic 
primer has been used in the production of interferonS, 24  compounds possessing 
both antiviral and anticancer properties. 
Probes are employed widely in molecular biology as aids to establishing the 
success of recombinant DNA incorporation. The probes, sequences of DNA 
complementary to the sequence of interest, are often labelled with 32P so their 
progress can be monitored. Synthetic oligonucleotideS have been used as 
specific probes in the determination of yeast iso-1-cytochrome c in mRNA 
structure and function. 11 
Recognition sites are sequences of DNA which are "recognised" by a 
specific enzyme which, when bonded, will act according to its function. 8 
Restriction enzymes are an example of this. They recognise a specific 
sequence in the DNA and then cleave the two strands leaving either 
"blunt-ends", where both strands have been severed at the same place, or 
"sticky-ends", where one cut is several nucleotides further along the duplex 
than the other. The latter process can be exploited by using a DNA ligase to 
join a piece of synthetic DNA duplex to these ends which can itself contain a 
recognition site, thus allowing recognition sites to be placed at the desired 
position in the oligonucleotide duplex. 
12 
13.4. Site-directed Mutagenesis 
Synthetic oligodeoxyribofluCleOtides containing one or more mis-matched 
bases may still bind to DNA containing a complementary site. Where the 
mis-matched DNA sequence is used as a primer and then cloned it is possible 
to produce DNA with any desired mutation at any site. It is also possible to 
construct deletions, natural sequences with one or more nucleotides removed, 
10 
by designing an oligonucleotide to bind to the sequences on each side of the 
sequence to be deleted, thus producing a hairpin loop in the natural DNA chain. 
The mis-matched sequence then acts as a primer for the synthesis of the DNA 
containing the deletion. 1819 
1.3.5. Molecular Structure of Synthetic DNA 
In order to study the molecular structure of DNA it is necessary to grow 
crystals, which requires sufficiently pure DNA in amounts not easily obtainable 
from natural sources. For this application self-complementary strands of DNA 
are often used and the crystals analysed using X-ray diffraction. Most natural 
DNA is thought to be in the right handed helical B form but studies on 
synthetic oligodeoxyri bon ucleOtide sequences have shown that they can exist 
in other forms including the left-handed helical B form 
21 and the left-handed 
zigzag or Z form. 25 
By measuring the melting temperature of self-complementary strands of 
DNA the effect of base pair mis-matches and non-natural bases on the stability 
of the duplex can be determined. 
11 
1.4. CHEMICAL SYNTHESIS 
1.4.1. Introduction 
The methods for the chemical synthesis of DNA have advanced greatly 
since Todd' first made a dinucleotide in the 1950s. These advances have 
resulted in the progression from a coupling reaction using a phosphodieSter 
reagent in solution phase to using phosphotrieSter - , and phosphite-trieSter 
reagents on solid phase today. 
The aim of all these various types of coupling procedure is to join a 
5'-hvdrOXyl on one nucleoside with a 3'-hydroxyl on another nucleoside via a 
bridging phosphate function, thus producing the sugar-phosphate chain which 
forms the backbone of the DNA structure. 
In the first attempts to produce such a linkage the obvious method to use 
seemed to be the reaction of a nucleotide containing an unprotected phosphate 
attached to the 5'-hydroxyl with another nucleotide containing a free 
3'-hydroxyl group. This method did in fact produce some product but was time 
consuming and gave low yields. Development of the method led to the use of 
a protecting group on the phosphate giving the phosphotrieSter method, which, 
after extensive modification in order to reduce coupling times, is still used 
widely today. 
It was not until the 1970's that Letsinger 9  saw the possibility of using a 
phosphite intermediate which would couple much more quickly than the 
corresponding phosphate, and could then be readily oxidised to the phosphate 
using iodine and water. This approach has also undergone a lot of 
development and is now used routinely in conjunction with automated solid 
phase synthesis methods to produce, on a small scale, synthetic 
oligonucleotideS containing 30 to 40 bases in a few hours. 
12 
1.4.2. The Phosphodiester Method 
This was the first general method to be used in the synthesis of di- and 
polynucleotides. Khorana et al. used and developed the phosphodiester 
approach for many years from 1958 when they used it to obtain dinucleotides 
containing the C 5 '-C3' linkage 
26  to the 1970's when they synthesized the genes 
for an alanine tRNA 13 and for a tyrosine suppressor tRNA. 2 
The synthesis of a dinucleotide using this method makes use of 
commercially available nucleotides with one having a protecting group on the 
5'-hydroxyl and the 3'-hydroxyl free to react, 1, and the other having the 
3'-hydroxyl protected and a phosphate group on the 5'-hydroxyl 2. Both the 
nucleotides require suitable protection on their bases. The condensation uses 
either dicyclohexylcarbodiiflhide (DCCI) or triisopropylbenzenesulPhoflYl chloride 
(TPSCI) and gives a protected dinucleotide 3 from which the protecting groups 
may then be removed, as shown in fig.1.6. Such a dinucleotide could be 
extended by further condensation reactions if the appropriate 5'-phosphate 
derivative is obtained. 
OH 
I 	 I 	 I 
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Fig.1.6 The Phosphodiester Approach 
This method of synthesis has several drawbacks including long reaction 
times for the condensations and low yields as chain length increases. 
Purification is also a long process including anion exchange chromatography 
13 
and without improvements in this area synthesizing oligonucleotides of more 
than a few bases would not be practical. 
1.4.3. The Phosphotriester Method 
The problems associated with the phosphodiester approach mainly derive 
from the fact that throughout the synthesis the phosphate linkages are 
unprotected and this can give rise to several side-reactions. Firstly, the 
phosphodiester functions are nucleophilic and therefore can cause both 
side-reactions during the rest of the synthesis and cleavage of internucleotide 
linkages. Both these possibilites can significantly reduce the yield of the 
reaction. The poor solubility of such compounds in organic solvents limits the 
number of processes, such as silica chromatography, which may be used for 
purification and necessitates the use of techniques involving aqueous solutions. 
These latter methods of purification such as ion-exchange chromatography 
involving the use of buffers may result in the loss of acid or base sensitive 
protecting groups from elsewhere in the oligonucleotide. For these reasons it 
was recognised that there was a need for a protecting group on the 
phosphodieSter linkage and this led to the development of the phosphOtriester 
method. 27 
This approach was first used by Todd et 81.1 in 1955 when he reported the 
synthesis of the first oligonucleOtide but subsequent researchers, including 
Khorana et ai.26 , made use of the apparently simpler phosphodiester method for 
many years. The scheme used by Todd is shown in fig.1.7. 
14 
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Fig.1.7 Todd's Phosphotriester Approach. 
In this synthesis the 5'-acetyl-3'-benzylPhOSPhOChlOridate nucleotide 4 was 
reacted with 3'-acetylthymidine 5 to give the fully protected dinucleotide 	6. 
This 	approach 	then 	remained unused 	until 1965 when 	Letsinger 	et 	al.5 ' 28 
examined the B-cyanoethyl group to protect the internucleotide linkages during 
oligonucleotide synthesis using a polymer support. As this method of 
synthesis could only be used on a small scale Letsinger 29 ' 30 then began to look 
at solution phase synthesis using the phosphotriester approach. Fig.1.8 shows 
the step by step synthesis of a dinucleotide using Letsinger's solution phase 
triester method with a -cyanoethyl protecting group on the phosphate. 
The synthesis starts with a 5'-protected thymidine derivative 1 which is 
reacted with -cyanoethyl phosphate in the presence of mesitylenesulphonyl 
chloride to give the phosphodiester 7. This compound is then reacted with 
unprotected thymidine in the presence of 2,4,6-triisopropylbeflZenesUlphOflvl 
chloride to give the fully protected dinucleotide 8. The protecting groups are 
removed with aqueous acetic acid followed by ammonium hydroxide to yield a 
thymidine dimer. Alternatively, by retaining the 6-cyanoethyl group on the 
phosphate it is possible to add further nucleotides by repeating these reactions 
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Fig.1.8 Letsinger's Phosphotriester Approach 
The above synthesis used unprotected thymidine with which to couple the 
nucleotide, which as well as giving the desired 	3'-5' 	
intern ucleotidic linkage 
also produces the unwanted 3'-3' linkage. Letsinger et 8!31 sought to 
remedy 
this by using the 	-benzoylprOPiOflVl group to protect the 3'-position of 
thymidine. This group can be removed by hydrazine-hydrate 
which will not 
affect 	the other 	protecting groups 	on the 	molecule. 	
The synthesis of 
oligodeoxyribonuCleotides containing bases other than thymidine, and the block 
synthesis of thymidine oligonucleOtides using this method was also reported by 
Letsinger et al.32 
16 
Another protecting group was developed for use in phosptlotrieSter 
synthesis by Eckstein et aI 3 ' 34 
 in 1967. They investigated the 
2,2,2-trichloroethyl group in the protection of internucleotide linkages and 
prepared thymidine dimers, trimers, and tetramers using this protection, as 
shown in Fig.1.9. 
HOCo 
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Fig.1.9 Eckstein's Phosphotriester Approach 
5'-Tritylthymidifle 	11 	was 	reacted 	with 	
2,2,2-trichiorOethYl - 
phosphodiChiOridate 	to 	give 
phosphochlOridate 12 as the main product and very little of the disubstituted 
phosphotrieSter, 	j (5_tr ity lthym idi fle_3')triS(2_Chl01oettVl) phosphate. 
	The 
phosphorylated nucleoside was reacted with 3'-acetylthymidifle 5 producing a 
fully protected thymidine dimer 13, which on treatment with 80% acetic acid to 
remove the trityl protection s  gave a dimer which could be fully deprotected. 
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of compound 5 will give a trinucleotide. The tetramer was obtained by block 
synthesis of two dimers and all the oligonucleotides were finally deprotected 
with concentrated aqueous ammonia to remove the acetyl groups, and with 
zinc dust in 80% acetic acid at room temperature to remove the trichioroethyl 
groups. In 1969 Eckstein et al.3  also reported using this group in the synthesis 
of short cytidine and adenosine oIiodeoxyribonucIeOtides. 
The next proposal of a protecting group came from Reese et a!4 when the 
use of the phenyl group was suggested. The synthetic pathway to the dimer 
was similar to Eckstein's and can be seen in fig.1.10. 
Fig.1.10 Reese's Phosphotriester Approach 
	
In 	this 	synthetic 	strategy 	Reese 	used 	the 	acid 	labile 
methoxytetrahydropyraflyl group 35 instead of the previously favoured trityl 
group 	to 	protect 	the 	5'-hydroxyl 
	
function. 	The 
5'_methoxytetrahydropyranylthlmidifle 	15 	was 	reacted 	with 	phenyl 
18 
phosphorOdiChlOridate in the presence of 2,6-lutidine to give a phosphorylated 
nucleoside 16 to which 3'-acetylthymidifle 5 and 2,6-lutidine were added. The 
resulting dimer 17 was deprotected using a O.1M NaOH solution for 5 mm. to 
remove the acetyl group, and then a formic acid solution to remove the 
methoxytetrahydrOPVraflyl group. The phosphate protecting group was 
removed by treatment with O.1M NaOH( aq. ) for 6 hours to yield a protected 
thymidmne dimer 18. Van Boom et a/36  also used this aryl protecting group on 
 
internucleotide linkages to make oligoribonucleOtideS including UpU and 
UpUpU. 
The above method has a potential problem in that the alkaline hydrolysis of 
the phenyl protected oligonucleotides may proceed with some cleavage of the 
internucleotide linkage. The incorporation of electron-withdrawing substituentS 
onto the phenyl ring can reduce this problem 27 . 
All of the methods for phosphotrieSter synthesis so far mentioned are 
generally "one-pot" reactions and so any nucleoside which has not been 
phosphorylated may subsequently react to give 3'-3' and 5'-5' linkages when 
the next nucleoside is added. The products of these side-reactions can be 
difficult to separate from the desired product and so a method which 
eliminates the formation of such compounds would be an improvement in the 
phosphotriester approach, enabling oligonucleotides of greater purity and 
higher yield to be produced. 
Cramer et a/6  reported such a method in 1973 when they used both the 
2,2,2-trichloroethyl and the -canoethyl group to protect the phosphate group. 
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Fig.1.11 Cramer's Phosphotriester Approach 
The 	synthesis starts 	with 	a. nucleoside protected 	with the 	acid labile 
dimethoxytrityl group 	19 and phosphorylates this using 
2,2,2-trichloroethylphOSphOdiimidaZOlidate and then removes the remaining 
imidazole with triethylamine and water to afford 20. The nucleotide is 
condensed with -cyanoethanol using triisopropylbenzeneSulPhOnyl chloride to 
give a fully protected triester 21, which is then treated with dilute aqueous 
20 
trifluoroacetic acid to remove the dimethoxytrityl group to form 22. 
Compounds 20 and 22 are reacted with the condensing agent, 
triisopropylbenzenesulPhoflvl chloride, to give the protected dimer 23 which can 
be deprotected using trifluoroacetic acid to remove the dimethoxvtrityl group, 
dilute sodium hydroxide to remove the -cyanoethyl group, and Cu/Zn then 
ammonia to remove the 2,2,2-trichloroethvl group, to give 24. Cramer prepared 
a series of di-, tn-, and tetraoligonucleotides using various combinations of 
bases with benzoyl protection on deoxycvtidine and deoxyadenosine,anld acetyl 
protection on deoxyguanosine exocyclic amino functions. 
Narang et al.7  also worked on developing a modified triester method using 
phenyl, o-chlorophenyl, and p-methylttiiophenyl groups instead of the 
2,2,2-trichloroethyl groups used by Cramer. The scheme can be seen in 
fig.1.12. Starting from thymidine, protected on the 5'-hydroxyl function by 
monomethoxytrityl 1, Narang produced the phosphitylated nucleoside 26 by 
addition of the suitably substituted phosphate 25 in the presence of 
triisopropylbenzenesulPhoyl chloride (TPSCI). Compounds 26 and 28 were 
condensed with tniisopropylbenzeneSulPhOflic acid and then treatment with 
0.1M sodium hydroxide at 0 °C for 30 seconds removed the -cyanoethyl group 
to afford 29. At this stage further additions are possible by a repetition of the 
cycle or the synthesis can be terminated by the addition of 3'-acetylthymidine 
5 to give a trinucleotide 30, from which the protecting groups can be removed 
with acetic acid, concentrated ammonia, and lastly 0.1M sodium hydroxide at 
room temperature. The p-(methylthio)pheflyl group was used in the synthesis 
of larger oligonucleotides and is cleaved by oxidation with N-chlorosuccinimide 
then treatment with alkali. Using this method Narang synthesized 
oligodeoxyni bon ucleotides up to fifteen bases long. 
21 
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Ftg.1.12 Narang's Phosphotriester Approach 
The "modified" phosphotriester method was developed by Narang et a137 
22 
when, in 1975, he described the use of arylsuiphonyltriazoles as condensing 
agents and also bis(triazolyl)-p-ChlOrOPheflYl phosphate as a phosphorylating 
agent. The synthesis of the phosphorylated nucleoside can be seen in fig-1-13. 
N 	 _____ 
	
N 	 B CN DMTrO-C 
H 
o-P=O cI_ - 	
I 	 OH (19) 
11 
0 	 +TEA 
N NL
I (31) 	 N 
(32) 
B 	 B 
DMTrO -CH7 	 DMTrO-C 
0 	 0 
I NCCH2CH20H 
O-.P=O 	 -. 	ci 	O-P=O ci -K - 
I - 	I 
ocH2cH2cN 	 N 
(34) 	 (33) 	II N 
Fig.1.13 Synthesis of a Nucleotide for Narang's Phosphotriester Approach 
The phosphorylating agent 32 was formed by the addition of 1,2,4-triazole 
to p-chlorophenvl phosphorodichiOridate 31 and the subsequent reaction with a 
5'-dimethoxytrityl nucleoside 19 gave a phosphorylated nucleoside 33. 
Reaction of 33 with -cyanoethanol gave the triester 34 which could 
presumably be deprotected with either sodium hydroxide or triethylamine to 
commence the synthesis of an oligonucleotide as in fig.1.14. The diester 35 is 
coupled 	to a 	3'-acetyl nucleoside 	36 	using 	one 	of 	two new 	proposed 
condensing agents, p-nitrobenzenesulphonyltriazOle (p-NBST) 	or 
23 
mesitylenesuiphonyltriazole (MST) to produce a protected dimer 37. The 
5'-protecting group can be removed with 80% acetic acid and another cycle of 
addition repeated if desired and when the synthesis is complete the protecting 
groups can be removed using sodium hydroxide solution. Using block 
synthesis in conjunction with this approach Narang produced a . hexamer 
containing guanosine, cytosine, and adenosine residues, and claimed that these 
new condensing agents increased yields and reduced sulphonation. 
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Fig.1.14 Narang's Phosphotriester Approach using Novel Condensing Agents. 
The next development came in the form of arylsuiphonyltetrazoleS which 
Narang et al.38 proposed in 1977. These were found to be more reactive than 
triazoles and triisopropylbenzenesulphonyl chloride. Narang et al. synthesized 
24 
beteQ—, 2,4,6-trimethylPe e.-, and 2,4,6-triisopropylbe i,- suiphonyltetrazoles, 
as in fig.1.15, and found that there was a correlation between the substitution 
of the benzene ring and the rate of condensation of nucleotides, the phenyl 
being more reactive than the 2,4,6-trim ethyl phenyl which was more reactive 
than the 2,4,6-triisopropylphenyl derivative. 
R 1 
0 	 ____ 
11 N 	N 
R2  _-c___s_- ci 	+ 	 II 11 	 N 
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BenzenesulphoflyltetraZOle R 1 =R 2 =R 3 H 
MesitylenesulphOflyltetraZOle R 1 =R 2 R3 =CH 3 
TriisopropylsuiphOflyltetraZOie 11 1 =11 2 =R 3 Pr2 
Fig.1.15 Synthesis of 
Aryl s ul p lion y ltetra z ole S. 
Another condensing agent, 1 _mesityienesulphonyl-3flitrO - 1,2,4-triazole 41 
(MSNT), fig.1.16, was reported by Reese et al.39 in 1978 when he was 





Reagents previously used for this purpose such as sodium hydroxide cause a 
significant amount of internucleotide cleavage. The conjugate base of 
25 
syn-4--nitrobeflZaldOXime was shown to be a better nucleophile for this 
purpose, causing much less cleavage of the internucleotide bonds. 40 
A new class of condensing agent, which gave stereospecific products was 
announced by Ohtsuka 	et aI 	who used 	
1-mesitylenesuiphOflyl 
5-(pyridin-2-yI)tetrazOlide (MSPy) and 1 _(2,4,6_triisoprOPVlbeflZefleSUIPh0flV 
5-(pyridin-2-yl)tetraZOlide 	(TPSPy) 	42, 	fig.1 .17, 	to 	
condense 
5_dimethoxytritylthYmidifle_3_0_(2_c0r0PhVt)Ph0t1ate with 
3'-O-benzylthymidifle. This reaction gave a single product whereas the same 
reaction using MSNT as a condensing agent gave two diastereoisOmerS, the 




R 0 	N 
o 	NN 
R (42) 
1-MesityleneSuiPhOnVi 5-(pyridin-2-vI)tetraZOle RCH 3 
l_(2,4,6_TriisopropylbenZeneSUlPhOnV1)_5_(PVi2_VI)tetz0h 	R='Pr 
Fig.1 .17 1 -ArylsuiphOflyl 5-(pyridin-2-Yl)tetraZOlideS. 
The -elimination mechanism used to remove the -cyanoethyl group was 
also made use of by Pfleiderer et a/ 23  when the 2-(p-nitrophenyl)ethVl (NPE) 
was proposed as a phosphate protecting group for the phosphotrieSter 
approach. The synthetic strategy is outlined in fig.1.18. 
26 
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Fig.1.1 8 Pfleiderer's Phosphotriester Approach 
DiphenylphosphOflate 43 was trarisesterified with 2-(p-nitrophenyl)ethaf101 44 
then converted to bis(p_nitrophenylethyl)PhOSPhOrOmOflOchloridate 45 with 
thionyl 	chloride. This 	was 	reacted with 	thymidine 	to give 	the 
5'-phosphorylated nucleoside 46, 	 to which 
2,5_dichlorophenylphosphOrOdiChlOridate and 1,2,4-triazole, and subsequently 
2-(p-nitrophenyl)ethanOl, 	were 	 added 	to 	form 
5'- b/flitropheflylethyl)phOSphOrVlthymidine_3'_(2,50r0PiV 




to give a diester 48 to which another nucleotide could be linked. At the end of 
the synthesis the 2-(p-nitropheflyl)ethyl group can be removed using 
1,5-diazabicyclO[5.4.0]UfldeC -5efle (OBU) to give the unprotected 
oligonucleotide, and using this method Pfleiderer produced a trimer. This 
method has the advantage that a 3'- or 5'- terminal phosphate group can be 
incorporated into the final product to give a oligonucleotide with the same 
number of phosphate ester groups as base-residues, instead of the structures 
containing one less that result from the usual methods, but Pfleiderer 44 ' 45 also 
showed that the 2-(p-nitrophenyl)ethvl group could be used as a phosphate 
protecting group with a trityl group on the 5'-hydroxyl and extending the 
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R=C 6 H 4CI 
R'=R"=Protected nucleoside 
ArS02CITSPCI or MSCI 
X=C1 or ARS020 
Fig.1.19 The Use of N-MethylimidaZOle with an Arylsuiphoflyl Chloride. 
In 1982 \J.A.Efimov et ai46 introduced the use of N-methylimidaZole with 
arylsuiphonyl chlorides to produce highly efficient condensing agents for the 
formation of phosphotriester internucleotide linkages. Yields and the rate of 
28 
condensation were both improved by this reagent which forms an intermediate 
N-methylimidazolium cation 51 possessing a high phosphorylating capability, 
see fig.1.19. 
Sproat and Bannworth 47  then suggested using 1-methylimidazOle with 
1_mesitylenesulphonyl-3-nitrO - 1,2,4-triazole (MSNT) which resulted in coupling 
times being reduced to times comparable to those observed by Efimov 46 but 
with the advantage that MSNT is easier to handle than mesitylenesulphonyl 
chloride. Another group of rate accelerating reagents proposed by Efimov at 
a!48  were oxygen-nucleophilic catalysts, in particular 4-substituted pyridine 
N-oxides having electron donating substituents, 54, fig.1.20, which are used in 
conjunction with the arylsuiphonyl chlorides previously mentioned by Efimov et 
a!46 	 x 
X=-N(CH3)2, -OCH3, -OCH 2CH3, -OCH 2C6H5. 	
0 
Fig.1.20 4-Substituted pyridine N-oxides 
The mechanism of phosphotriester bond formation in the presence of 
0-nucleophilic catalysts is not fully understood but may be via the formation of 
the N-phosphoryloxyPyridifliUm salt. The authors also report that the reagent 
reduces modifications of 2-N-acylguafline and thymidine and increases the rate 
of coupling to times comparable with the phosphite approach. The rate of 
condensation also interested Matteucci at 8/ 9 who showed that 
neighbouring-group participation could be used to speed up the coupling 
reaction between nucleotides by using the 1-methyl-2-
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fig. 1.2 1. 
Fig.1 .21 1_Methyl_2_(2_hYdrOXVPheflYl)imz 0 Ie in PhosphotrieSter 
Synthesis 
The 	triethylammofliUm 	salt 	of 	
5'_dimethoxytritylthymidine -3' 
(2-methylimidazOle)PhenYl phosphate 55 was condensed with thymidine 
attached to a silica support via its 3'-hydroxyl function 56, using 
mesitylenesulphonvl chloride and 1-methylimidaZOle as condensing agents, to 
give the protected dimer 57. This protecting group compares favourably with 
those previously used and gives a 5-10 fold rate increase over the 
p-chloropheflVl group. The phosphate triester is deprotected at the end of the 
synthesis using concentrated ammonia at 60 °C for 12 hours. Efirñov 
et a150 
improved the previous method by using their 4-substituted derivatives of 
pyridine N-oxide48  in place of the 1-methyl-2-(2-hydroxyphenyl)imidazole as 
phosphate protecting groups and, in particular the 1_oxido-4-alkoxy -2- PiCOIYI 
derivative 58, see fig.1.22, showed an increase in the rate of condensation, 










o 	(58) 	° 
Fig.1.22 Use of the 1-Oxido-4-alkOXV-2-PicOlYl Group 
The phosphotriester method of oligonucleotide synthesis has thus 
progressed from a technique requiring 36 hours for a coupling in solution  to 
one needing less than 2 mm. on solid phase. 
50 With the development of more 
effective phosphate protecting groups and condensing agents it has reached a 
stage where the synthesis of a 20-residue oligonucleotide can be performed in 
8 hours. 51 
14.4. The Phosphite-triester Method 
The phosphotriester method has been improved significantly in terms of its 
yield and rate of condensation in recent years but in the mid 1970s this 
approach still involved a lengthy coupling step. In 1975 Letsinger et al.9 
proposed a new method for oligonucleotide synthesis in an attempt to reduce 
greatly the time necessary for each nucleotide addition. The new method was 
based on the observation that phosphorOchlOriditeS react rapidly with alcohols 
to give phosphite-trieSterS and that these can be easily oxidised to phosphates 
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Fig.1.23 Letsinger'S Phosphite-triester Approach. 
The product 62 contained a natural 3'-5' internucleotide link and was 
formed by the reaction of 5'_O-phenoxyaCetYl -thymidine 59 with 
o-chlorophenyl phosphorOdichiOridite to give the phosphorylated nucleoside 60. 
This was coupled with 3'_monomethOXytritylthymidine to give the phosphite 
dimer 61 which was oxidised by iodine and water to produce a protected 
thymidine dinucleotide 62. The dimer can be converted to a trimer by cleavage 
of the phenoxyacetiC ester with ammonium hydroxide and a further coupling 
with another nucleotide, but attempts to synthesize trithymidine from the dimer 
resulted in low yields. This is probably caused by the instability of the 
phosphotriester link towards the phosphochlOridite reagent. Other protecting 
groups were considered and the 2,2,2-trichoroethyl group 52 was shown to be 
suitable. The reaction scheme was similar to that found in fig.1.23 except that 
2,2,2-trichloroethyl phosphorChlOridite was used in place of o-chlorophenvl 
32 
phosphorodichloridite and this development made the synthesis of a thyrnidine 
tetranucleotide possible. The coupling step in this method takes 5 mm. and the 
whole reaction cycle for each addition takes less than one hour. This method 
was also shown to be applicable to the synthesis of oligoribonucleotides by 
Ogilvie et aIP3 who made a heptaribonucleotide using the phosphite-triester 
chemistry described above. 
A comparison of phosphate protecting groups for use in oligonucleotide 
synthesis by the dichloridite procedure was made by Ogilvie 
54  in 1980, who 
investigated the 2,2,2-trichloroethyl, 2,2,2-tribromoethyl, benzyl, methyl, 
B-cyanoethyl, p-chlorophenyl, 2-phenylethyl, and 2-p-nitrophenylethyl groups 
and found that the trichioroethyl, methyl and -cyanoethyl groups were the 
most useful, and Matteucci and Caruthers 55 produced several dimers using the 
methyl group, resulting in yields of over 90%. 
One drawback of using dichloride reagents for the condensation reactions is 
that symmetrical, as well as the desired unsymmetrical, products are formed 
and these mixtures can be difficult to separate and also--can re-duc-e—y-i-elds. 
Another problem is the susceptibility to hydrolysis and oxidation of the 
nucleotides, and for this reason reactive intermediates are generally used as 
soon as they are prepared. 
In 1981 Beaucage and Caruthers 
56 proposed a solution to this problem in 
the form of deoxynucleoside phosphoramidites which can be stored as dry, 
stable powders and used for oligonucleotide synthesis as shown in fig.1.24. 
5'-Dimethoxytritylthymidine 63 is reacted with chloro-N,N-dimethyl -
ammnomethoxyphos phi ne to produce a stable phosphorylated nucleoside 64, 
which is activated with 1H-tetrazole 65 and coupled to 3'-O-levulinylthymidine 
giving a phosphite-triester 66. Oxidation of 66 with iodine and water affords 
33 
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Fig.1.24 Phosphoramidites for the Phosphite-triester Approach. 
The N,N-dimethylamiflo phosphoramiditeS, although used in the synthesis of 
oligonucleotides 57 ' 5859  have a variable degree of purity, the major contaminant 
being the hydrolysis product (the deoxynucleoSide phosphonate). They also 
have a variable stability when dissolved in acetonitrile without activation. 
These observations led McBride and Caruthers 60  to investigate other 
deoxynucleOside N , N_dia lkylamiflomethoxyphosPhmes including those 
containing the diisopropylafl'iflo, morpholino, pyrrolidino, and 
2,2,6,6-tetramethylpiperidiflO groups. The phosphitylating agent used for each 
derivative was the chloride, see fig.1.25. The pyrrolidino derivative 68c proved 
to be quite volatile and reactive with atmospheric moisture, the 
34 
2,2,6,6,-tetram ethyl pipe ridiflo derivative 68d was a highly reactive solid, and 
hence was difficult to handle, but the diisopropylamiflO 68a and morpholino 68b 
derivatives were found to be easier to handle, and gave the purer, more stable 
deoxynucleoSide N,N-dialkvaminO phosphoramiditeS which were shown to form 
dimers by reaction with a suitably protected nucleoside after activation with 
tetrazole. 
/-\ 
CI —P—OCH3 	 X -N[CH(CH3)]2 . 	
-N 	0 	
_NJ 
X 	(68) 	 (a) 	 (b) 	 (c) 	 (d) 
Fig.1.25 Various Phosphitylating Agents. 
Adams et al.61  also performed similar experiments when they investigated 
the stability of N,N-diethyl, N-methyl, N-isopropyl, N,N-diisopropyl 
phosphoramidites, concluding that the diisopropyl group conferred the most 
stability. The findings of these investigations provoked interest in the use of 
the N,N-diisopropyl and N-morpholiflO groups for phosphorus protection in the 
synthesis of oligodeoxyribonucleOtides by the phosphite-triester method. 
62,63,64 
The next combination of phosphorus protecting groups to be examined was 
the B-cyanoethyl group with the N,N-dialkylaminO and the N-morpholinO 
groups by Sinha et a!65  in 1983. The phosphorylated nucleosides were 
prepared as shown in fig.1.26. A 5'-dimethoxytrityl protected nucleoside 69 is 
reacted with -cyanoethyl N,N_dialkylaminO/NmOrPhOliflO monochloridite 70 to 
give a phosphorylated nucleoside 71. Of the three phosphorylating agents the 
_ cyanoethy l_N ,N_dii SO p rOPVlamifl0m0n0l0thite gave the best results, and 
along with the B-cVanoethVI-N-morpholinomonochloride, was used to make 
phosphoramidites from which oligodeoxyribonucleOtideS were synthesized. 
66 
The -cyanoethyI group has the advantage over the methyl group that it is 
35 
cleaved in concentrated ammonia at the same time as the base-protecting 
groups, whereas the methyl group requires a second treatment with thiophenol 
in order to obtain a fully deprotected oligonucleotide. 
B 	 B
C1 	
I [(cH3)2CHkNCH2CH, DMTrO 	
+ NCCHCH_O_P_< R2 __ _______ 	
DUTrO 
OH 	(69) 	 o (71) 	I 
R1=R2CH3 	 (70) 
R1=R2(CH3)2CH 	
NccH2cH2—o NN ( 2 
R 1 +R2 (CH2CH2)20 
Fig.1.26 Sinha's Phosphorylated Nucleoside. 
In an attempt to improve the yields of phosphite-trieSter reactions in 
solution phase Pfleiderer et 8l.67  used various cyclic amines in conjunction with 
the methoxy group to prepare thymidine phosphoramiditeS and then thymidine 
dimers with varying yields. He also used the p-nitrophenylethvl group with 
cyclic 	amines to produce a 	phosphitylating 	agent, 	see 
fig.1.27, 	which, when 
reacted with a nucleoside, gave phosphoramiditeS which 
were very stable and 
may possibly have an application in large scale solution synthesis of 
oligodeoxyriboflucleotideS. 
ci 
n=6, 8, or 12. 	
NO2 	 CH2cH20_F_H2)n 	
(72) 
Fig.1.27 Pfleiderer's Phosphitylatiflg Agent. 
Other substituents have been suggested as a replacement for the methyl 
group, see fig.1.28, and these include the 2_cyano-1,1-dimethvlethvl group 
68 73 
which can be removed under mildly basic conditions and the o-chloropheflVl 
36 
group 69 74, the latter giving a much more stable phosphoramidite than the 
methyl group produces and was activated with N-methylaniline trifluoroacetate 







<c5 c1 I f\ 0-P-N 	0 (74) 
Fig-1.28 Phosphitylating Agents. 
In 1979 Dahl 70 made a study of the rates of reaction of phosphoramiditeS 
with various substituentS on the phosphorus and found that N-substituents 
showed NEt 2 >N'Pr2 >N(CH 2CH2)20>NMePI1 and 0-substituents varied as 
Me>CH2CH2CN>CHMeCH2CN>CMe2CH2CN>>C6H4CI. This is as expected 
from inductive and steric effects. 
A slightly different approach to the phosphoramidite method was proposed 
by Uznanski et a!71  who made 5'-0-dimethoxytritYlflUCleOside 
3'_0-phosphordimOrPhOliditeS 76 from 5'-O-dimethoxytritYlflUCleOSide 69 and 
chlorodimorphOliflOPhoSPhifle 75, see fig.1.29. The phosphoramidite 76 can be 
coupled to a polymer attached nucleoside using tetrazole to give a dimer 77. 
Subsequently the amidite P-N bond is cleaved by mild acid hydrolysis to afford 
78. The 5'-hydroxyl is deprotected with dichloroacetic acid and then further 
nucleotides can be added. The oxidation is performed at the end of the 
synthesis, instead of at every step, using iodine and water. 
37 
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Fig.1 .29 Uznanski's Phosphoramidite Method. 
A recent development in phosphite-triester chemistry is the use of the 
1,1,1,3,3,3-hexafluOrO2PrOPVl group by Takaku et al?' who found that the 
phosphitylating agent 79 could be distilled without thermal decomposition, see 
fig.1 .30. 
38 



























Fig.1.30 Takaka's Phosphoramidite Method. 
The 	phosphitylating 	agent 	79 	was 	reacted 	with 	
a 
5'_O-dimethoxytritylnUCleOSide by activation with diisopropylammOniUm 
tetrazolide to give the phosphoramidite 80 which is then reacted in the usual 
way with a 3'-protected nucleoside and tetrazole to form a protected dimer 81. 
The phosphate protecting group is removed at the end of synthesis by 
treatment with oximate. The authors later refined this method to use 3'- [bis 
(1,1,1,3,3,3_hexafluorO-2-Pr0PVI)Ph0SPh1teS]73 as starting materials and 
N-methylimidazOle to couple them to 3'-protected nucleosides. 
The phosphite-triester method offers the adyantage over the 
phosphotriester approach of fast coupling reactions but also involves the use 
39 
of relatively unstable starting materials and during synthesis reactive 
intermediates are used giving scope for side-reactions to occur. 
1.4.5. The H-Phosphonate Approach 
In the two methods previously mentioned, different strategies for the 
formation of internucleotide bonds exist. In the case of the phosphotrieSter 
method the starting nucleotide must be activated by a condensing agent and in 
the phosphite-triester approach protonatiOn of the starting material must occur 
to commence the synthesis and hence this method requires anhydrous 
conditions. 
An attempt to combine the advantages of both the phosphOtriester 
approach, with its stable nucleotides, and the phosphitetriester approach, with 
its speed of reaction, the H-phosphOflate method was developed and has been 
used to synthesize oligodeoxyribOnuCleotides74. An example of this approach 
to DNA synthesis can be seen in fig.1.31. 
A 5'_O_dimethOxYtritYlflucleoside 3'-H phosphOflate 82 was coupled to a 
nucleoside attached to a polymer support 83 
by activation with TPSCI, or 
similar condensing agent to give a dimer 84. This could be extended further by 
acid cleavage of the dimethoxytrityl group and further additions of nucleotides. 
When the synthesis is completed the oligonucleOtide is treated with iodine and 
water to oxidize the phosphite function to a phosphate 85 and the 5'-hydroxyl, 
and base, protection, if any, is removed. 
40 
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- 	 Fig.1.31 The H-Phosphoflate Approach: 
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1.5. PROTECTING GROUPS 
1.5.1. Introduction 
The use of protecting groups in synthetic organic chemistry has increased 
in recent years as the synthesis of larger and more complex molecules has 
been attempted. By the use of a suitable protecting group it is possible to 
block temporarily certain reactive sites on a molecule and so allow others to 
be chemically modified before removing the protecting group. The synthesis of 
oligonucleotideS benefits particularly from the use of protecting groups as the 
multi-stage syntheses involved can give rise to side-reactions at each stage 
and lead to a low overall yield of the desired product. Nucleotides contain 
many potentially reactive sites on the base, sugar and phosphate, and for each 
area specialised protecting groups are required which have the desired degree 
of stability under synthesis conditions and are cleaved under conditions which 
have no detrimental effect on the oligonucleotide. As well as the stability of 
the protecting group it is also vital to take into consideration how each group 
fits into the overall protecting group strategy of the molecule. This is 
especially important where selective deprotectiOn of certain functions in a 
specific order is necessary during the synthesis of the oligonucleotide. 
1.5.2. Sugar hydroxyl protection 
The 2'-deoxyribOse sugar in DNA and ribose in RNA have two and three 
hydroxyl groups respectively, all of which may require protection during 
oligonucleotide synthesis. The 5'-hydroxyl, being a primary alcohol function, is 
more reactive than both the 3' - , and where it occurs, the 2'-hydroxyl functions 
which are both secondary alcohols. Thus the protecting group strategy for 
RNA is more complex than that for DNA because, as well as having one more 
hydroxyl to protect, it has to differentiate between two- secondary alcohols. 
The first groups used for sugar protection were acetyl 1 ' 26  and benzoyl, 75 both 
42 
of which are cleaved by alkaline hydrolysis. 
The 5'-Hydroxyl 
The most popular method of protecting the 5'-hydroxyl group was developed 
by Khorana et al.75  in 1962. Previously he had used the trityl group 86a but 
found that it was too stable in 80% acetic acid and so to make it more labile 
p-methoxy groups were introduced onto the phenyl rings. Each substitution 
increased the rate of hydrolysis by about a factor of ten and it was finally 
decided that the dimethoxytrityl group (DMTr) 86c had the required degree of 
acid lability, fig.1.32. 	 R 
OH OH 
R" (86) 
a, R=R'R"H b, R=R'H,R"OCH3 c, R=H,R'R"OCH3 d, R=R'R"0CH3 
Fig.1.32 The Trityl Protecting Groups 
Base labile protecting groups were also used by Khorana and Weinmanfl 76 
with the investigation of the pivaloyl group (Me 3CC(0) -), and by Letsinger and 
Ogilvie 77 who proposed the p-nitrophenyl group for 5'-protection. Later Ogilvie 
and Letsinger78  introduced the isobutyloxyCarbOnVl group which has 
comparable selectivity for the primary hydroxyl to the pivaloyl group and gives 
better yields than the p-nitrophenyl group. 
Another acid labile group used was the ter?-butyldimethVlSilVl group 
79 
which, although cleaved by 80% acetic acid, could also be selectively removed 
43 
by tetra-n-butylammOfliUm 	fluoride which 	has 	no 	effect 	on trityl 
groups. 
Gaffney et a180 also mention using the 	terD-butyldiphenylSilyl 
group which is 
deprotected in the same way, and can be used on acid sensitive nucleosides. 
A group which can also be removed under neutral conditions is the levulinyl 
(4-oxopentanoyl) group 81 . This has been used for the protection of the 
5'-hydroxyl group in RNA synthesis and can be cleaved with hydrazine in 
pyridine/acetic acid. 
In 	1978 	ChattopadhyaYa 	and 	Reese 
82 
	suggested 	using 	the 
9-phenylxanthefl -9-Vl (pixyl) protecting group, 87, fig.1.33, which is cleaved 
under the same conditions, and with a comparable acid lability to the 
dimethoxytrityl group, but whose deoxynucleOSide derivatives crystallise more 
readily than the dimethoxVtrityl_deOXVflUCleosides, hence facilitating purification. 
208 
o; ==C o 
(87) 
OH 
Fig.1.33 A 5'-O-Pixyl Protected Nucleoside 
Reese et 8i83 introduced the concept of a "protected" protecting group by 
using the 2-dibromomethVlbeflzOvl 
group which is comparatively stable to acid 
and alkali but when oxidised with silver perchlorate to the aldehyde and 
then 
treated with morpholine yields the free nucleoside. 
Pfleiderer et 8!84  used the B-elimination process to cleave the 
2,4_dinitrophenylethOXycarbOnyl group with tertiary amines. This group is very 
sensitive towards bases and is more labile than the B-cyanOethVl group. 
Chattopadhyaya introduced the fl u oren_9_ylmethoXycarbOflvl group 85  88 (Fmoc) 
44 
into DNA synthesis from peptide chemistry. This group is also cleaved by 
B-elimination using a base such as triethylamine or piperidine and its use as a 
5'-protecting group, fig.1.34, was demonstrated by the synthesis of thymidine 
octanucleotide. He also showed that this group was compatible with the 
phosphoramidite approach on solid phase 86  by making an oligonucleotide and 
using 1,8-diazabicyclo[5.4.0]undec 7 efle (DBU) to remove the Fmoc group from 
the hydroxyl function. 
/\ 




Fig.1.34 Fmoc as a 5'-Protecting Group 
The Emoc group has been recently reported by Gait et al.87 to be useful in 
RNA synthesis on solid phase but some side-reactions still cause concern 
when DBU is used for the deprotection. 
The 3'-Hydroxyl 
The most frequently used 3'-hydroxyl protecting group is the base labile acetyl 
group which 	was first used 	by 	Todd 
1, 
	and later 	by 	Khorana 76 , 	for 	DNA 
synthesis. Ogilvie and Letsinger used a base labile group on the 5'-hydroxyl in 
order to introduce the acid labile monomethoxytrityl group onto the 3'-hydroxyl 
function. 
The use of a silyl protecting group for 3'-protection was suggested by 
Ogilvie 	et 8l.88 ' 89 who developed a method for the selective 	silylation 	
of the 
3'-hydroxyl on a ribonucleotide with the TBDMS group. 	Pfleiderer 
et aI.84 also 
used the p-nitrophenylethyl group as a 3'-protecting group. 
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The 2'-Hydroxyl 
The 2'-hydroxyl group occurs only in RNA and must be protected during 
oligoribonucleotide synthesis. The most popular group to use for this purpose 
is the acid labile tetra hydropyranyl (THP) group 89 but this has the 
disadvantage that a mixture of diastereoisomers is formed when it is used to 
protect a nucleoside and so the methoxytetrahydropyraflyl .(MTHP) group 90 








Fig.1.35 The Tetra hydropyranyl Protecting Groups 
The next development of this group occurred when van Boom et al.90 
exchanged the ring oxygen for sulphur to produce a thioether and for an -S0 2- 
group to give a suiphone. These groups are respectively slightly more and 
considerably less acid labile than the MTHP group and are achiral. 
In his search for a protecting group which would be stable to strongly 
acidic conditions but cleaved at a higher pH (2.5) Reese 
91 suggested the 
1 _[(2_chl oro_4_ methyl)phenyll_4_methoxvpiPeridifl_4Y1 (Ctmp) group 91, 
fig.1.36, which was cleaved faster at pH 2.5 than at pH 1.0. 
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Fig.1.36 The Ctmp Protecting Group 
In 1986 Tanaka et a!92  described the use of the o-nitrobenzvl group as a 
2'-protecting group in the solid phase synthesis of oligodeoxyribofluCleOtideS. 
This protection was removed by irradiation with UV light in ammonium formate 
solution. The tert-butyldimethylsilyl (TBDMS) group has been used as a 
2'-protecting group in conjunction with the H-phosphonate approach by 
Stawinski et a!93 . TBAF is used to cleave this group. 
Recently the use of tetrahydrofuraflyl 94  as a more acid labile group than 
tetrahydropyranyl was proposed. Used with a non-acid labile group on the 
5'-hydroxyl this group makes the deprotectiOn of oligonucleotides at the 
2'-hydroxyl easier. 
Multiple Hydroxyl Protection 
Some protecting groups are used to protect more than one hydroxyl function 
and an example of this occurs in the reaction between p-nitrophenyl 
chloroformate and a ribonucleoside which results in the formation of a 
2',3'cyclic carbonate 
77 which can be removed by alkaline hydrolysis. 
A useful method for distinguishing between the 2'- and 3'-hydroxyl on a 
ribose 	was 	developed 	by Markiewicz 95 who used 
the 
47 
tetraisopropyldisiloxafle1,3diVl group to protect the 5'- and 3'-hydroxyls 
leaving the 2'-hydroxyl free to react with another protecting group. The 
protecting group works by first reacting at one end with the 5'-primary 
hydroxyl, from which position the 3'-hydroxyl is in the correct place to react 
intramolecularly with the other end of the reagent. Either the 5'- or 3'- end 
can be selectively cleaved by use of the correct conditions. 
Transient protection is also useful, allowing the base to be protected whilst 
a temporary protecting group prevents any reaction on the sugar. Reagents 
used for this purpose include trimethylchlorosilafle 96  and isobutyric anhydride 
80 
which are cleaved by alkaline hydrolysis when the base protection is 
completed. 
1.5.3. Base Protection 
The heterocyclic bases are permanently protected during DNA synthesis at 
the exocyclic amino function. A number of N-protecting groups have been 
developed for this purpose, the most commonly used ones being anisoyl, 
benzoyl, and isobutyryl 97 . As well as the need to protect these functions it has 
been shown that the O of thymidine and the 0 6 of guanosine may also require 
some protection during oligonucleotide synthesis. Reese et al.98 showed that 
guanosine can be acylated on the 0 6-position with arenesulphonyl chlorides 
and MSNT in pyridine, which implies such side-reactions occur in the synthesis 
of oligonucleotides by the phosphotriester approach in which these reagents 
are used. Similar results were also reported by Hata et a199 ' 100  who showed 
that guanosine is easily phosphorylated, sulphonated, and silylated at the 
06-position. 
Problems may also be encountered when using the phosphitetriester 
method of synthesis. Eadie and Davidson 101  discovered chemical modification 
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of guanosine when using the phosphoramidite approach which generates a 
fluorescent species, possibly from the displacement of an 0 6-phosphite-triester 
by N,N-dimethylaminopyridifle (DMAP). 
Thymidine has also been reported to undergo side-reactions during 
phosphite-triester synthesis. Gao et al.102 showed that N 3-methylation of 
thymidine occurs when the methyl triester of a thymidine oligonucleotide is 
treated with DBU or triethylamine. 
As previously mentioned, the anisoyl, benzoyl, and isobutyryl groups are 
commonly used for the protection of exo-cyclic amino functions. In 1972 
Khorana et al.103  used anisoyl for cytidine 92, benzoyl for adenosine 93, and 
isobutyryl for guanosine 94 protection, fig.1.37, and this protecting group 
strategy has been extensively used since then although some researchers 
97 use 
benzoyl for cytosine instead of anisoyl. These groups are all deprotected using 
concentrated ammonium hydroxide. 
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Fig.1.37 Base Protected Nucleosides 
As the deprotection of the 5'-hydroxyl of the sugar often involves treatment 
with acid the problem of depurination, particularly with deoxyadenosine 
protected with benzoyl, arises. In an effort to prevent this occurring Froeer 
and Matteucci 64 introduced the N 6-di-n-butylformamidine 
(N 6-di-n-butylaminomethylene) group 95 which greatly reduced the 
49 
depurination of the adenosine nucleoside and was cleaved in concentrated 






Fig.1.38 N 6-Di- ,,-butylformamidine Protected Adenosine 
The move towards protecting the 0
4 function of uridine and the 0 6  function 
of guanosine was initiated by Reese et al.104  who suggested using the phenyl 
and the 2,4-dimethvlpheflyl groups to protect uridine, and the 2-riitrophenyl 
group to protect guanosine. Cleavage of these protecting groups with oximate 
ion occurs at the same time as the deprotection of the 2-chiorophenyl group 
from the phosphate function. Later Reese 
105 also used the phenyl group to 
protect the O function of thymidine and removed it in the same way. 
Gaffney and Jones 106 were also concerned with 0 6-guanosine protection 
and investigated the use of the trimethylsilyl group which is cleaved under 
neutral conditions with TBAF, and a variety of substituted ethyl groups which 
are cleaved by B-elimination. Chattopadhyaya' °7  also used the B-elimination 
mechanism to cleave the Fmoc protecting group from the cytosine, adenosine, 
and guanosine exo-cyclic amino functions. When the deprotection was 
performed with ammonia in pyridine it was complete within 40 mm. This is 
much faster than the several hours required by the conventional amino 
protecting groups. 
Despite the problems of selectivity introduced by using acid labile groups 
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on both the base and the 5'-hydroxyl, Hata et a!,108 ' 109  investigated the use of 
the monomethoxytritYl (MMTr) group as an amine protecting group on 
guanosine, adenosine. and cytosine and the use of the dimethoxytrityl (DMTr) 
group on adenosine. Both these groups are deprotected by treatment with 
0.01M HCI but remain intact when the DMTr group on the 5'-hydroxyl is 
deprotected with ZnBr2. Hata et al. 110  elaborated the trityl group by using the 
4,4',4"_tris(anisoylOXy)trityl group to protect the 06 of adenosine and cleaved it 
with dilute alkali via a 1,6-elimination. 
Pfliederer et 8/ i
ll used the p-nitrophenylethyl (NPE) group to protect 
cytidine and adenosine on their amino functions and guanosine, thymidine, and 
uridine on the oxygen of their amide functions. This was an attempt to 
simplify deblocking procedures as the p-nitrophenylethyl group can be 
deprotected with OBU at the same time as it is removed from the phosphate 
triester. Pon et al. 
11
2 also noticed the need for guanosine protection during 
oligonucleotide synthesis and made use of Pfliederer's p-nitrophenvlethyl group 
to prepare an oligodeoxyribOflUCleotide containing 36 base residues. 
Another use for the -cyanoethyl group was suggested by Gaffney et a!80 
who used it as 06- protectionfor guanosine and cleaved it with DBU. 
In 1987 Schulhof et al. 13  noted that although conditions for the synthesis 
of oligonucleotides have become much milder with the introduction of the 
phosphoramidite method, the groups commonly used for base protection 
derived from the ptiosptiodieSter method and involved overnight treatment with 
concentrated ammonium hydroxide at 60 °C to deprotect them. This 
deprotection period was reduced to 4 hours at room temperature by using the 
phenoxyacetyl group on adenosine and guanosine, and isobutyryl on cytidine. 
The success of these protecting groups was illustrated by the synthesis of an 
51 
18 base residue oligodeoxyribonuCleotide. but it was noticed 
114 that the 
phenoxyacetyl group on guanosine is partially replaced by an acetyl group 
during the capping procedure with acetic anhydride. This problem was solved 
by using phenoxyacetic anhydride for capping instead. 
Guanosine has also been protected at the 0 6_ and N 2-positions with the 
(butylthio)carbonyl 5  group which is also cleaved relatively quickly; 3 hours in 
concentrated ammonia and methanol. 
1.5.4. Phosphorus Protection 
The protection of the phosphate function is important during DNA synthesis 
as is illustrated in the improved yields obtained from the phosphotriester 
approach as against the phosphodiester method. The range of groups that 
have been used for phosphorus protectiOn includes phenyl and substituted 
chiorophenyls which are removed with sodium hydroxide. -cyanoethyl which 
is removed with concentrated ammonium hydroxide and p-nitrophenylethyl 
removed by DBU, both utilising the s-elimination process, 2,2,2-trichloroethyl 
removed by zinc/80% acetic acid, and methyl removed by thiophenol. Other 
groups have been investigated but have been found to be of limited use so far. 
A more comprehensive account of phosphorus protecting groups can be found 
in the section on "chemical synthesis". 
1.5.5. Current Protecting Group Strategies 
As the choice of protecting groups available for the sugar, base and 
phosphorus function grows, the number of possible protecting group strategies 
grows with it. When deciding on a particular strategy for protection several 
factors must be considered, the most important one being that all the groups 
are compatible with each other i.e. the deprotection conditions used for one 
group during the synthesis will not cleave or modify other protecting groups. 
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Other considerations 	include the 	availability of the protecting group, and the 
yield in which derivatives can be obtained and their solubility. 	Some of the 
protecting group strategies currently in use are discussed below. 
For the phosphotriester approach, the method described by Gait 
51 uses 
benzoyl protection for the N 4  function of 2'-deoxycytidine, isobutyryl for the N 2 
of 2'-deoxyguanosine, and, in an attempt to eliminate the problem of 
depurination, di-n-butylaminomethylefle for the N 6 of 2'-deoxyadenosine. For 
the 5'-hydroxyl protection either the pixyl or DMTr group can be used, and 
phosphorus protection takes the form of the 2-chiorophenyl group and use of 
the triettiylammonium salt. The condensing agent used is MSNT and the 
coupling reaction is accelerated by the use of 1-methylimidazole. The 
phosphoramidite approach, also described by Gait, 
51 involves the use of the 
same protecting groups on the bases as the phosphotriester method uses and 
DMTr is generally used for 5'-protection. The phosphorus protection uses 
either the methyl, or more recently the -cyanoethvl group, and the 
N,N-diisopropylamino group with tetrazole as the activating agent. 
More recent research 53,116 has indicated that the base labile Fmoc group 
can be used for DNA synthesis on solid phase, thus eliminating the problem of 
depurination as no acid labile groups are used. The Fmoc group is attached to 
the 5'-hydroxyl function and a methyl N,N-diisopropylamino phosphoramidite is 
used. This approach has been extended to RNA synthesis by Gait et al.87 
where the exo-cyclic amino base protection is benzoyl for cytdine and 
adenosine, and isobutyryl for guanosine. The 5'-protecting group is Fmoc and 
the 2'-hydroxyl is protected by the acid labile MTHP, and the 
B-cyanoethvl N,N-diisopropylamino phosphoramidite is used. 
Other combinations which have recently been employed in RNA synthesis 
117 
53 
include using the acid labile groups pixyl and Ctmp, the pixyl being attached to 
the 5'-position and the Ctmp group, being stable under the conditions required 
for removing the pixyl group, protecting the 2'-hydroxyl. The coupling took 
place via a 8_cyanoethyl.N,NdiiSOPrOPYlamiflO phosphoramidite function. 
Another strategy 
94 for RNA synthesis involves using 5'-levulinyl, which is 
cleaved under neutral conditions, and the 2'-tetrahydrofuraflyl group with the 
same phosphoramidite as described above. 
54 
1.6. SOLID PHASE SYNTHESIS 
1.6.1. Introduction 
For most areas of synthesis in organic chemistry reactions are performed in 
solution and then the product is obtained from the reaction mixture by means 
of one or more purification techniques, and indeed, the first workers performing 
oligonucleotide synthesis also used this method. In 1963 Merrifield 
118 reported 
the use of an insoluble solid support in the synthesis of peptides, and later, in 
1965 Letsinger5  also used a polymer support to synthesise di- and 
trinucleotides. Since these pioneering experiments the concept of solid phase 
synthesis has been used and developed by many researchers and now is a 
commonly used technique in the synthesis of oligonucleotides. 
1.6.2. The Principle of Solid Phase Synthesis 
This type of synthesis makes use of a solid support which is insoluble in all 
the solvents used and to which the growing oligonucleotide is covalently 
bound via a suitable linker. This type of synthesis has several advantages over 
more conventional methods, the major one being that the time taken to 
construct an oligonucleotide is drastically reduced as excess reagents can be 
rinsed away and there is no need for the lengthy chromatographic separation 
of products at each stage. Another advantage is that the scale of operation 
can be decreased, thus reducing the amount of protected nucleotide required 
for each addition. Employing a method involving solid phase synthesis allows 
the process to be mechanised which can also reduce the amount of labour and 
synthesis time. However when large amounts (>50 mgs.) of DNA or RNA are 
required solution methods must still be used. 
The solid support is generally in the form of small beads or particles of 
silica gel,55 ' 119  polystyrene/divinylbenZene, 5 glass, 
47 or polyamide,' 20" 21 each of 
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which has a varying degree of loading and rigidity. The growing 
oligonucleotide is attached to the solid support via a linker which is generally a 
succinate derivative and is cleaved at the end of the synthesis by mild alkaline 
hydrolysis, using ammonium hydroxide which can also be used to remove the 
base protecting groups. A spacer is also used to give the oligonucleotide 
room to grow and its length can have an effect on the final yield of the 
product. 122 
16.3. Use in Synthesis 
Since it was first proposed many researchers have shown an interest in 
solid phase synthesis and the phosphotriester and, later, the phosphoramidite 
methods have been used to produce oligonucleotides. In 1979 Itakura at al. 23 
performed the first successful phosphotriester synthesis on solid phase. By 
using a block coupling method they made T 19  in 49% yield. Then Ogilvie at 
al. 124  used a silica gel support in conjunction with the phosphite-triester 
approach to make an RNA hexamer, and Matteucci and Caruthers 
119 used 
similar conditions to produce a DNA dodecanucleotide in 30% yield. Since then 
many oligonucleotides have been synthesized, most of them using the 
phosphoramidite method. 
In both approaches to synthesis the resin to be used must'-first be 
functionalised by addition of the linker and the first nucleoside to give a loaded 
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Fig.1.39 The Phosphotriester Solid Phase Synthesis Cycle 
The polymer with the nucleoside attached 96 is treated with trichioroacetic 
acid to deprotect the 5'-hydroxyl affording 97 and then coupled to a suitably 
protected nucleotide 98 using MSNT as a condensing agent and 
1-methylimidazole as an accelerating agent to give a fully protected dimer 99. 
The cycle can be continued by detritylating the dimer and coupling to another 
nucleotide. This is continued until the desired oligonucleotide has been 
synthesized. At this point the protecting groups are removed and the linker 
cleaved using ammonium hydroxide. 
The phosphite-triester cycle, shown in fig.1.40, is very similar but involves 
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Fig.1.40 The Phosphite-Triester Solid Phase Synthesis Cycle 
The dimethoxytrityl group is removed from the polymer attached nucleoside 
96 to give a free 5'-hydroxyl 97. A phosphoramidite nucleotide 100 is activated 
with tetrazole and coupled to the resin bound nucleoside to form a 
phosphite-triester dimer 101 which is then oxidised by iodine and water to 
produce a phosphate linkage 102. The cycle can be repeated by detritylation of 
this dimer and addition of further nucleotides until the desired oligonucleotide 
is made, at which point it is cleaved from the resin using ammonium hydroxide. 
An additional step, a capping reaction, can be introduced into the synthesis 
cycle of either approach. The usual reagent to be employed is acetic anhydride 
and capping takes place after the oxidation step in the phosphite-triester 
method and after the coupling step in the phosphotrieSter approach. Its 
function is to protect any unreacted 5'-hydroxyls in order to prevent further 
nucleotide addition. The inclusion of this step in a synthesis cycle reduces the 
number of n-i oligonucleOtide impurities which can result if a growing 
oligonucleotide fails to react during one coupling step, and its purpose is to 
make separation of the final product easier. 
1.6.4. Automated Synthesis 
In the past few years automated oligonucleotide synthesis has been 
improved by the commercial production of computer controlled DNA 
synthesizers. When programmed with the desired sequence and loaded with 
the correct reagents these automatically synthesise DNA without manual 
intervention. Some machines can construct more than one 
oligodeoxyribOnuCleOtide sequence at a time but with all automated synthesis 




2.1. Problems with DNA synthesis 
The chemical synthesis of DNA can be performed by one of two general 
methods, the phosphotriester method or the phosphite-triester approach, both 
of which are discussed in part 1.4 in the introduction. These methods have 
both undergone great improvement since they were first proposed but they are 
still not without their problems. The phosphotriester method involves the 
coupling of a phosphate function to an alcohol and as this reaction proceeds 
relatively slowly an accelerating agent must be added to produce reaction rates 
which allow the synthesis of DNA to be performed in a matter of hours, instead 
of days. Although there has been great improvement in the coupling speed of 
this type of reaction it is still appreciably slower than the phosphite-triester 
method. This latter approach takes advantage of the fact that P compounds 
are much more reactive than their 
pV equivalents. The coupling reaction 
involves a phosphite function which, after coupling is completed, can be 
oxidised to the more stable phosphate. 
When considered only in terms of speed the phosphite-triester method 
seems more desirable but it too has drawbacks. The monomers used in the 
synthesis of DNA by this method are very reactive, not only towards the 
alcohol in the synthesis but also towards water and oxygen during storage and 
use. This problem has been partially resolved by preparing the more stable 
phosphoramidites which are activated with an acid such as tetrazole 
immediately before use, but even these compounds are not stable for more 
than a few days when dissolved in acetonitrile for use on an automated 
synthesizer. 
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A second problem with this method of synthesis is the inclusion of an 
oxidation step involving the use of iodine and water. As most syntheses are 
performed on solid phase on a small scale the potential problems of bond 
cleavage, which may occur during this step when it is performed on a larger 
scale in solution, have not undergone sufficient investigation. 
The choice of coupling method is only one source of problems; another 
comes from the choice of protecting groups and the overall protecting group 
strategy (see part 1.5). Whether the phosphotriester or phosphite-triester 
method is chosen the 5'-hydroxyl protecting group most commonly used is 
4,4'-dimethoxytrityl (DMTr). This group is removed by treatment with an acid 
such as di- or trichloroacetic acid which, as well as efficiently removing the 
DMTr function can also cause depurination (cleavage of the base from the 
ribose ring), particularly in the case of N 6-benzovl -2'-deoxyadenOSifle. This 
problem is only significant when large oligodeoxyribonucleotides, or ones 
containing a high proportion of 2'-deoxyadenosine, are synthesized. In these 
cases the repeated acid treatment, and consequent increase in depurination, 
reduces yields and makes purification of the desired sequence more difficult. 
There are several solutions to this problem. It is possible to use zinc 
bromide 125 to remove the trityl group, or the N-protecting group could be 
changed 64 to make the protected purine less susceptible to acid attack. 
Another solution is to avoid the acid treatment altogether by using a 
5'-protecting group which can be cleaved under different conditions. One such 
group, 9-fluorenylmethoxycarbOflyl (Fmoc), has already been studied 
86,87,116 and 
subsequently we investigated the possibility of using the 2,2-b/s 
(4-nitrophenyl)ethoxycarbOflyl (Bnpeoc) group as a 5'-hydroxyl protecting group 
for use in the synthesis of DNA. The Bnpeoc group had previously been 
developed and used for amine protection in the synthesis of peptides 126 . Both 
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the Fmoc and Bnpeoc groups are cleaved by a B-elimination process with a 
base such as piperidine or OBU. It has been shown that Fmoc is more base 
labile than Bnpeoc 126. a factor which it was hoped would lead to greater 
stability of Bnpeoc derivatives in solvents such as acetonitrile prior to use in 
automated synthesis. 
The use of a base labile group at the 5'-position also allows the use of an 
acid labile protecting group on the 2'-hydroxyl function during RNA synthesis. 
This functional group is sometimes protected by the acid labile THP or MTHP 
groups, both of which show some cleavage during the acid treatment to 
remove the DMTr group. A base labile group on the 5'-hydroxyl function would 
be compatible with such groups. 
2.2. Bnpeoc as 5'-hydroxyl protection for thymidine 
In order to investigate the possibility of using the Bnpeoc group for 
5'-hydroxyl protection it was necessary to synthesize a nucleotide monomer 
which could then be converted into an oligonucleotide. It was decided that 
thymidine would be the most convenient nucleoside to employ for these 
studies as it could be used without having to consider exocyclic-amine 
protecting groups. The Bnpeoc group was introduced into the nucleoside by 
using the chloroformate of 2,2-b/s (4-nitropheflyl)ethaf10 1 . This reacted with 
the 5'-hydroxyl function to form a carbonate linkage. The primary hydroxyl 
reacts much faster than the secondary 3'-hydroxyl and so very little of the 
3'-protected or 3',5'-di protected product is observed. The yield of the 
5'-protected nucleoside obtained from this reaction is acceptable, and 
comparable to that obtained when the Fmoc group is used in place of Bnpeoc. 
To make the 	phosphoramidite it 	was first 	necessary 	to 
make 	the 
phosphitylating agent. 	This 	could then 	be reacted 	with 	the 
5'-protected 
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nucleoside to give a monomer which could be used for DNA synthesis. The 
reaction scheme leading to the phosphoramidite is shown in fig.2.1. 
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Fig.2.1 Synthesis of a Phosphoramidite 
The first step in making the phosphitylating agent is the reaction of 
phosphorus trichioride with methanol and the isolation of the product by 
distillation. The reaction, and especially the distillation, resulted in the 
formation of an explosive yellow phosphorus compound as well as the product, 
and care should be taken during its synthesis. As phosphorus trichloride is 
very reactive towards methanol it was expected that using one equivalent of 
each reagent would provide the best yield of methyl phosphodichloridite 103 
but it was found that better yields were obtained when more methanol was 
added. In the next step two equivalents of the secondary amine, 
N,N-diisopropylamine, were added, one to replace a second chlorine and one to 
react with the hydrogen chloride which was produced. The product, 
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N,N-diiSOprOpVl methy6hosphOramidYl chloride 104, was distilled from the 
reaction mixture and, as above, a small amount of the explosive phosphorus 
compound was also formed. 
2,2-B/s (4-nitrophenyl)ethanOl 105 was obtained by the method described 
by Florence 126 and was converted to the chioroformate 106 by reaction with 
phosgene. The nucleoside was protected using the chioroformate 106 in 
anhydrous conditions to produce a 5'-protected nucleoside 107 in good yield 
after chromotograPhv. The synthesis of the phosphoramidite 108 was 
performed under dry, oxygen free conditions in order to obtain the product in 
the highest purity possible. The phosphoramidyl chloride 104 reacted with the 
5'-protected nucleoside 107, with hydrogen chloride being eliminated, to form a 
P-O bond onto the 3'-hydroxyl function. This phosphoramidite 108 is isolated 
as an oil which can be precipitated with hexane to give a powder which is 
more stable, and may be stored for several months in a freezer without 
decomposition. 
2.3. Stability Studies 
Once it had been shown that it was possible to obtain thymidine protected 
at the 5'-position with the Bnpeoc group it was then thought necessary to 
investigate the stability to various reagents of the carbonate linkage formed, 
and also to study the deprotection of the Bnpeoc group. 
It has previously been shown 
126 that the urethane link between the Bnpe 
group and an amino acid is stable to tertiary amines but can be cleaved by 
secondary amines such as piperidine and by the bases OBU and DBN. In order 
to ascertain whether the carbonate linkage would also be stable to tertiary 
amines several experiments were performed and the stability of 
5'-O-Bnpeoc-thymidine 107 was monitored by tic. It was shown that the 
64 
Bnpeoc protected nucleoside was stable to a solution of 10% triethylamine in 
methylene chloride for 24 hours, and only showed slight cleavage after 7 days. 
When acetonitrile was used in place of the methylene chloride a small degree 
of cleavage was observed after 30 mm. and deprotection was complete after 24 
hours. 
N,N-diisopropylethylamine in tetrahydrofuran is used during the synthesis of 
the phosphoramidite from the 5'-protected nucleoside. When 
5'-O-Bnpeoc-thvmidine 107 was exposed to 4 equivalents of this amine in 
tetrahydrofuran over 2 hours no cleavage of the carbonate linkage was 
observed. 
The synthesis of the protected nucleoside involves the use of 
N,N-dimethylaminopyridine (DMAP) in order to obtain a reasonable yield. To 
determine whether this reagent could also cause loss of the protecting group 1 
equivalent of DMAP was added to 5'-O-bnpeoc-thymidine 107 in methylene 
chloride and in pvridine. After 24 hours both of these studies showed a small 
amount of loss of the protecting group from the nucleoside. 
As well as looking at the stability of the carbonate link the deprotection of 
the Bnpeoc group from the nucleoside is also important. The deprotection of 
the Bnpeoc group proceeds via a s-elimination process and non-nucleophilic 
bases such as OBU (1,8-diazabicyclo[5.4.0]ufldec7efle) 109 and DBN 
(1,5-diazabicylco[4.3.0]flOfl -5ene) 110 can be used to remove this protecting 
group selectively whilst leaving the exo-cyclic amine protecting groups intact, 
see fig.2.2. 
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Fig.2.2 Bases used for DeprotectiOn 
The mechanism of deprotectiofl is illustrated by the following model 
system. The elimination reaction is initiated by removal of a proton from the 
-position of 2,2_b/s (4-nitropheflyl)ethYl benzyi carbonate 111 and proceeds to 
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Fig.2.3 The B-Elimination Mechanism 
OBU acetate, which had been shown to deprotect Bnpeoc protected amino 
acids 126 under neutral conditions, was studied initially. 5'-O-Bnpeoc-thYmidifle 
107 was treated with 1 equivalent of DBU acetate in acetonitrile and using tic it 
was shown that the nucleoside was slowly deprotected, more than 1 hour 
being required for complete deprotection to occur. A similar study was also 
performed on Bnpe benzyl carbonate 111 using 10 equivalents of 
DBU acetate 
in 	acetonitrile and this also took more than one hour to cleave 
completely. 
These results indicate that OBU acetate does not perform the deprotection fast 
enough and so the use of DBU without the acetic acid buffer was explored. 
Bnpe benzyl carbonate was treated with 1 equivalent of DBU in acetonitrile and 
the reaction, monitored by tic, showed that complete deprotection took only 4 
mm. With 2 equivalents of DBU the deprotection was completed in 2 mm., and 
it took only 30 seconds with 25 equivalents. The results show that the Bnpe 
benzyl carbonate link can be cleaved in solution phase and so the next step 
was to determine the effect of OBU on the nucleoside. 5'-O-Bnpeoc-thymidifle 
107 was deprotected with 10 equivalents of DBU in acetonitrile and the 
deprotected nucleoside, thymidine, was isolated by chromotography. The mp, 
tic, 1 H n.m.r. and mass spectrum all confirmed that thymidine had been isolated 
and tic showed that the protecting group had been converted to the olefin. 
The stability of the Bnpeoc-nucleoside linkage towards tetrazole was also 
determined by dissolving 5'-O-Bnpeoc-thymidifle 107 in acetonitrile and adding 
tetrazole. Tic showed it to be completely stable for at least 2 hours. 
2.4. Solid Phase Synthesis 
The synthesis of an oligonucleotide from a monomer containing the Bnpeoc 
group as 5'-hydroxyl protection is the next step towards determining the 
suitability of this group for use in DNA synthesis. All the syntheses were 
performed on an automated synthesizer and a copy of a synthesis cycle used 
can be found in appendix 1. The main variations in the syntheses attempted 
were: i, varying the 5'-hydroxyl protecting group; ii, varying the deprotection 
times and reagents for the 5'-hVdroxyl group; iii, varying the phosphorus 
protecting group. It was decided that (Tp) 5T (A) would be the target 
oligonucleotide as it contained only thymidine nucleotides and hence needed 
only one monomer for its preparation and also was long enough to be 
observed by reverse phase and ion-exchange HPLC. 
The sequence prepared by protocol (1) was made as a standard employing 
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the commonly used protecting groups, DMTr for the 5'-hydroxyl and 
-cyanoethyl for phosphorus protection. The deprotection conditions for the 
DMTr group are 10% trichloroacetiC acid in methylene chloride and this takes 
50 seconds in each cycle. The sequence made by protocol (2) was synthesized 
in a similar way but the deprotection conditions had to be modified. From the 
deprotectiOn conditions previously discussed it can be seen that a solution of 
DBU in DMF gives the best conditions for removal of the Bnpeoc group but as 
the effect of DMF on the linker to be used was not certain and it was decided 
to conduct the deprotection in acetonitrile, extending the time from 50 to 120 
seconds in order to allow the complete deprotection to occur. The linker used 
had to be stable to base and so the succinyl-sarcosyl (SARC) linker 
127 was 
chosen. The synthesis was performed using 5'-O-Bnpeoc-thymidifle 
3'-N,N-diisopropyl methyl phosphoramidite 108 and then compared with (1A) 
using reverse phase HPLC. The standard, (1A), showed mainly one peak as 
would be expected and (2A) showed a small broad peak with a similar retention 
time. In order to determine whether these oligonucleotideS were in fact 
idenitical they were both purified using preparative ion-exchange HPLC which 
will separate sequences according to the number of phosphates they contain. 
When analysed by ion-exchange HPLC both sequences showed mainly one peak 
with the same retention time, and in both cases small peaks for all the deletion 
sequences were present. The main peak in each case was collected and then 
analysed by reverse phase HPLC. (1A), the standard, showed just one peak but 
(2A) gave two major peaks and a minor one in close proximity, see appendix 2. 
A mixed injection of (1A) and (2A) confirmed that one of the peaks from (2A) 
was the same as the standard. The second major peak was thought to be 
caused by the N 3-methylatiOn of thymidine by the methyl protecting group on 
phosphorus during the treatment with DBU, and the small peak probably 
resulted from two of the thymidines being methylated. This result has also 
been observed by Gao et al 102 using OBU or triethylamine in pyridine and may 
proceed by the mechanism proposed in fig.2.4. 






















Fig.2.4 The Methylation of Thymidine 
The basic OBU molecule abstracts the proton from the N
3-position leaving a 
negatively charged species which then attacks the methyl group on 
phosphorus. 
Another problem which occurred with the synthesis of (2A) was the low 
yield of oligonucleotide produced, as observed by HPLC. The reason for this is 
unknown but may be due to cleavage of the linker during the DBU treatment. 
In order to investigate this possibility several more (Tp) 5T sequences (3A-6A) 
were synthesized using DMTr as 5'-protection and were treated with DBU. 
Protocol (3) was run on an automated synthesizer and whilst (A) was still 
attached to the resin via the SARC linker, and whilst still protected at the 
5'-end with DMTr, and with methyl protection on the phosphorus, it was 
washed in a 10% solution of DBU in acetonitrile. After this treatment the DMTr 
group was removed with trichloroacetiC acid, the methyl groups were removed 
with thiopheriol, and the oligonucleotide was cleaved from the resin with 
concentrated aqueous ammonia. (4A) was synthesized under the same 
conditions but the DBU in acetonitrile treatment was performed after the 
removal of the final 5'-DMTr group. 
Reverse phase HPLC analysis showed that the products from both of these 
protocols had formed in a yield comparable to that of the standard, and so the 
absence of 5'-protection on a 6-residue oligonucleotide does not cause 
cleavage of the linker on treatment with DBU in acetonitrile. Both (3A) and (4A) 
showed interesting results on ion-exchange HPLC. They each displayed four 
peaks, one of which co-eluted with the standard, (1A), and the others 
presumably were the mono-, di- and tn- thymidine_methylated compounds as 
ion-exchange HPLC demonstrated that they consisted mainly of 
oligonucleotides containing five phosphates by comparison with (1A). 
The sequence prepared by protocol (5) was synthesized as above and 
treated with OBU in acetonitrile before removal of the final 5'-DMTr group but 
in this case the phosphorus protection was -cyanoethyl instead of methyl. 
(6A) was prepared as for (4A) but again substituting the -cyanoethyl group for 
the methyl group on phosphorus. Reverse phase HPLC of these two sequences 
showed that they were not affected by the DBU treatment. 
The effect of piperidine on oligonucleotideS containing methyl protection on 
the phosphate functions was investigated with (7A). (Tp) 5T bound to the resin 
with the SARC linker and containing the DMTr protecting group on the 
5'-hydroxyl was treated with 10% piperidine in acetonitrile for 10 mm. before 
being fully deprotected and cleaved from the resin. Reverse phase HPLC 
showed a major peak which co-eluted with the standard sample and a small 
peak which was presumably the oligonucleotide containing the N-methylated 
thymidine. On ion-exchange HPLC only one peak was observed. 
From these experiments it can be concluded that i, bases such as DBU and, 
to a lesser extent, piperidine, result in the N 3-methylation of thymidine in 
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oligonucleotides containing methyl protection on phosphorus, and ii, the effect 
of these bases on the SARC linker attached to a hexamer was not the cause of 
the reduced yields observed when Bnpeoc was used as a 5'-protecting group. 
2.5. Alternative Protecting Group Strategies 
The need for a modification of the monomer to be used was evident from 
the results of the solid phase synthesis experiments. The N 3-methylation of 
thymidine was a problem which had to be avoided and, in view of the fact that 
an alternative could not be found for OBU for the deprotectiOn of the Bnpeoc 
group, the possible solutions were i, to use a protecting group on the 
1\1 3-position of thymidine or ii, to find an alternative phosphorus protecting 
group. 
The investigation of thymidine protection led us to use the anisoyl group on 
the N 3-position. This protecting group is cleaved in aqueous ammonia and has 
previously been used for uridine 128 and cytidine 103. It was necessary to 
prepare a phosphoramidite containing this protecting group, the synthesis of 
which can be seen in fig.2.5, and then determine its viability during the solid 
phase synthesis of an oligonucleotide. The synthesis starts with the silylation 
of thymidine 113 by trimethylsilyl chloride, which is used to protect the 
hydroxyl functions on the ribose ring. The next step is the reaction of the 
nucleoside with anisoyl chloride and finallV the removal of the silyl groups with 
aqueous pyridine to give N 3-anisoylthymidifle 114. This reaction gave quite a 
low yield (37%) which may be due to the sensitivity of the anisoyl chloride to 
water. The nucleoside was then reacted with Bnpeoc-CI 106 forming 
5'_O_Bnpeoc-N3-aflisOylthYmidifle 115 which was converted to the 
phosphoramidite 116 by use of a phosphitylating agent 104. 
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Fig.2.5 Preparation of an N 3-Protected Phosphoramidite 
In order to enable us to compare the Bnpeoc group with Fmoc we also 
made a similar phosphoramidite using Fmoc as the 5' -hydroxyl protecting 
group, see fig.2.6. 
The synthesis is similar to that for the Bnpeoc derivative, starting with 
N 3-anisoylthymidifle 114 which was reacted with 9-fluorenylmethVl 
chloroformate to give 5_O_(9_fluorenyImethVl)_N3_aniS0YlthVmme 117 in an 
acceptable yield. The phosphoramidi.te was obtained Using 
N,N_diisopropylmethylPhosPhoflamidyl 	chloride 	104 	
to 	give 
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Fig.2.6 Preparation of an Fmoc,N 3-anisoylthymidifle 
Phosphoramidite 
Using phosphoramidite 118 the sequence prepared by protocol (12), (Tp) 5T, was 
synthesized using 10% OBU in acetonitrile for 180 seconds per cycle. 
Ion-exchange HPLC showed a small peak which had the same retention time as 
the standard sample. When the phosphoramidite 116 was used in a synthesis 
(protocol (13)) under identical conditions, no product at all was observed by 
ion-exchange HPLC. No deletion sequences were observed in either case. In 
the synthesis using Fmoc as the 5'-protecting group it is not likely that the 
deprotection time was too short since if that had been the case then it would 
be expected that the deletion sequences would be visible on the ion-exchange 
HPLC trace. In the case of Bnpeoc it is possible that the deprotectiOn time was 
much too short, not even allowing sufficient coupling to take place initially, 
before the first capping step. The addition of the anisoyl group to thymidine 
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may provide some steric hinderance during the deprotection step of Bnpeoc 
with DBU and possibly also during the coupling step. 
The second alternative to the N 3-methylation of thymidine was to alter the 
phosphorus protecting group. A base labile group could not be used and so 
the acid labile 2,2,2-triphenylethyl group was investigated. The use of an acid 
labile group on phosphorus would mean that the oligonucleotide required only 
one acid treatment at the end of the synthesis and therefore the problems of 
depurination and cleavage of acid labile 2'-protecting groups would be reduced 
compared with the use of an acid treatment in each cycle when employing the 
DMTr group for 5'-protection. To determine whether it was possible to 
synthesize oligodeoxyribOflucleOtides using the 2,2,2-triphenylethyl group for 
phosphorus protection the phosphoramidite monomer was made, see fig.2.7. 
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Fig.2.7 Preparation of a 2,2,2_TriphenylethyiPhoSPhOramidite 
2,2,2-TriphenylethanOl 	119 was 	prepared 	by the 	reduction 	of 
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2,2,2-triphenylacetic acid with lithium aluminium hydride. The trimethylsilyl 
ether of the alcohol was then prepared and reacted with phosphorus trichioride 
at low temperature to maximise the yield of the mono-substituted phosphine 
120, (see below). The addition to this reagent of N,N-diisopropylamine gave 
the phosphoramidyl chloride 121 which was reacted with 
5'-O-BnpeoC--thymidifle 107 at the 3'-position to give the required 
phosphoramidite 122 in reasonable yield. 
To investigate its rate of coupling the phosphoramidite 122 was dissolved 
in acetonitrile, and tetrazole and benzyl alcohol were added. The reaction was 
observed by tic but after 30 mm. the starting material remained unchanged. 
The lack of reactivity displayed by this phosphoramidite is probably due to the 
steric bulk of the phenyl rings on the phosphorus protecting group. 
A study was made of the optimum conditions required to obtain the 
mono-substituted phosphine 120 by varying the number of equivalents of 
alcohol, protected as the trimethylsilyl ether, used, and by altering the 
temperature at which the reaction was performed. The results, obtained by 31 P 
n.m.r. analysis and summarised in table 3, show that the best conditions involve 
the use of 1 equivalent of the silyl ether and a low temperature. Phosphorus 
trichioride would be more reactive towards the first substitution of the alkoxy 
group than the second or third substitutions and hence the low temperature 
enables some increase in selectivity in favour of the desired reaction. 
2.6. Bnpeoc as 5'-Hydroxyl Protection for 2'-Deoxyadenosifle 
The problem of N 3-methylation of thymidine during oligonucleotide 
synthesis, and the lack of a viable solution, led us to consider using another 
nucleotide for further investigation of the Bnpeoc group. The three remaining 
bases all require exo-cyclic, amine protection and N6-benzoyl- 
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2'-deoxyadenoSifle was the example chosen for investigation. 
To determine the deprotection conditions for the Bnpeoc group and its use 
in synthesis a series of stability studies were performed on the 
5'-Bnpeoc-protected nucleoside, and then the nucleotide was synthesized and 
used to make oligonucleotides by a solid phase method. The synthesis of the 
phosphoramidite can be seen in fig.2.8. 
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Fig.2.8 Synthesis of a 2'-Deoxyadeflosifle Phosphoramidite 
N 6_Benzoyl-2'--deOXyadeflOSifle 93 was reacted with chloroformate 106 to 
give 5__Bnpeoc _N 6_be rl 2Oyl_2'_deOXYadefl05me 	123 in 	a 
reasonable yield. 
This was 	converted 	to 	the 	phosphoramidite by 
reaction with 
N ,N_diisop ropyImethyIhOsPhoramidyl 	chloride 	104 	to 	give 
5'-O-Bnpeoc-N r'-benzoVI-2'-deoxVadenosine -3 '-O- N ,N-diisopropv l1MethV I  
phosphoramidite 124 in good yield. 
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Before commencing with an oligonucleotide synthesis the stability of the 
Bnpeoc group towards DBU and piperidine was determined. Using 
5'_O_Bnpeoc_N6_benzOVl-2'_deOxYaden0se 123 dissolved in various solvents, 
and with varying amounts of DBU added, the time for complete deprotection of 
the Bnpeoc group from the nucleoside was determined (table 2.) When 
methylene chloride was used as a solvent with 10 equivalents of OBU the 
reaction was slow (taking more than 10 mm. for complete deprotection). The 
rate increased when acetonitrile was employed as a solvent (5 mm.), and when 
using DMF the deprotectiOn was complete in 1 mm. With a 10 fold increase in 
the amount of DBU this time was reduced to 15 seconds (100 equivalents of 
DBU in these experiments is a ca 10% solution). 
Piperidine was also used in a deprotection study and with 10 equivalents of 
piperidine in DMF the cleavage of Bnpeoc from the nucleoside took 12 mm. and 
using 100 equivalents this time was reduced to 5 mm. As reactions take even 
longer in solid phase synthesis than in solution, this is too slow to be useful. 
The conditions for the attempts at oligonucleotide synthesis using the 
phosphoramidite 124 are presented in table 6, (913) and (lOB). In the synthesis 
of (913) the deprotection was performed using DBU in methylene chloride and, 
as these conditions result in slow cleavage of the Bnpeoc group, reverse phase 
HPLC showed all the deletion sequences and a small product peak, confirmed 
by a mixed injection with the standard, (813). Similar results were observed on 
ion-exchange HPLC where all the deletion sequences were seen. When DBU in 
DMF was used for the deprotection, (lOB), reverse phase HPLC showed two 
peaks, the major one of which co-eluted with the standard sample. Although 
(lOB) contained the desired oligonucleOtide the yield was much smaller than 
would be expected. To determine whether this was due to cleavage of the 
oligonucleOtide from the resin (11B) was made by conventional methods and 
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was washed with 10% OBU in DMF prior to cleavage from the resin-
Ion-exchange HPLC showed that this treatment had not affected the yield or 
purity of the product. 
2.7. Stability Studies 
By examination of the HPLC traces and determination by u.v. of the quantity 
of oligonucleotide produced in each synthesis, it can be seen that when 
Bnpeoc is employed as a 5'-hydroxyl protecting group on either thymidine or 
N6_benzoyl-2'-deOXYadeflOsine, the yield is much lower than would be 
expected with (for example) oligonucleotides synthesized using the 5'-DMTr 
group. The reason in some cases, such as when DBU in methylene chloride is 
used for the deprotection, may be incomplete removal of the Bnpeoc group, but 
when solvents such as DMF are used the deletion sequences, which are a sign 
of incomplete deprotectiofl or coupling, are not observed, but still the yield of 
product is low. In an attempt to discover the cause of the unsatisfactory yields 
further experiments were conducted on the linker, on short oligonucleotides, on 
the oxidation conditions, and on solution phase coupling reactions. 
The first experiment tested the stability of the SARC linker to OBU in DMF 
by suspending resin, functionalised with 5'-O-DMTr-thymidifle bound by the 
linker, in the solution. The resin was then filtered off and washed. When 
tested with concentrated hydrochloric acid the resin gave an orange solution 
indicating that the nucleoside was still bound to it after the treatment with 
DBU, but the filtrate remained colourless when subjected to the same treatment 
indicating that no loss of the protected nucleoside had taken place. 
Several experiments had already been performed to examine the stability to 
OBU in DMF of hexamers and octanlers, joined to the resin by the SARC linker, 
but it is possible that the growing oligonucleotide may be cleaved from the 
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resin at an earlier stage in the synthesis. To examine this possibility the 
polynucleotides (dA), (dA)p(dA), (dA)p(dA)p(dA) and (dA)p(dA)p(dA)P(dA) were 
synthesized by conventional methods except that the SARC linker was used. 
Each was washed with a solution of DBU in DMF then cleaved from the resin 
and the amount of polynucleotide present was determined by u.v. absorbance. 
When these results were compared with a control experiment which omitted 
the DBU/DMF wash it was observed that the monomer showed about 5% 
cleavage from the resin but the dimer, trimer and tetramer were unaffected. 
The results show that if this cleavage occurs within a synthesis it would only 
have a slight affect on the final yield and could not be the sole reason for the 
low yields observed. 
The next part of the synthesis cycle to be investigated was the oxidation 
step involving iodine and water. To test the stability of the Bnpeoc-nucleoside 
carbonate linkage 5._O_Bnpeoc_thVmidifle3'Oacetate 125 was synthesized by 
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Fig.2.9 Synthesis of a 5',3'-Protected Nucleoside 
The fully protected nucleoside was made by the reaction of acetic 
anhydride with 5'-O-Bnpeoc-thymidifle 107 to give 
5._O_Bnpeoc_thymidine_3'_Oacetate 125. This was then treated with a 
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solution of iodine and water in THF and 2,6-lutidine, as is used during the 
synthesis, and then 125 was isolated in almost quantitative yield, showing that 
the carbonate linkage is stable to the oxidising conditions employed. 
The important step of coupling was next studied. The reaction of 
methyl,hosphoramidite 116 with methanol was followed by tic and found to be 
complete within 2 mm. Methanol was chosen as the least sterically hindered 
alcohol available. This reaction was repeated with 
5._O_DMTr_thymidine_3'_O_N,N_dii50pr0PV1JmethYPh05Ph0mte 126 and 
methanol to give the same results. These results suggest that such 
nucleotides protected with Bnpeoc do undergo a coupling step in the same 
way that DMTr-nucleotides do. In order to verify that the product formed was 
the one desired, the reaction was performed on a larger scale and the product 
was isolated by chromotographV and characterisation showed it to be the 
required nucleoside-dimethVDhOSPhate 127a. The reaction scheme can be 
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Fig.2.10 Coupling of a Phosphoramidite with an Alcohol 
The next step was to repeat this coupling using a more sterically hindered 
alcohol, for which purpose benzyl alcohol was chosen. 
5'-O-Bripeoc-thymidine-3'-O-N,N-diisopropyl methylphosphoramidite 108 was 
reacted with benzyl alcohol and tetrazole, then oxidised with iodine and water 
to give 5'-O-Bnpeoc-thymidine-3'_-O-benzylmethyphosPhate 127b. 
Characterisation confirmed that this was the required product. 
The coupling of a phosphoramidite with a 3'-protected nucleoside was 
attempted to determine whether a nucleoside would be too hindered to couple 
to a 5'-O-Bnpeoc-protected nucleotide. The nucleoside used was 
thymidine-3'-O-acetate 5 and was obtained by the scheme shown in fig.2.1 1. 
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Fig.2.11 Synthesis of a 3'-Protected Nucleoside 
Thymidine 113 was reacted with 4,4'-dimethoxytrityl chloride to give the 
5'-protected nucleoside 63. This was further protected by treatment with 
acetic anhydride and then the 5'-protecting group was removed by aqueous 
acetic acid to give thymidine-3'-O-acetate 5. 
The 	coupling 	reaction 	took 	place 	in 	solution 	between 
5'-O-Bnpeoc-N 3-anisoyl-thymidine--3'-O-N,N-diisOPrOPVl 
methvphosphoramidite 116 and thymidine-3'-O-acetate 5 using tetrazole to 
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activate the phosphoramidite. The reaction was monitored by tic and showed 
the conversion of the phosphoramidite, in the presence of excess nucleoside, 
to a product, presumably the dimer, in 20 mm. This reaction is quite slow, and 
if it only proceeds at a comparable, or slower rate, on solid phase with excess 
phosphoramidite then it would account for the reduced yields observed. 
28. Use of 8-Cyanoethyl Phosphoramidites 
The Fmoc group has been investigated as a base labile 5'-hydroxyl 
protecting group for use in oligonucleotide synthesis with varying phosphorus 
protection. Its use was first reported with the N,N-diisopropyl 
methylphosphoranlidite 86 ' 116  in which reasonable product yields and purity were 
obtained. The methyl group is removed by thiophenol and so it remains stable 
throughout the DBU or piperidine treatment used to remove the Fmoc group. 
Later Gait et al.87  used the N,N_diisopropyl/-cyaflOethVPhOSPhoramidite with 
Fmoc for RNA synthesis. The B-cyanoethyl group is base labile and so may be 
removed from the internucleotide phosphate function during the OBU treatment 
employed to cleave the 5'-Fmoc protecting group, leaving a phosphodiester 
which may undergo side-reactions during the remaining coupling steps. 
The synthesis of two (Tp) 5T oligodeoxyribonucleOtideS was performed using 
the 5 _O_Bnpeoc_thym idi ne_3'_O_N,Ndii sop r0Pyl/B_cV 0eth1 VI 
phosphoramidite 128, the synthesis of which can be seen in fig.2.12. 
5'-O-Bnpeoc-thVmidifle 107 is reacted with phosphitylating agent 
N,N-diisopropyl _cyanoethyDhosphOramidYl chloride in anhydrous, oxygen free 










02 N CH3 
CI 
0 &N 






Fig.2.12 Synthesis of a 8-Cyanoethyl Phosphoramidite 
The synthesis of (A) by protocol 14 was performed using DBU in acetonitrile 
for the Bnpeoc deprotectiOn and reverse phase HPLC of the product showed 
several peaks, the major one of which co-eluted with a standard sample of 
(Tp) 5T oligonucleotide (1A). On ion-exchange HPLC several peaks 
were again 
observed 	but 	the 	major one was shown to 	be the 	desired 
product 	by 
comparison with the standard sample. 
The sequence prepared by protocol (15) was synthesized from the 
phosphoramidite 128 but piperidine in acetonitrile was used for the 
deprotection step, which was increased from 50 to 600 seconds. Ion-exchange 
HPLC of the product showed several peaks, one of which co-eluted with the 
standard sample. Both methods (14) and (15) gave the required product but 
also showed evidence of deletion sequences, possibly due to insufficient 
deprotection time, and both gave low yields when compared to a standard 
DMTr synthesis. 
The next two sequences to be synthesized also used the -cyanoethVl 
group for phosphorus protection but protocol (16) had the Fmoc group on the 
5'-position, and used phosphoramidite 130, the synthesis of which can be seen 
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in fig.2.13. Thymidine 113 is reacted with 9-fluorenylmetilyl chioroformate to 
give 5'-O-Fmoc-thymidifle 129, which is phosphitylated by N,N-diisopropyl 
B_cyanoethylphosPhOramidyl chloride to produce the required phosphoramidite 




























Fig.2.13 Synthesis of a -Cyanoethyl Phosphoramidite 
(16A) and (17A) were prepared to compare the purity and yield of 
oligonucleotides made from Fmoc-protected phosphoramiditeS with those 
synthesized from Bnpeoc-nucleotides. The sequence prepared by protocol (16), 
(Tp) 5T, was deproteced using 10% OBU in DMF which 
should result in a faster 
deprotection time than when acetonitrile is used as a solvent. 	Reverse 
phase 
HPLC showed the product as the 	major peak but also indicated that some 
impurities 	were 	present. Sequence 	A. prepared by 	protocol 	
(17), 	was 
synthesized in the same way except that Bnpeoc was used on the 5'-position 
and the deprotection time was increased from 100 to 200 seconds. 	
Reverse 
phase HPLC analysis of the product again showed the desired product as the 
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major peak, in addition to similar impurities as before. Both (16A) and (17A) 
looked very similer on hplc and both were low yielding syntheses showing that 
Bnpeoc compares with Fmoc when allowance is made for a longer deprotection 
time requirement. However both protecting groups have produced 
oligcuiucieotides in disappointing yields by this method of synthesis. 
2.9. Phosphorus NMR Studies 
The coupling of phosphoramidites with methanol, benzyl alcohol and 
3'-O-acetyl-thymidine has already been investigated using tic as a means of 
monitoring the reactions. This method only shows that the starting material is 
converted to another compound and cannot provide a clear indication of which 
reactions are taking place or of what products are formed. 
The first coupling reaction to be investigated by 31 P n.m.r. was the reaction 
between 5'-O-Bnpeoc-thymidine-3'-O-N,N-diisopropyl methvi(phosphoramidite 
108 and 3'-O-benzoyi-thymidine 131. The pure starting material gave two 
products when the 3'-protected nucleoside was added, one of which was the 
addition product, 5'-O-Bnpeoc-thymidine-3'-O-methyl,(3' -O-benzoyl -thymidifle) 
phosphite 132 at 139.9 ppm, and the other peak at 9.3 ppm was probably due 
to the reaction of the phosphoramidite with water during tetrazole activation to 
give the phosphonate 134. When this reaction mixture was oxidised with 
iodine and water two major peaks appeared at -1.3 and 1.5 ppm, probably due 
to the desired phosphate 133 and the oxidised phosphonate which would form 
a phosphate 135 under these conditions; the reactions can be seen in fig.2.14. 
1' 
II 
CH3O— P0C • 
0 









02N 	 I 	 kJH20 
CH,O— P-0— C ) 
(132) 	 0—CO—Ph 
V 0,N 
H0—C 






CH30''NtPr2 	1"0 + 











(134) 	 II 
0 
O2N 








Fig.2.14 Phosphoramidite Coupling Reactions 
The next coupling rections to be tried were those between a series of 
N,N-diisoprOpyl methyiphosphoramidites and methanol. The phosphoramiditeS 
were protected with either DMTr, Fmoc or Bnpeoc on the 5'-hydroxyl group. It 
was decided to use these three different protecting groups to compare their 
effect, if any, on the coupling and oxidation reactions, and methanol was 
chosen as it had previously been shown (see synthesis of 127) to couple to a 
phosphoramidite to form the dimethyl phosphate when oxidised. Each of the 
reactions was performed using deuterated acetonitrile as solvent and the 31 P 
n.m.r. spectrum was recorded on (i), the starting material, (ii), the reaction 
product with methanol and tetrazole, and (iii), the products after oxidation with 
iodine and water. During the coupling step it was important that no water was 
present in the reaction and so the methanol was distilled from magnesium 
methoxide and the deuterated acetonitrile was obtained from freshly opened 
vials. The reaction scheme is shown in fig.2.15. 
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Fig.2.15 The Coupling of a Phosphoramidite with Methanol 
The major peaks observed at each of these stages are shown in table 1, all 
the spectra were recorded over a spectral width of 20,000 Hz. 
Table 1 
6p (36 MHz, CD3CN) 
Compound (a) (b) (c) 
136 149.0 149.0 148.6 
137 140.4 140.3 140.1 
138 -0.4,-1.5 -0.5,-1.4 0.9,-0.5,-1.3 
The chemical shifts of all three phosphoramiditeS 136 are, as would be 
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expected, very similar and the reaction with methanol to 
form the dimethyl 
phosphites 	137 also leads to compounds with very little difference 
in 	their 
chemical shifts. When these compounds are oxidised with 
iodine and water in 
each case at least two products are observed. The peak at 0.9 ppm in the case 
of 138c is a minor peak by comparison with the other two. 
In order to investigate these products further the spectrum of reaction 138a 
was recorded over a spectral width of 2,000 Hz, thus allowing better resolution 
of the peaks. This spectrum showed two peaks as previously, at -0.4 ppm the 
peak was very sharp but at -1.5 ppm a very broad peak was observed. The 
same process was applied to reaction 138b and again a sharp peak at -0.5 ppm 
and a very broad peak at -1.4 ppm were observed. When the spectrum of 
reaction 138c was recorded over 2,000 Hz four peaks were seen. The one at 
-0.5 ppm was sharp and the one at -1.3 ppm was broad. These two peaks are 
similar in chemical shift to those observed in 138a and 138b. The two other 
peaks in - 138c consisted of a small, sharp peak at 1.6 ppm and a broad peak at 
0.9 ppm. 
In an attempt to assign each of these peaks a proton coupled spectrum of 
138c was recorded over 1,000 Hz on a 81 MHz spectrometer. The two narrow 
peaks were so small as to be barely visible when coupled, the one at 1.6 ppm 
showing a small multiplet. The broad peaks were much more intense, the one 
at 0.9 ppm showed a triplet (which was probably an overlapping doublet of 
quartets as small side peaks were also observed), the coupling constant being 
11 Hz. The peak at -1.3 ppm showed a less well defined triplet (the triplet was 
probably a doublet of doublets), see appendix 3. 
The final set of spectra to be obtained from 138c were decoupled variable 
temperature spectra ranging from +60 °C to -7 °C. At +60°
C the signals 
appeared as sharp peaks, at +40 °C the two major peaks (0.9 ppm and -1.3 ppm) 
began to get broader, and at +25 °C the major peaks became very broad and 
remained thus at +9 °C and -7 °C. Throughout this temperature variation the 
minor peaks (1.6 ppm and -0.5 ppm) remained well defined. 
These results suggest that where DMTr, Fmoc and Bnpeoc are used as 
5'-hydroxyl protecting groups the reaction of methanol with the 
phosphoramidite, and the subsequent oxidation, result in several products, the 
side-reactions taking place during the oxidation step. In the cases where Fmoc 
and Bnpeoc are used two peaks are observed after the oxidation step, the 
broad one suggesting a sterically hindered molecule such as the required 
product which has a nucleoside and two methyl groups attached to the 
phosphorus, and the sharp peak which may be the result of the nucleoside 
being cleaved from the phosphate to give dimethyl phosphate. The results can 
be compared with those obtained from the coupled and variable temperature 
spectra of reaction 138c where OMTr was used for 5'-hydroxyl protection. The 
variable temperature experiments suggest that the two broad peaks are the 
result of the phosphorus being attached to a bulky molecule and the proton 
coupled spectrum suggests that each broad peak also has a methyl group 
attached to the phosphorus. As both the required product and the product 
with one of the methyl groups cleaved and replaced by a proton would give 
similar proton coupled 31 P n.m.r. spectra it 	is not possible to determine which 
peak belongs to which compound. Comparison with the Bnpeoc and Fmoc 
experiments suggest that if the required product is formed in these 
experiments then by comparing the chemical shifts the peak at -1.3 ppm is the 
product. The two narrow peaks are probably due to the nucleoside being 
cleaved from the phosphate function, and in one case a methyl group is also 
cleaved, to give methyl and dimethyl phosphate. 
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From these studies one may conclude that the oxidation of a phosphite to a 
phosphate by iodine and water can result in the cleavage of one or more 
groups from the phosphate. These reactions were performed in solution phase 
with methanol as the nucleophile but it is probable that when a nucleoside is 
used similar cleavage products will result, and this will cause a reduction in the 
yield of the oligonucleotide being synthesized. 
2.10. Base Protection by Bnpeoc 
A wide range of groups have been developed for the protection of the 
heterocyclic bases during oligonucleotide synthesis. One such group, the 
p-nitrophenylethyl group, has been used for the protection of all the bases by 
Pfleiderer et al but was found to be more stable to the deprotectiOn 
reagent, 	OBU, than was required. 	The 2,2-bis 
(4-nitrophenyl)ethyl group 	is 
more labile towards DBU and it should be possible to introduce the 
group in 
the same manner as the p-nitrophenylethVl group. 
The first objective was protection of the 0
4 function of thymidine. 
Pfleiderer performed this using the iodide derivative of his protecting group and 













Fig.2.16 Preparation of Bnpe I 
2,2-b/s (4-nitrophenyl)ethaflO1 	105 was 	reacted 	
with 	N-methyl 
N,N_dicyclOheXylCarbOdiimidium iodide 139 to give 2,2-b/s (4-nitrOpheflYl)ethyl 
iodide 140 in good yield. Previous attemps to produce this compound by 
reaction of Bnpe CI 
126 with sodium iodide in DMF, and reaction of Bnpe Br 
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with magnesium to generate the Grignard reagent then reaction with iodine 
resulted in a mixture of the starting material (Bnpe Cl or Br), the product 140 
and 1,1-b/s (4-nitrophenyl)ethene. The required compound could not be 
seperated by chromatography or crystallisation from these mixtures but was 
shown to be present by 1 H n.m.r. 
Pfleiderer 	formed 	
pnitrophenylethyl_3'_ObeflzoY5: 
MMTr-thymidifle by reacting the 5',3'-protected nucleoside with 
p-nitrophenvlethyl iodide in the presence of silver carbonate in an SO 
alkylation reaction. When a similar reaction was tried using Bnpe I only 
starting material could be isolated. 
With the disappointing results obtained using thymidine it was decided to 
try to protect a different base and 2'-deoxyadeflOSifle was chosen. The 5'- and 
3'-hydroxyls were protected by Markiewicz'S 95  bifunctional protecting group to 
give 3',5'_(tetraisoprOPyldisilOXafle1 ,3_diyl)-2'-deoxyadefloSifle 141. This was 
then reacted with 1 -methyl-3 - [2,2 b/s 
(4_nitrophenyI)ethOXICarbOfly1] 
imidazolium chloride 142 to form the N 6-protected 2'-deoxyadeeflOsifle 143 as 
shown in fig.2.17. 
The reaction gave the required product in low yield and insufficient material 
was obtained for deprotection studies. Due to the difficulties in obtaining 
Bnpeoc-protected nucleoside bases and the existence of acceptable 
alternatives in the form of the benzoyl, anisoyl and isobutyryl groups it was 
decided not to pursue this area of research any further. 
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Fig.2.17 Protection of 2'-dA at N 6 with the Bnpeoc Group 
2.11. Use of Zinc Iodide in Phosphotriester Synthesis 
When the phosphotriester method is used for oligonucleotide synthesis an 
accelerating agent is often used to decrease the time required for each 
coupling step. The agent generally used is 1-methylimidazole 51 
In peptide synthesis zinc iodide has been shown to increase the speed of 
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The use of zinc iodide as a possible accelerating agent in phosphotrieSter 
synthesis was explored by studying the coupling times for triethylammoflium 
(5_Q_DMTr_thVmidifle_3'_0_2_chl0r0PhenVI phosphate) 144 with 
-cyanoethanoi. This reaction forms a nucleotide 146 from which the 5'-DMTr 
group can be deprotected and the nucleotide is then able to be coupled to 
another molecule of the starting material 144. 
The reaction was first performed using tic as a monitoring system but this 
failed to show the coupling reaction clearly. Instead it was decided to use  31 P 
n.m.r. to follow the reaction. A series of three experiments were performed: (i), 
the coupling of the phosphotrieSter with -cyanoethanol using MSNT as the 
coupling agent; (ii), the same, but with the addition of 1-methylimidaZOle as an 
accelerating agent; and (iii), the coupling with the addition of zinc iodide to 
compare its effect on the speed of the coupling step. The reactions were 
initially performed at room temperature but this resulted in reaction rates 
which were too fast to measure using the n.m.r. technique so the spectra were 
recorded at a temperature of -30 °C. 
The results obtained can be seen in tables 4 and 5 in the experimental 
section, and the reaction is shown in fig.2.18. 
Fig.2.18 Coupling of a phosphate to 8_Cyanoethaflol 
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These three compounds gave different chemical shfts using 31 P n.m.r. and 
so the ratio of product 146 to intermediate 145 could be determined. If water 
was present in the reaction compound 145 would be converted back to 144 so 
an excess of MSNT was used to ensure the triethylammOfliUm phosphate 144 
remained activated. 
When the reaction was performed under the conditions described with 
MSNT but no accelerating agent it took 31 mm. for all compound 145 to be 
converted to either the product 146, or the starting material 144. The 
reformation of the starting material was probably due to there being 
insufficient MSNT present. This reaction was repeated adding 
1-methylimidazOle with the -cyanoethanoI and this gave a reaction time of 
less than 50 seconds. When zinc iodide was added as an accelerating agent 
the reaction followed the same pattern as the first reaction and its presence 
did not result in an increased coupling rate. 
The systematic uncritical use of zinc iodide in oligonucleotide synthesis 
could not be proposed in any event as some loss of DMTr protecting groups, 
which is already known to occur with zinc bromide 125 , may be expected. 
2.12. Conclusions 
The principle objective of this research has been the introduction of the 
Bnpeoc protection strategy (recently established in peptide synthesis) into DNA 
synthesis. This required the preparation of site-specifically protected monomers 
which was achieved in adequate yield. Following solution studies, these 
monomers were applied to the automated solid phase method to produce 
several model nucleotides. However the overall yields in comparison with 
Fmoc and other protecting group strategies were poor; the underlying chemical 
nature of Bnpeoc (its greater stability to bases relative to Fmoc, its greater 
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steric bulk 	etc.) 	is presumed to be responsible for this. 	
Modifications to the 
synthetic protocol, such as extending reaction times and moving to 
dipolar 
aprotic solvents have been shown to compensate partially for these drawbacks, 
but more work would be required to reach the level of commercial viability. 
Studies of the oxidation step in phosphite-triester synthesis showed that 
cleavage of protecting groups and nucleosides from phosphorus occurs under 
the conditions generally employed and although solid phase synthesis may not 
be affected by these side-reactions any large scale solution phase synthesis 




The melting points were obtained using a Reichert 7905 hot plate and are 
quoted without correction. Thin layer chromatography was performed using 
silica gel coated plastic sheets, 60F2 54  (Merck) and the solvent systems used 
were: (A) 10% methanol! 90% methylene chloride, (B) 50% ethyl acetate! 50% 
methylene chloride, (C) 30% ethyl acetate! 70°!o toluene, and (0) 40% ethyl 
acetate! 60% 40-60 °C petroleum ether. The compounds were visualised by u.v. 
absorption at 254nm and potassium permanganate spray, or where applicable, 
HCI spray to indicate the position of the dimethoxytrityl containing compounds, 
or anisaldehyde spray (in acidic ethanol) to reveal sugar containing compounds. 
Infra-red spectra were measured on a Perkin Elmer 781 spectrometer as a 
bromoform mull or methylene chloride solution. Ultraviolet spectra were 
obtained using a Varian Cary 210 spectrometer with distilled acetonitrile as a 
solvent. Proton N.M.R. spectra were produced using a Bruker WP200 operating 
at 200MHz or a Perkin Elmer R32 operating at 80MHz, both using 
tetramethylsilane as a reference. 13Carbon N.M.R. spectra were recorded on a 
Bruker WP200 operating at 50MHz or a Bruker WH360 operating at 90MHz. 
31 Phosphorus N.M.R. spectra were recorded on a Jeol FX90 operating at 36MHZ 
or a Bruker WP200 operating at 81MHz, both using phosphoric acid as a 
reference. Mass spectra, both low and high resolution were obtained using a 
fast atom bombardment (FAB) technique on a Kratos MS50TC, using 
thioglycerol as a solvent. High performance liquid chromatography (HPLC) 
analysis was performed on Gilson and Perkin Elmer systems using various 
reverse phase and ion exchange columns with solvents and gradients as shown 
below: 
Reverse Phase Systems 
Solvent A: 0.1M NH 40Ac in 100% H 20 
Solvent B: 0.1M NH 40Ac in 20% CH 3CN/ 80%H20 
System A System B 
time (mm) %B time (mm) 
0.0 0.0 0.0 0.0 
3.0 0.0 33.0 100.0 
4.0 12.0 35.0 100.0 
25.0 50.0 36.0 0.0 




System D System E 
me (mm) %B time (mm) 
0.0 0.0 0.0 0.0 
3.0 0.0 3.0 0.0 
4.0 5.0 4.0 20.0 
24.0 45.0 24.0 80.0 
26.0 100.0 26.0 100.0 
28.0 100.0 28.0 100.0 










Solvent A: 0.029M KH 2PO4 in 20% CH3CN/ 80% H 20 pH=6.4 
Solvent B: 0.66M KH 2PO4 in 20% CH3CN/ 80% H 20 pH=6.4 
System C System F 
time (mm) %B time (mm) 
0.0 10.0 0.0 0.0 
2.0 10.0 2.0 0.0 
22.0 100.0 22.0 15.0 
23.0 100.0 25.0 100.0 
26.0 100.0 27.0 0.0 
30.0 10.0 35.0 0.0 
All solvents were dried using the drying agents indicated and were distilled 
before use: methylene chloride (calcium hydride), tetrahydrofuran (sodium and 
benzophenone under N2), acetonitrile (calcium hydride), pyridine (potassium 
hydroxide), diethyl ether (sodium), hexane (molecular sieves type 4A), 





Methanol (60.8 ml, 1.5 mol), (freshly distilled from Mg) was added dropwise 
over 2 hours to phosphorus trichloride (88 ml, 1.0 mol) with stirring at -20 °C, 
and vented through an air condenser and calcium chloride tube. The reaction 
was allowed to reach room temperature and left to de-gas overnight. The 
product was obtained by distillation using a Vigreux column. The fraction 
boiling at 90-91 °C was collected and redistilled to give the required product as 
a colourless liquid, (22.75g. 17%); b.p. 91-92 °C (lit 91.5 °C) 130; 5H (80 MHz, 
CDCI3) 3.88 (3H, d, CH 30, JP-o-CH 10.2 Hz); iSp (80 MHz, COd3) 182.3. 
N,N_DiisopropylmëthylPhOSPhoflamidVl chloride 
(104) CH 30P(Cl)N'Pr2 
N,N-Diisopropvlamine (48 ml, 0.34 mol), (distilled from CaH2) was added 
dropwise to a solution methyl phosphodichlOridite (103) (16.2 ml, 0.17 mol) 
stirring in 60 ml of methylene chloride at -10 °C under argon over 30 mm. The 
reaction was allowed to reach room temperature and then filtered to remove 
the diisopropylamine hydrochloride. After evaporation of the methylene 
chloride in vacuo and a further filtration the required product was obtained by 
distillation under reduced pressure as a colourless liquid (12.4g. 37%); b.p. 
840C/12mmHg (lit. 35-36 °C/0.02mmHg) 60  5H (81 MHz, COd3) 1.20 (12H, d, CH3, 
H-C-CH 6.8 Hz), 3.56 (314, d, CH30, JP-o-CH 
14.1 Hz), 3.80 (21-1, m, 'Pr CH,); Sp (80 
MHz, COd3) 184.7. 
2,2- Bis (4-nitropheflyl)ethyl chloroformate 
(106) BnpeocCl 
The compound was prepared by the method of Florence 
126 
2,2-B/s (4-nitrophenyl)ethaf10 1  (10.24g, 35.6 mmol) was dissolved in 120 ml 
of methylene chloride and phosgene (20% solution in toluene), (29.0 ml, 53.3 
mmol) was added followed by the addition of N-methylmOrPhOline (3.92 ml, 
35.6 mmol) over 20 minutes. After an hour the solution was filtered to remove 
the N-methylmOrPhOlifle hydrochloride and the solvent was evaporated in 
vacuo. The residue was dissolved in 100 ml of dioxan and the remaining 
N-methylmOrPhOline hydrochloride was filtered off. The solvent was 
evaporated in vacuo to give a yellow oil which was crystallised from diethyl 
ether and chloroform to give the required compound as a white solid, (10.25g, 
82%); mp 94-95 °C; v r .. (bromoform mull) 1775 (C=O), 1595-1610 (aromatic 
C-C), 1520 and 1350 cm (NO2); *SH (80 MHz, COd3), 4.7-4.9 (3H, m, bnpe 
B-CH 
and ct-CH2), 7.39 (4H, d, J 46 8.8 Hz, bnpe aromatic CH's), 8.21 (4H, d, JAB 
8.8 Hz, 
bnpe aromatic CH's); 6 (50 MHz, CDCI3), 48.9 (bnpe B -C), 71.7 (bnpe 
CL-C), 
124.1 (aromatic 3'-C), 129.0 (aromatic 2'-C), 145.5 (aromatic 4'-C), 147.3 
(aromatic 1'-C), 150.5 (C=O). 
5'-0-[2,2-  B/s (4_nitrophenVl)ethOXVCarb0nVh]thVm 1 
(107) 5'-O-Bnpeoc-T 
Thymidine (1.24g. 5.14 mmol) was co-evaporated twice with dry pyridine 
and then dissolved in 20 ml of pyridine. 2,2-B/s (4-nitrophenyl)ethyl 
chloroformate (106) (2.16g, 6.17 mmol) and N,N_dimethylamiflOPvridine (0.063g, 
0.51 mmol) were added and the reaction was stirred at room temperature for 
24 hours. The pyridine was removed in vacuo and the residue was dissolved in 
100 
methylene chloride (50 ml) and washed with water (2x50 ml) and brine (2x50 
ml). The solution was dried over sodium sulphate, filtered, and the solvent was 
removed in vacuo to produce a yellow foam which was purified using dry flash 
chromatography, eluting with 0-10% methanol in methylene chloride, to give 
the title compound as a yellow foam (0.615g. 64% ); softening point 103-108 °C; 
tic Rf(A) 0.4; 'max (bromoform mull) 3700-2500 (N-H and 0-H), 1745 (C0), 1575 
and 1405 cm -1 (NO 2); X max  (CH3CN) 271 nm, £ max  21000; 6H  (200 MHz, 
d 6-acetone) 1.73 (31-1, s, CI-13), 2.03 (11-1, m, 2'-H). 2.23 (1H, m, 2'-H), 3.02 (lH, S. 
3'-OH), 4.06 (11-1, m, 4'-H), 4.37 (2H, m, 5'-H), 4.70 (11-1, m, 3'-H), 4.92 (31-1, s, bnpe 
8-CH and ct-Cl2), 6.30 (11-1, t. JAB 6.8 Hz, 1'-1-1), 7.45 (11-1, s, 6-H), 7.72 (41-1, d, JAB 
8.8 Hz, bnpe aromatic CH's), 8.22 (41-1, d, JAB  8.8 Hz, bnpe aromatic CH's), 10.05 
(11-1, br.s, N-H); 6c  (50 MHz, d 6-acetone) 10.8 (5-CH 3
), 38.6 (2'-C), 48.5 (bnpe 
B-C), 66.8 (bnpe a-C), 67.9 (5'-C), 70.0 (3'-C), 83.2 and 84.0 (1'-C and 4'-C), 
109.3 (5-C), 122.9 (bnpe 3-C), 128.7 (bnpe 2-C), 134.9 (6-C), 146.5 (bnpe 4-C), 
149.6 (4-C), 153.7 (bnpe 1-C), 162.7 (2-C); m/z (FAB) 557 (MW) 433; HRMS (FAB) 
found 557.15198 (MW), C 25 H25 N4011 requires 557.15197 (<lppm). 
5'-O-[2,2- Bis (4_nitrophenVl)ethoxycarbOflVl1_thYmidifle3'ON, 
diisopropyl methyl phosphoramidite 
(108) 5'-0-Bnpeoc-T-3'-O-N,N-'Pr2 Me phosphoramidite 
5'-0-[2,2- B/s (4-nitrophenVl)ethOXYCarbOnVl]thYmidifle (107) (0.604g. 1.09 
mmol) was co-evaporated twice from a 50:50 mixture of pyridine : methylene 
chloride and then closed with a septum pierced with a needle and placed in an 
evacuated desiccator overnight. The desiccator was then filled with argon and 
the flask removed. The nucleoside was dissolved in 4 ml of tetrahydrofuran 
and to the flask was attached an argon filled balloon allowing pressure 
equalisation on addition of reagents. N,N-diisopropylethylamine (0.76 ml, 4.4 
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mmol) and then N,N_diisopropylmethylPhOSPhOflamidVl chloride (104) (0.84 ml, 
4.4 mmol) were added and the reaction stirred for 10 mm. Methanol (0.13 ml, 
3.3 mmol) was added to quench the excess phosphitylating agent and the 
reaction mixture was poured into 25 ml of argon-saturated ethyl acetate. This 
was washed with the following argon-saturated solutions: 2x20 ml water; 1x20 
ml 10% aqueous sodium carbonate; 2x20 ml brine, then dried over sodium 
sulphate, (which was filtered off under argon), and the solvent removed 
in 
vacuo to produce a red/brown oil. This was dissolved in 4 ml of toluene and 
precipitated into 200 ml of hexane at -20 °C. The precipitate was filtered off 
and dried overnight in an evacuated desiccator to give the title compound as a 
pale grey solid (0.632g. 81%); mp 84-90 °C; tic Rf(B)  0.6; max (methylene 
chloride solution) 2960 (C-H), 1750 (C=O), 1595-1610 (aromatic C-C), 1525 and 
1350 cm -1 (NO2); '5H (200 MHz, CDCI 3
) 1.1-1.2 (12H, m, 'Pr CH3), 1.78 (3H, S. 
5-CH 3), 2.15 (1H, m, 2'-H), 2.40 (1H, m, 2'-H), 3.33 (3H, d, PO-CH 
13.3 Hz, 
-OCH 3), 3.5-3.6 (2H, m, 'Pr CH), 4.16 (1H, m, 4'-H), 4.3 (3H, m, 5'-H and 3'-H), 
4.6-4.7 (3H, m, bnpe ct-CH2 and -CH), 6.22 (1H, t. JAB 6.8 Hz, 1'-H), 7.20 (1H, s, 
6-H), 7.39 (4H, d, JAB 8.7 Hz, bnpe aromatic H's), 8.19 (4H, d, JAB 8.8 Hz, bnpe 
aromatic H's), 10.77 (1H, s, N-H); 6 (50 MHz, CD 3CN), 11.1 (5-CH3), 23.3 ('Pr 
CH3), 37.8 (2'-C), 42.3 (d, J0p 12.3 Hz, -OCH3), 48.6 (bnpe s-C), 49.5 (d, JCNP 
17.2 Hz, 'Pr CH), 66.6 (bnpe ct-C), 68.2 (5'-C), 72.0 (2d, Jco' 17.7 Hz, 3'-C), 82.4 
(2d, J0p 13.0 Hz, 4'-C), 84.3 (1'-C), 109.9 (5-C), 123.4 (bnpe aromatic 3-C), 
128.9 (bnpe aromatic 2-C), 135.2 (6-C), 146.7 (bnpe aromatic 4-C), 149.9 (4-C), 
153.9 (bnpe aromatic 1-C), 163.2 (2-C); op (81 MHz, CDCI3), 150.6 and 150.3; 
m/z (FAB) 718 (MH) 734 and 539; HRMS (FAB) found 718.24889 (MW), 
C 32 1­1 41 N 5012P requires 718.24891 (<lppm). 
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2,2-Bis (4-nitrophenyl)ethyl benzyl carbonate 
(111) BnpeocOBz 
2,2-B/s (4-nitrophenyl)ethyl chloroformate (106) (1.239, 3.5 mmol) was 
dissolved in 10 ml of pyridine. Benzyl alcohol (0.36 ml, 3.5 mmol) and 
N,N-dimethylaminopyridifle (0.021g. 0.18 mmol) were added and the reaction 
was stirred for 24 hours. The solution was poured into 20 ml of water and 
extracted with 3x15 ml of methylene chloride. The combined organic extracts 
were washed with 2x20 ml water, 2x20 ml brine, dried over sodium sulphate 
and the solvent removed in vacua The remaining oil was purified by flash 
chromatography, eluting with 0-2% methanol in methylene chloride to give a 
white solid which was further purified by recrystallisation from chloroform to 
give the title compound as a white solid (0.49g. 33%); mp 198-200 °C; tIc Rf(c) 
0.6; vma, 
(bromoform mull) 1750 (C=O), 1595-1610 (aromatic C-C), 1520 and 
1350 (NO2), 860,740 cm -1 (aromatic C-H); Amax  (CH 3CN) 275 nm, Cmax  34000; 6 H 
(80 MHz, COd3) 4.6 (5H, m, bnpe ct-CH2, -CH and benzyl CH 2), 7.33 (4H, d, JAB 
8.8 Hz, bnpe aromatic C-H's), 7.33 (5H, m, benzyl aromatic C-H's), 8.16 (4H, d, 
AB 8.7 Hz, bnpe aromatic C-H's). 
N 3-Anisoyl-thymidine 
(114) N3-An-T 
Thymidine (1.08g. 4.45 mmol) was co-evaporated twice with pyridine and 
then dissolved in 15 ml of pyridine. Trimethylsilyl chloride (5.65 ml, 44.5 mmol) 
was added and after 30 mm. the excess was removed in vacuo and anisoyl 
chloride (2.28g, 13.4 mmol) was added. After stirring for 3 days, 20 ml of water 
was added and the reaction was stirred for 1 hour to remove the trmmethylsilyl 
groups and then the solvents were removed in vacua The residue was 
103 
dissolved in 100 ml of methylene chloride and washed with 2x100 ml of 0.11VI 
aqueous triethylammoniufli bicarbonate, WOO ml water, WOO ml brine, dried 
over sodium sulphate and the methylene chloride removed in vacuo to give a 
pale brown oily solid. This was purified by dry flash chromatography, eluting 
with 0-5% methanol in methylene chloride to produce the required product as 
a white foam, (0.61g. 37%); softening point 73-78 °C; tic  Rf(A)  0.4; Vma, 
(bromoform mull) 3700-3100 (OH), 2940 (aliphatic C-H), 1740 (C=O), 1700 and 
1650 (thymidine C=O's), 1600, 1520 and 1430 (aromatic C-C), 860-750 cm- 1 
(aromatic C-H); X max  (CH 3CN) 257 nm, CmaX  18000; 6H (200 MHz, CDCI3) 1.85 
(3H, s, 5-CH 3), 2.20 (21-1, s, 2'-H), 3.7 (31-1, m, 4'-H and 5'-H's), 3.79 (31-1, s, 
-OCH3), 3.86 (21-1, m, 3'-H and 5'-OH), 4.35 (11-1, s, 3'-OH), 6.15 (11-1, t. JAB  6.3 Hz, 
1'-H), 6.90 (21-1, d, JAB  8.9 Hz, anisoyl aromatic C-H's), 7.64 (11-1, s, 6-H), 7.82 (21-1, 
d, JAB 8.8 Hz, anisoyl aromatic C-H's); 6
C  (50 MHz, COd3) 12.3 (5-CH3), 39.8 
(2'-C), 55.6 (-OCH 3), 61.9 (5'-C), 70.9 (3'-C), 85.7 (4'-C), 87.0 (1'-C), 110.7 (5-C), 
114.5 (anisoyl aromatic 3- and 5-C), 123.6 (anisoyl aromatic 1-C), 133.0 (aniso'jl 
aromatic 2- and 6-C), 136.6 (6-C), 149.4 (4-C), 163.0 (2-C), 165.3 (anisoyl 
aromatic 4-C), 168.0 (C=O); m/z (FAB) 377 (MH) 261 251; HRMS (FAB) found 
377.13487, C 18 H 21 N207 requires 377.13486 (<lppm). 
5'-O-[2,2- Bis (4-nitrophenyi)ethoxycarbonVil-N
3-anisoyi-thymidine  
(115) 5'-O-Bnpeoc-N 3-Afl-T 
N 3-Anisoyl-thymidifle (114) (0.3819. 1.01 mmol) was co-evaporated twice 
with pyridine and then dissolved in 2 ml of pyridine. 2,2-B/s 
(4-nitrophenyl)ethyl chloroformate (106) (0.448g, 1.28 mmol) was added and the 
reaction was stirred for 24 hours. The solvent was evaporated in vacuo and 
the residue was dissolved in 50 ml of methylene chloride and washed with 
2x50 ml water, 2x50 ml brine, dried over sodium sulphate, and the methylene 
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chloride was evaporated in vacuo to yield a yellow oil. This was purified using 
dry flash chromatography, eluting with 0-2% methanol in methylene chloride to 
give the title compound as a pale yellow foam, (0.390g, 56%); softening point 
110-114°C; tIc Rf(A)  0.7; vm,, (bromoform mull) 3700-3300 (OH), 2960 (aliphatic 
C-H), 1745 (bnpe C=O), 1660 (amide C=O), 1605, 1510 and 1450 (aromatic C-C), 
1520 and 1350 (NO2), 870-750 cm -1 (aromatic (C-H); X max  277 nm, E max  26000; 
H (200 MHz, CDCI 3) 1.79 (3H, s, 5-CH 3
), 2.12 (1H, m, 2'-H), 2.25 (1H, m, 2'-H), 
2.95 (1H, br.s, 3'-OH), 3.82 (3H, s, -OCH3), 4.00 (1H, m, 4'-H), 4.30 (3H, s, 3'-H 
and 5'-H's), 4.58-4.77 (3H, m, bnpe ct-CH2 and -CH), 6.17 (1H, t. JAB 6.4 Hz, 
1'-H), 6.89 (2H, d, JAB  9.0 Hz, anisoyl aromatic H's), 7.33 (1H, s, 6-H), 7.39 (4H, d, 
AB 8.8 Hz, bnpe aromatic H's), 7.81 (2H, d, J AB 
8.9 Hz, anisoyl aromatic H's), 
8.14 (4H, d, JAB  8.7 Hz, bnpe aromatic H's); S C (50 MHz, COd3) 
12.4 (5-CH3), 
40.0 (2'-C), 49.3 (bnpe s-C), 55.6 (-OCH 3), 67.2 (bnpe ct-C), 68.7 (5'-C), 70.6 
(3'-C), 83.4 (4'-C), 85.4 (1'-C), 110.8 (5-C), 113.9 (anisoyl 3- and 5-C), 123.7 
(anisoyl 1-C), 124.0 (bnpe 3- and 5-C), 129.0 (bnpe 2- and 6-C), 132.9 (anisoyl 
2- and 6-C), 135.4 (6-C), 147.1 (bnpe 4-C), 149.2 (4-C), 154.4 (bnpe 1-C), 162.7 
(2-C), 165.2 (anisoyt 4-C), 167.7 (anisoyl amide C=O); m/z (FAB) 691 (MH); 
HRMS (FAB) found 691.18875 (MH), C 33H 31 1\1 4013 requires 691.18874 (<lppm). 
5'-O-[2,2- B/s (4_nitrophenyl)ethoxycarboflyl]_N 3_afliSOVFthVmidifle 3'N 
diisopropyl methyl phosphoramidite 
(116) 5'-O-Bnpeoc-N 3-T-3'-N,N-'PF2Me phosphoramidite 
5'-0-[2,2- B/s (4_nitrophenyl)ethoxyCarbOflyl]_N 3_afliSOyHthymidifle 	(115) 
(0.310g. 0.449 mmol) was co-evaporated twice with pyridine and then placed in 
an evacuated desiccator, closed with a septum pierced with a needle, and left 
in an evacuated desiccator overnight. The desiccator was then filled with 
argon and the needle removed. The nucleoside was dissolved in 2 ml of 
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tetrahydrofuran and an argon filled balloon was attached to the flask. 
N,N-Diisopropylamine (0.31 ml, 1.8 mmol) and then N,N-diisopropyl 
methylphosphonamidyl chloride (104) (0.35 ml, 1.80 mmol) were added and the 
reaction was stirred for 10 mm. during which the solution turned from yellow 
to pale brown. Methanol (0.05 ml, 1.3 mmol) was added to quench the excess 
phosphitylating agent and the reaction was poured into 25 ml of argon 
saturated ethyl acetate. This was then washed with the following argon 
saturated solutions: 2x20 ml water; 2x20 ml saturated aqueous sodium 
carbonate; 1x20 ml brine, and dried over sodium sulphate which was filtered off 
under argon. The solvent was removed in vacuo and the resulting brown oil 
was dissolved in 4 ml of toluene and precipitated into 200 ml of hexane at 
-20°C. The precipitate was filtered off and dried in an evacuated desiccator to 
give the title compound as a white solid, (0.301g. 79%); softening point 
98-106°C; tIc Rf(B) 0.7; Vmax (bromoform mull) 2980 (alkyl C-H), 1750 (bnpe 
C=O), 1660 (anisoyl C=O), 1605, 1310 and 1450 (aromatic C-C), 1520 and 1350 
(NO2), 870-740 cm -1 (aromatic C-H); 6  (200 MHz, CDCI3) 1.13 (12H, m, 'Pr CH3), 
1.82 (3H, s, 5-CH 3), 2.21 (1H, m, 2'-H), 2.45 (1H, m, 2'-H), 3.32 (3H, d, JCop 13.3 
Hz, P-O-CH3), 3.53 (2H, m, 'Pr2 CH), 3.84 (3H, s, anisoyl CH3), 4.17 (1H, m, 4'-H), 
4.36 (3H, m, 5'-H's and 3'-H), 4.73 (3H, m, bnpe ct-CH2 and'B -CH), 6.22 (1H, t, 
AB 6.4 Hz, 1'-H), 6.91 (2H, d, JAB 8.9 Hz, anisoyl aromatic H's), 7.30 (1H, s, 6-H), 
7.40 (4H, d, JAB 8.7 Hz, bnpe aromatic H's), 7.84 (2H, d, JAB 8.9 Hz, anisoyl 
aromatic H's), 8.18 (4H, d, JAB 8.7 Hz, bnpe aromatic H's; 6 (50 MHz, CDCI3) 
12.5 (5-CH 3), 24.5 ('Pr CH 3), 39.3 (2'-C), 42.9 (d, J COp 12.25 Hz, P-O-CH3), 49.3 
(bnpe 8-CH), 50.1 (d, JCNP 11.9 Hz, 'Pr CH), 55.5 (anisoyl -OCH3), 67.1 (bnpe 
ct-CH2), 68.7 (5'C), 72.1 (2d, J,tjp 17.2 Hz, 3'-C), 83.1 (2d, Jccop 14.9 Hz 4'-C), 
85.5 (2s, 1'-C), 110.8 (5-C), 114.4 (anisoyl aromatic 3- and 5-C), 124.1 (bnpe 
aromatic 3-C and anisoyl aromatic 1-C), 129.0 (bnpe aromatic 2- and 6-C), 
132.9 (anisoyl aromatic 2- and 6-C), 135.0 (6-C), 147 (bnpe aromatic 4-C), 149.0 
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(4-C), 154.3 (bnpe aromatic 1-C), 162.5 (2-C), 165.0 (anisoyl aromatic 4-C), 
167.5 (anisoyl amide C=O); Sp (36 MHz, CDCI3) 150.2 and 149.8; m/z (FAB) 852 
(MH) 868 820 673 592; HRMS (FAB) found 852.28570 (MH 4 ), C40H47N5014P 
requires 852.28569 (<lppm). 
5'_O_(9_FluoreIyImethOXVCarbOflYl)N 3-afliS0V1-thYmuh 1 
(117) 5'-O-Fmoc-N 3-Afl-T 
N-3-Anisoyl-thymidifle (114) (0.414g. 1.01 mmol) was co-evaporated twice 
from pyridine and then dissolved in 20 ml of pyridine. 9-Fluorenylmethyl 
chloroformate (0.344g, 1.33 mmol) was added and the reaction was stirred for 2 
hours before removing the solvent in vacua The residue was dissolved in 50 
ml of methylene chloride and washed with 2x40 ml water, 2x40 ml brine, dried 
over sodium sulphate, and the solvent evaporated in vacuo to produce a yellow 
oil. This was purified by dry flash chromatography, eluting with 0-5% methanol 
in methylene chloride to give the required product as a white foam (0.413g, 
63% ); softening point 89-92 °C; tic Rf(A) 0.6; Vmax (bromoform mull) 3700-3200 
(OH), 2940 (alkyl C-H), 1740 (anisoyl amide C=O and fmoc carbonate C=O), 1700 
and 1650 (thymidine C=O), 1600, 1510 and 1450 (aromatic C-C), 1250 (ether 
C-O-C), 840 cm -1  (aromatic C-H); X max  275 266 272 287 nm, Emax 
28000 30000 
29000 23000; 6 (200 MHz, COd3) 1.81 (3H, s, 5-CH3), 2.08 (1H, m, 2'-H), 2.29 
(1H, m, 2'-H), 3.24 (1H, br.s, 3'-OH), 3.82 (3H, s, -OCH3), 4.07 (1H, m, 4'-H), 
4.19-4.63 (6H, m, fmoc -CH and (&-CH2, 3'-H and 5'-H's), 6.27 (1H, t. JAB 6.4 
Hz, 1'-H), 6.92 (2H, d, JAB 9.0 Hz, anisoyl aromatic H's), 7.30-7.77 (9H, m, fmoc 
aromatic H's and 6-H), 7.86 (2H, d, JAB  8.9 Hz, anisoyl aromatic H's); 6c (50 
MHz, CDCI3), 12.4 (5-CH3), 40.3 (2'-C), 46.7 (fmoc B-CH), 55.5 (-OCH3), 66.9 
(fmoc ct-CH2), 69.8 (5'-C), 70.8 (3'-C), 84.1 and 85.1 (1'-C and 4'-C), 111.0 (5-C), 
114.4 (anisoyl aromatic 3- and 5-C), 120.0 (fmoc tertiary aromatic C), 124.0 
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(anisoyl aromatic 1-C), 124.7, 127.1 and 127.9 (fmoc tertiary aromatic C's), 132.9 
(anisoyl aromatic 2- and 6-C), 135.0 (6-C), 141.2 and 142.9 (fmoc quaternary 
aromatic C's), 149.2 (4-C), 154.8 (2-C), 165.1 (anisoyl aromatic 4-C), 167.7 
(amide C=O); m/z (FAB) 599 (MH); HRMS (FAB) found 599.20292 (MH), 
C 33H31N209 requires 599.20292 (<lppm). 
methyl phosphoramidite 
(118) 5'-O-Fmoc-N3-Afl-T-3'N,NPr2 Me phosphoramidite 
(117) 	(0.302g, 
0.505 mmol) was co-evaporated twice with pyridine then closed with a septum 
pierced with a needle and placed in an evacuated desiccator overnight. The 
desiccator was then filled with argon and the flask removed. The nucleoside 
was dissolved in 2 ml of tetrahydrofuran and an argon filled balloon was 
attached to the flask. N,N-Diisopropylethylamifle (0.35 ml, 2.02 mmol) and then 
N,N_diisopropylmethylPhOSPhOnamidyl chloride (104) (0.39 ml, 2.02 mmol) were 
added and the reaction was stirred for 10 mm. The solution was then poured 
into 20 ml of argon saturated ethyl acetate and washed with the following 
argon saturated solutions: 2x20 ml water; 2x20 ml saturated aqueous sodium 
carbonate; 1x20 ml brine, dried over sodium sulphate and the solvent removed 
in vacuo to give a pale yellow oil. This was dissolved in 3 ml of toluene and 
precipitated into 200 ml of hexane at -20 °C. The solid was filtered off and 
dried overnight in an evacuated desiccator to give the required product as a 
white solid (0.240g. 63%); softening point 81-86 °C; tIc Rf(B) 0.7; Vmax 
(bromoform mull) 2960 (alkyl C-H), 1750 (anisoyl amide C=O and fmoc 
carbonate C=O), 1700 and 1660 (thymidine C=O), 1600, 1520 and 1450 (aromatic 
C-C), 1260 (ether C-O-C), 850 cm -1 (aromatic C-H); oH (200 MHz, CDCI3) 1.16 
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(12H, m, 'Pr CH 3), 1.83 (3H, s, 5-CH 3), 2.15 (1H, m, 2'-H), 2.48 (1H, m, 2'-H), 3.36 
(3H, d,JP-CH 13.3 Hz, P-0-CH3), 3.47-3.67 (2H, m, 'Pr CH), 3.83 (3H, s, anisoyl 
-OCH3), 4.23-4.59 (7H, m, fmoc ct-CH2 and B-CH, 3'-H, 4'-H and 5'-H's), 6.34 
(1H, t. JAB 6.7 Hz, 1'-H), 6.92 (211, d, JAB 8.8 Hz, anisoyl aromatic H's), 7.25-7.78 
(9H, m, fmoc aromatic H's and 6-H), 7.87 (2H, d, JAB 8.9Hz, anisoyl aromatic H's); 
'Sc (50 MHz, COd3) 12.5 (5-CH 3), 24.5 ('Pr CH3), 39.6 (2'-C), 42.9 (d, J0p 12.2 Hz, 
P-O-CH3), 46.6 (fmoc B-CH), 50.0 ('Pr CH), 55.5 (anisoyl O-CH3), 66.7 (fmoc 
ct-CH2), 69.9 (5'-C), 72.4 (d, J0p 16.8 Hz, 3'-C), 83.6 (d, J0,, 14.6 Hz, 4'-C), 85.1 
(2s, 1'-H), 111.1 (5-C), 114.3 (anisoyl aromatic 3- and 5-C), 120.0 (fmoc tertiary 
aromatic C), 124.2 (anisoyl 1-C), 124.7, 127.1 and 127.9 (fmoc tertiary aromatic 
C's), 132.9 (anisoyl aromatic 2- and 6-C), 134.8 (6-C), 141.2 and 142.9 (fmoc 
quaternary aromatic C's), 149.2 (4-C), 154.7 (2-C), 165.0 (anisoyl aromatic 4-C), 
167.7 (amide C=O); 'Sp (81 MHz, CDCI3) 150.3 and 150.9. 
2,2,2-Triphenviethanol 
(119) Ph 3CCH20H 
2,2,2-Triphenylacetic acid (4.17g. 14.5 mmol) was dissolved in 400 ml of 
sodium dried diethyl ether and lithium aluminium hydride (1.13g. 29.7 mmol) 
was added slowly whilst stirring under nitrogen. The reaction was stirred for 
16 hours and turned from a grey suspension to a yellow solution. The reaction 
was quenched with 2M aqueous potassium hydrogen sulphate and the ether 
layer was washed with 3x100 ml water, 2x100 ml brine, dried over sodium 
sulphate and the solvent removed in vacuo to afford a white solid which was 
recrystallised from 	ethanol 	to 	give the 	required 	product 	(3.12g. 78%); mp 
105-107°C (lit. 110 °C 131 ); tIc Rf(D) 0.5; "max (bromoform mull) 3580 and 
3500-3200 (0-H), 2900 (alkyl C-H), 1600, 1490 and 1450 (aromatic C-C), 
1100-1000 (aromatic C-H), 750 and 700 cm -1  (aromatic C-H); 'SH (80 MHz, 
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COd ) 1.62 (1H, s, OH), 4.66 (2H, s, methylene H's), 7.27 (15H, S. aromatic H's); 
S C (50 MHz, COd3) 58.7 (ethyl 8-C), 70.1 (ethyl ct-CH2), 126.4 (aromatic 4-C), 
128.0 (aromatic 2-C), 129.3 (aromatic 3-C), 145.0 (aromatic 1-C); m/z (FAB) 257 
(MH-OH) 243. 
2,2,2-TriphenylethoxyphOSphOdiChlOridite 
(120) Ph 3CCH20PCI2 
2,2,2-Triphenylethanol (119) (0.167g. 0.608 mmol) was dissolved in 5 ml of 
methylene chloride and trimethylsilyl chloride (0.154 ml, 1.22 mmol) and 
triethylamine (0.253 ml, 1.82 mmol) were added. After stirring for 1 hour under 
nitrogen the triethvlamine hydrochloride was filtered off and the solvent 
removed in vacua The residue was dissolved in ethyl acetate and the 
remaining triethylamine hydrochloride was filtered off and the solvent 
evaporated in vacuo to produce a red oil. 6H  (200 MHz, CDCI3) 0.34 (9H, S. 
SiCH3), 4.97 (2H, s, methylene H's), 7.57 (15H, m, aromatic H's). This was 
dissolved in 5 ml of methylene chloride and cooled to -78 °C, then 
trictilorophosphifle (0.053 ml, 0.608 mmol) was added and the reaction stirred 
for 6 hours under nitrogen before being allowed to reach room temperature 
slowly. The solvent was removed in vacuo to give the title compound as a 
colourless oil (0.210g. 92%); 6H  (80 MHz, CDCI3) 5.26 (2H, d, P-o-CH 
7 Hz, 




Freshly prepared 2,2,2_triphenylethOXvPhosPhodic oridite (120) (1.269, 3.36 
mmol) was dissolved in 5 ml of methylene chloride and N,N-diisopropylamifle 
(0.94 ml, 6.71 mmol) was added. The solution was 
stirred for 10 mm. under 
nitrogen then the diisopropvlamine hydrochloride was filtered off under suction 
in a dry argon atmosphere, and the methylene chloride was removed in vacua 
Further diisopropylamine hydrochloride was removed to give the title 
compound as an oil (1.35g, 94%); 6H (80 MHz, CDCI3) 1.1-1.2 (12H, m, 'Pr CH3), 
3.8 (2H, m, 'Pr CH), 5.29 (2H, s, methylene H's), 7.23 (15H, m, aromatic H's); 6, 
(36 MHz, CDCI3) 181.2. 
5'-O--[2,2- Bis (4_hitrophenVl)ethOXcarb0flYthYmide_ 3 _OT 
diisopropyl 2,2,2-triphenylethyl phosphoramidite 
(122) 5'_O_Bnpeoc-T-3'-ON,NPr2 Ph 3CCH2 phosphoramidite 
5'-O-[2,2- B/s (4_nitrophenyl)ethOXYCarbOflYlFthYm 	
(107) (0.405g. 0.728 
mniol) was co-evaporated with 10% pyridine in methylene chloride then closed 
with a septum pierced with a needle and left in an evacuated desiccator 
overnight. The desiccator was filled with argon and the needle removed from 
the flask and an argon filled balloon attached to the flask. The nucleoside was 
dissolved in 5 ml of tetrahydrofuran and N,N-diisopropylamine (0.506 ml, 2.91 
mmol) and thenN,N-diisopropyl-(2,2,2-triphenylethyl)phosphonamidyI chloride, 
(121) (1.28g. 2.91 mmol) were added and stirred for 15 mm. under argon before 
the reaction was quenched with methanol (0.09 ml, 2.18 mmol) and poured into 
20 ml of argon-saturated ethyl acetate. This was washed with the following 
argon-saturated solutions: 1x20 ml water; 2x20 ml 10% aqueous sodium 
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carbonate; 2x20 ml brine, dried over sodium sulphate and filtered off under 
argon. The solvent was evaporated in vacuo and the residue was dissolved in 
5 ml of ethyl acetate and precipitated into 500 ml of hexane at -78 °C. The 
precipitate was filtered off and dried in an evacuated desiccator to give the 
title compound as a cream solid (0.418g,60%); softening point 69-73
°C; tIc 
Rf(B) 0.6; 'max 
(bromoform mull) 2980 (alkyl C-H), 1750 (bnpe C=O), 1720-1650 
(thymidine C=O), 1600, 1510 and 1450 (aromatic C-C), 1520 and 1350 (NO2), 
860-740 cm -1 (aromatic C-H); 6N (200 MHz, CDCI3) 0.99-1.35 (12H, m, 'Pr CH3), 
1.79 (3H, s, 5-CH 3), 2.15 (114, m, 2'-H), 2.44 (11A, m, 2'-H), 3.50 (2H, m, 'Pr CH), 
3.93 (2H, s, P-OCH2), 4.16 (114, m, 4'-H), 4.33-4.39 (3H, m, 3'-H and 5'-H's), 
4.62-4.76 (3H, m, bnpe ct-CH2 and B-CH), 6.18 (111, m, 1'-H), 7.08-7.35 (16H, m, 
aromatic phenyl H's and 6-H), 7.40 (4H, d, JAB 8.4 Hz, bnpe aromatic H's), 8.19 
(4H, d, JAB 
8.7Hz, bnpe aromatic H's); & (50 MHz, COd3) 12.3 (5-CH3), 24.3 ('Pr 
CH3), 39.2 (2 1-C), 43.0 ('Pr CH), 49.3 (bnpe B-CH), 67.1 (bnpe ct-CH2), 68.7 (5'-C), 
69.9 (P-OCH2), 72.0 (3'-C), 83.0 and 84.9 (1'- and 4'-C), 110.7 (5-C), 124.1 (bnpe 
aromatic 3-C), 127.7 (bnpe aromatic 2-C), 126.1 128.9 and 129.3 (phenyl 
aromatic 2-, 3- and 4-C's), 135.2 (6-C), 145.4 and 146.0 (bnpe 4-C and Ph 3C-), 
147.2 (phenyl aromatic 1-C), 150.0 (4-C), 154.3 (bnpe aromatic 1-C), 163.5 (2-C); 
S, (36 MHz, CDCI3) 148.9 and 147.8. 
5'-0-[2,2-  Bis 	
ne 
(123) 5'_O_Bnpeoc-N 6-BZ2'dA 
N 6_Benzoyl-2'-deOXVadeflosine (0.276g, 0.777 mmol), was co-evaporated 
twice with pyridine and then dissolved in 2 ml of pyridine and 2,2-bis 
(4-nitrophenyl)ethyl chloroformate (106) (0.327g. 0.933 mmol) was added and 
the reaction was stirred for 18 hours. The solution was then poured into 50 ml 
of water and extracted with 3x20 ml of methylene chloride. The combined 
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organic layers were washed with 2x50 ml water, 1x50 ml brine, dried over 
sodium sulphate and the solvent removed in vacuoto yield a pale brown foam. 
This was purified by dry flash chromatography, eluting with 0-4% methanol in 
methylene chloride to give the title compound as a white foam (0.245g. 47%); 
softening point 109-113 °C; tIc Rf(A) 0.4; Vma,  (bromoform mull) 3700-3100 (0-H 
and N-H), 2960 (alkyl C-H), 1750 (bnpe C=0), 1700 (amide C=0), 1610 (amide 
N-H), 1590, 1510 and 1450 (aromatic C-C), 1520 and 1350 cm -1 (NO2); Amax 277 
nm, Cmax  25000; 6H (200 MHz, CDCI 3) 2.52 (1H, m, 2'-H), 2.64 (1H, m, 2'-H), 4.20 
(1H, m, 4'-H), 4.32 (2H, m, 5'-H), 4.62 (4H, m, 3'-H and bnpe ct-CH2 and 5-CH), 
5.01 (1H, br.s, 3'-OH), 6.43 (1H, t. JAB  6.0 Hz, 1'-H), 7.30 (4H, d, JAB  8.5 Hz, bnpe 
aromatic H's), 7.38 (3H, m, benzoyl 3-, 4- and 5-H), 7.93 (2H, s, benzoyl 2- and 
6-H), 8.00 (4H, d, JAB  8.5 Hz, bnpe aromatic H's), 8.08 (1H, s, 2-H), 8.57 (1H, s, 
8-H), 9.50 (1H, br.s, amide H); 6 C (50 MHz, CDCI 3) 39.8 (2'-C), 48.9 (bnpe B -C), 
67.4 (bnpe cL-C), 68.6 (5'-C), 71.2 (3'-C), 84.3 and 84.4 (1'-C and 4'-C), 123.1 
(5-C), 123.8 (bnpe aromatic 3-C), 127.7 and 128.5 (benzoyl aromatic 2- and 
3-C), 128.9 (bnpe aromatic 2-C), 132.7 (benzoyl aromatic 4-C), 133.1 (benzoyl 
aromatic 1-C), 141.5 (2-C), 146.1 (bnpe aromatic 4-C), 149.2 and 151.1 (6-C and 
4-C), 152.0 (8-C), 154.2 (bnpe aromatic 1-C), 165.1 (amide C=O); m/z (FAB) 670 
(MH); HRMS (FAB) found 670.18976 (MH), C 32H28N7010 requires 670.18975 
(<lppm). 
51-042,2- B/s (4_nitrophenyl)ethoxycarbOflyl] -N6-beflZOYF2'deOxyadeflosifle 
-3'-O-N,N-diisopropvl methyl phosphoramidite 
(124) 5'-O--l3npeoc-N 6-Bz-2'-dA-3'-O-N,N-'Pr2 Me phosphoramidite 
5'-O-[2,2- B/s (4_nitrophenyl)ethoxcarbonyl]-N 6-benzoYk 
2'-deoxvadenosine (123) (0.2559, 0.336 mmol) was co-evaporated twice with a 
50:50 mixture of pyridine : methylene chloride and then placed in an evacuated 
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desiccator overnight covered with a septum pierced with a needle. The 
desiccator was filled with argon and an argon filled balloon was attached to the 
flask. The nucleoside was dissolved in 2 ml of tetrahydrofuran and 
N,N-diisopropylethylamine (0.24 ml, 1.35 mmol) and then 
N,N_diisopropvlmethylPhOSPhOflamidYi chloride (104) (0.26 ml, 1.35 mmol) were 
added and the reaction was stirred for 10 mm. The reaction was quenched 
with methanol (0.04 ml, 1.01 mmcl) and then poured into 20 ml of argon 
saturated ethyl acetate and washed with the following argon saturated 
solutions: 1x20 ml water; 2x20 ml saturated aqueous sodium carbonate; 1x20 
ml brine, dried over sodium sulphate and filtered in a dry argon atmosphere. 
The solvent was removed in vacua to give a yellow oil which was dissolved in 
3 ml of toluene and precipitated into 100 ml of hexane at room temperature. 
The precipitate was filtered off and dried overnight in an evacuated desiccator 
to give the title compound as a white solid (0.219g, 78%); softening point 
98-104°C; tic R f ( 6) 0.5; umax 
(bromoform mull) 2960 (alkyl C-H), 1750 (bnpe 
C=O), 1705 (amide C=O), 1610 (amide N-H), 1590, 1510 and 1450 (aromatic C-C), 
1520 and 1350 cm -1  (NO2); 6H (200 MHz, CDCI3) 1.13 (12H, m, 'Pr CH3), 2.62 (1H, 
m, 2'-H), 2.73 (1H, m, 2'-H), 3.33 (3H, 2d, JpoC 13.3 Hz, -OCH3), 3.56 (2H, m, 'Pr 
CH), 4.25-4.40 (3H, m, 4'-H and 5'-H's), 4.63 (4H, m, bnpe ct-CH2 and -CH and 
3'-H), 6.42 (1H, t. JAB 6 Hz, 1'-H), 7.31-7.52 (7H, m, bnpe aromatic H's and 
benzoyl 3-, 4- and 5-H), 7.96-8.12 (7H, m, 2-H, bnpe aromatic H's, benzoyl 2- 
and 6-H), 8.46 (1H, s, 8-H); &c (50 MHz, COd3) 24.4 ('Pr CH 3), 39.2 (2'-C), 42.8 
(d, 	12.3 Hz, -OCH3), 49.1 (bnpe BCH), 50.3 (d, cNp 
17.8 Hz, 'Pr CH), 67.0 
(bnpe a-CH2), 68.6 (5'-C), 72.6 (2d, JCOp 18 Hz, 3'C), 83.6 (2d, JCop 
14.4 Hz, 
4'-C), 84.5 (2s, 1'-C), 123.5 (5-CO. 124.0 (bnpe aromatic 3-C), 127.8 and 128.6 
(benzoyl aromatic 2- and 3-C), 129.0 (bnpe aromatic 2-C), 132.6 (benzoyl 
aromatic 4-C), 133.4 (benzoyl aromatic 1-C), 141.3 (2-C), 146.2 (bnpe aromatic 
4-C), 149.5 (6-C), 151.3 (4-C), 152.2 (8-C), 154.2 (bnpe aromatic 1-C), 164.9 
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(amide C=O); op (36 MHz, COd3), 149.8; m/z (FAB) 831 (MH) 847 652; HRMS 
(FAB) found 831.28675(MH), C 39H 44N8011P requires 831.28669 (<lppm). 
5'-O-[2,2- B/s (4_nitrophenyl)ethOxyCarbOflYlFthYmidine-3'-O-acetate 
(125) 5'-O-Bnpeoc-T-3'-OAC 
5'-O-[2,2- B/s (4_nitrophenyl)ethOXVCarbOflylFthymidifle (107) (0.469g, 0.844 
mmol) was co-evaporated with pyridine then dissolved in 8 ml of pyridine and 
acetic anhydride (0.48 ml, 5.06 mmol) was added and the solution stirred 
overnight. The pyridine was removed in vacua and the resulting brown oil was 
dissolved in 50 ml of methylene chloride and washed with 2x30 ml water, 2x30 
ml saturated aqueous sodium carbonate, 1x30 ml brine, dried over sodium 
sulphate and the solvent removed in vacua The oil obtained was purified by 
dry flash chromatography, eluting with 0-3% methanol in methylene chloride to 
produce the title compound as a pale brown foam (0.319g. 78%), softening 
point 98-103°C; tIc Rf(A) 0.7; v m , x  (methylene chloride solution) 2960 (alkyl 
C-H), 1760-1670 (C=O's), 1525 and 1350 cm (NO2); X max  (CH 3CN) 269 nm, 
C max 
 20000; 6H (200 MHz, COd3) 1.70 (31-1, s, 5-CH3), 2.01 (3H, s, acetyl CI -1 3) ,  
2.04 (11-1, m, 2'-H), 2.35 (11-1, m, 2'-H), 4.13 (1H, m, 4'-H), 4.34 (2H, m, 5'-H), 4.7 
(3H, m, ct-CH2 and B-CH), 5.12 (11-1, m, 3'-H), 6.22 (1H, t JAB 8.1 Hz, 1'-C), 7.19 
(1H, s, 6-H), 7.37 (4H, d, JAB 8.8 Hz, bnpe H's), 8.10 (41-1, d, JAB 
8.8 Hz, bnpe H's), 
9.90 (111, s, amide H); Oc 
 (50 MHz, COd3) 12.3 (5-CH3), 20.6 (acetyl CH3), 36.9 
(2'-C), 49.3 (bnpe -CH), 67.3 (bnpe c&-CH2), 68.8 (5'-C), 73.6 (3'-C), 81.7 (4'-C), 
84.7 (1'-C), 111.2 (5-C), 124.0 (bnpe aromatic 3-C), 129.0 (bnpe aromatic 2-C)), 
134.9 (6-C), 146.0 (bnpe aromatic 4-C), 150.3 (4-C), 154.2 (bnpe aromatic 1-C), 
163.7 (2-C), 170.3 (acetyl C=O); m/z (FAB) 599 (MW); HRMS (FAB) found 




Thymidine (3.207g. 13.25 mmol) was co-evaporated with pyridine then 
dissolved in 35 ml of pyridine and 4,4'-dimethoxytritvl chloride (5.837g, 17.23 
mmol), triethylamine (2.40 ml, 17.23 mmol) and N,N-dimethylaminopyridine 
(0.081g. 0.66 mmol) were added. The reaction was stirred for 4 hours and then 
poured into 100 ml water and extracted with 2x400 ml diethyl ether. The 
combined organic layers were washed with 3x200 ml water, WOO ml brine, 
dried over sodium sulphate, and the solvent was removed in vacuo to give a 
brown oil. This was crystallised from chloroform and diethyl ether to produce 
,- 
the required product as a white, crystalline solid (5.379g, 75%); mp 142-144'C; 
Rf(A) 0.4; 'umax (methylene chloride solution) 2940 (alkyl C-H), 1710-1680 
(C=O's), 1610, 1510 and 1430 cm -1  (aromatic C-C); 6H (80 MHz, CDCI3) 1.34 (3H, 
s, 5-CH 3), 2.33 (1H, m, 2'-H), 2.40 (1H, m, 2'-H), 3.37 (2H, m, 5'-H), 3.48 (1H, m, 
4'-H), 3.73 (6H, s, -OCH3), 4.05 (11-1, m, 3'-H), 4.55 (1H, br.s, 3'-OH), 6.38 (1H, t, 
AB 6 Hz, 1'-H), 6.78 (4H, d, JAB  8.9 Hz, aromatic H's), 7.25 (4H, d, JAB  8.9 Hz, 
aromatic H's), 7.24 (5H, m, aromatic H's), 7.55 (1H, s, amide H); 6c (50 MHz, 
COd3) 11.7 (5-CH 3), 40.8 (2'-C), 55.1 (-OCH3), 63.6 (5'-C), 72.3 (3'-C), 84.7 (4'-C), 
86.3 (1'-C), 86.7 (DMTr Ar 3C), 111.1 (5-C), 113.1 (DMTr MeO-aromatic 3-C), 
126.9, 127.8 and 128.0 (DMTr phenyl aromatic 2-, 3- and 4-C), 129.9 (DMTr 
MeO-aromatic 2-C), 135.3 (DMTr MeO-aromatic 1-C), 135.7 (6-C), 144.3 (DMTr 
phenyl aromatic 1-C), 150.7 (4-C), 158.5 (DMTr MeO-aromatic 4-C), 164.1 (2-C); 
m/z (FAB) 545 (MH) 438 303; HRMS (FAB) found 545.22877 (MW), C 31 H331\1207 
requires 545.22876 (<lppm). 




5'-O-(4,4'-Dimethoxytrityl)-thymidine (63) (1.024g. 1.85 mmol) was dissolved 
in 10 ml of pyridine and acetic anhydride (0.566g. 5.55 mmol) was added and 
the solution stirred for 24 hours. The pyridine was removed in vacuo and the 
residue dissolved in 50 ml of methylene chloride and washed with 2x100 ml 
water, WOO ml saturated aqueous sodium carbonate, WOO ml brine, dried 
over sodium sulphate, and the methylene chloride was evaporated in vacuo to 
produce a white foam. The nucleoside was then refluxed in 80% aqueous 
acetic acid for 5 hours and the solvent was removed in vacuo to give an 
orange oil which was purified by dry flash chromatography, eluting with 0-5% 
methanol in methylene chloride to produce a pale yellow foam. This was 
further purified by crystallisation from methylene chloride and diethyl ether to 
give the required product as a white solid (0.043g. 23%); mp 174-175 °C; Rf(A) 
0.8; umax  (bromoform mull) 2940 (alkyl C-H), 1730-1660 cm -1 (C=O's); 5H  (200 
MHz, d 6-DMSO) 1.78 (3H, s, 5-CH 3), 2.06 (3H, s, acetyl CH 3), 2.27 (2H, m, 2'-H), 
3.63 (2H, m, 5'-H's), 3.98 (1H, m, 4'-H), 5.2 (2H, m, 3'-H and 5'-OH), 6.18 (1H, t, 
AB 7 Hz, 1'-H), 7.74 (1H, s, 6-H); 6c  (50 MHz, d 6-DMSO) 12.4 (5-CH3), 20.9 
(acetyl CH 3), 36.6 (2'-C), 61.4 (5'-C), 74.8 (3'-C), 83.8 (4'-C), 84.7 (1'-C), 109.8 
(5-C), 135.9 (6-C), 150.6 (4-C), 163.8 (2-C), 170.1 (acetyl C=O); m/z (FAB) 285 




(63a) 5'-O-DMTr-T-3'-O-CO - Ph 
5'-O-(4,4'-Dimethoxytrityl) -thym idine (63) (0.2029, 0.365 m mol) was 
dissolved in pyridine and benzoic anhdride (0.1519. 0.547 mmol) and 
N,N-dimethylamiflopyridine (0.0089g, 0.073 mmol) were added and the reaction 
was stirred for 48 hours. It was then poured into 50 ml water and extracted 
with 4x15 ml methylene chloride. The combined organic layers were washed 
with 1x50 ml water, 2x50 ml saturated aqueous sodium carbonate, 1x50 ml 
brine, dried over sodium sulphate, and the solvent was removed in vacuo to 
give a yellow oil. This was purified by dry flash chromatography, eluting with 
0-3% methanol in methylene chloride to give the required product as a white 
foam (0.216g, 92%); softening point 107-111 °C; tIc Rf(A) 0.7; 'max (methylene 
chloride solution) 2960 (alkyl C-H), 1730-1680 (C=O's), 1610, 1510 and 1430 
cm-1 (aromatic C-C); SH (200 MHz, CDCI 3) 1.43 (31-1, s, 5-CH3), 2.60 (2H, m, 2'-H), 
3.56 (21-1, m, 5'-H's), 3.77 (31-1, m, -OCH3), 4.30 (11-1, m, 4'-H), 5.72 (11-1, m, 3'-H), 
6.56 (11-1, t. JAB 6.0 Hz, 1'-1-1), 6.84 (4H, d, JAB 8.8 Hz, DMTr aromatic H's), 
7.23-7.58 (12H, m, DMTr and benzoyl aromatic H's), 7.66 (11-1, s, 6-H), 8.04 (21-1, d 
AB 7.1 Hz, benzoyl aromatic H's), 9.66 (1H, br.s,.N-H); 5c (50 MHz, COd3), 11.6 
(5-CH3), 38.0 (2'-C), 55.1 (-OCH3), 63.6 (5'-C), 75.8 (3'-C), 84.0 and 84.3 (1'-C 
and 4'-C), 87.1 (DMTr Ar 3C), 111.6 (5-C), 113.2 (DMTr methoxy aromatic 3-C), 
127.1-130.0 (benzoyl aromatic 2- and 3-C, DMTr methoxy aromatic 2-C, and 
DMTr phenyl aromatic 2-, 3- and 4-C), 133.4 (benzoyl aromatic 4-C), 135.1 
(DMTr methoxy aromatic 1-C), 135.3 (6-C), 144.1 (DMTr phenyl aromatic 1-C), 
150.6 (4-C), 158.6 (DMTr methoxy aromatic 4-C), 163.9 (2-C), 165.9 (benzoyl 
aromatic 1-C); m/z (FAB) 649 (MW); HRMS (FAB) found 648.24717 (MH), 




5'-O-(4,4'-Dimethoxytrityl)-3'-0-beflZOYFthYmidifle 	(63a) 	(4.407g. 	6.80 
mmol) was dissolved in 50 ml of a 1% p-toluenesulphonic acid solution in 95% 
chloroform / 5% methanol and stirred for 10 mm. ioo ml of methylene 
chloride was added to the organic solution which was then washed with 2x50 
ml 5% aqueous sodium hydrogen carbonate, 1x100 ml water, 2x100 ml brine, 
dried over sodium sulphate and the solvent was removed in vacua The 
resulting oil was crystallised from ethanol to produce the required compound 
as a white solid (1.295g. 55%); mp 182-185 °C; tic Rf(A) 0.5; Vma. (bromoform 
mull) 3700-3200 (0-H and N-H), 2960 (alkyl C-H), 1730-1630 cm -1  (C=O's); 6,. 
(200 MHz, d6-DMSO) 1.80 (31-1, s, 5-CH 3), 2.44 (21-1, m, 2'-H), 3.72 (21-1, m, 5'-H), 
4.17 (11-1, m, 4'-H), 5.27 (11-1, br.s, 5'-OH), 5.50 (11-1, m, 3'-H), 6.31 (11-1, t JAB 7.2 
Hz, 1'-1-1), 7.49-8.03 (51-1, m, aromatic benzoyl H's), 7.80 (11-1, s, 6-H), 11.34 1H, s, 
amide H); ôc  (50 MHz, d 6-DMSO), 12.3 (5-CH 3), 36.8 (2'-C), 61.5 (5'-C), 75.7 
(3'-C), 84.0 and 84.7 (4'-C and 1'-C), 109.9 (5-C), 128.8 and 129.4 (benzoyl 
aromatic 2- and 3-C), 133.6 (benzoyl aromatic 4-C), 136.0 (6-C), 150.6 (4-C), 
163.7 (2-C), 165.3 (benzoyl aromatic 1-C); m/z (FAB) 347 (MW); HRMS (FAB) 
found 347.12428 (MH 4 ), C 17 H 19N206 requires 347.12430 (<lppm). 
5'-O-[ Bis (4-nitrophenyl)ethoxycarbOflylF3'OdimethVl phosphate 
(127a) 5'-0-Bnpeoc-T-3'-O-Me2 phosphate 
5'-0-[2,2- B/s (4_nitrophenyl)ethoxycarbOflyll -thymidifle3'ON,N 
diisopropylmethyphosphoramidite (108) (0.156g. 0.218 mmol) was dissolved in 
1 ml of acetonitrile and tetrazole (0.076g. 1.09 mmol) and methanol (0.044 ml, 
1.09 mmol) were added and the solution was stirred under nitrogen for 10 mm. 
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A solution of iodine (0.05 M) in water : pyridine : tetrahydrOfuran (1:10:40) (4.35 
ml, 0.218 mmol) was added and the solution was stirred for a further 10 mm. 
The solvent was removed in vacua and the brown oil remaining was dissolved 
in 25 ml of methylene chloride and washed with 1x25 ml water, 2x25 ml 10% 
aqueous sodium thiosuiphate, 1x25 ml brine, dried over sodium sulphate and 
the solvent evaporated in vacua to give a pale brown foam. This was purified 
by dry flash chromotographv, eluting with 0-5% methanol in methylene 
chloride to give the title compound as a pale brown foam (0.047g. 31%); 
softening point 76-80°C; tIc Rf(A) 0.6; v m,x  (methylene chloride solution) 2960 
(alkyl C-H), 1750 (bnpe C=O), 1720-1680 (thymidine C=O's), 1520 and 1350 cm- I 
(NO2); X max  268 nm, E max  20000; 6H (200 MHz, CD
3CN), 1.70 (3H, s, 5'-H), 1.93 
(2H, m, 2'-H), 3.70 (6H, d, JC0p 12.1 Hz, -OCH3), 4.23 (1H, m, 4'-H), 4.30 (2H, m, 
5'-H's), 4.75 (3H, m, bnpe ct-CH2 and B-CH), 4.88 (1H, m, 3'-H), 6.15 (1H, t. JAB 
6.9 Hz, 1'-H), 7.23 (1H, s, 6-H), 7.52 (4H, d, JAB 8.9 Hz, bnpe p-disubstituted 
aromatic H's), 8.14 (4H, d, JAB 8.9 Hz, bnpe p-disubstituted aromatic H's), 9.56 
(1H, br.s, N-H); 6C (50 Hz, CD 3CN) 11.2 (5-CH 3
), 37.1 (2'-C), 48.7 (bnpe B-C), 
54.0 (d, Jcoi' 
5.0 Hz, -OCH3), 66.5 (bnpe ct-C), 68.4 (5'-C), 76.4 (d, J0p 5.0 Hz, 
3'C), 81.7 (d, J0p 6.2 Hz, 4'-C), 84.5 (1'-C), 110.3 (5-C), 123.6 and 129.1 (bnpe 
2- and 3-C), 135.5 (6-C), 146.9 (bnpe aromatic 4-C), 150.1 (4-C), 153.9 (bnpe 
aromatic 1-C), 163.4 (2-C); S (36 MHz, CD 3CN) 0.7; m/z (FAB) 665 (MW) 539; 
HRMS (FAB) found 665.14957 (MH), C 27H30N4014P requires 665.14959 (<1 ppm). 
5'-0-[ Bis (4_nitrophenyl)ethOXVCarbOflVl]thYm 	
e-3--O-benzVl methyl 
phosphate 
(127b) 5'_O-Bnpeoc-T-3'0BZ Me phosphate 
5'-O-[Bis 
methyl phosphoramidite (108) (0.201g, 0.280 mmol) was dissolved in 10 ml of 
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acetonitrile and benzyl alcohol (0.155 ml, 1.40 mmol) then tetrazole (0.0989, 1.40 
mmol) were added and the reaction was stirred for 15 mm. A solution of 
iodine (0.1 M) in water : pyridine : tetrahydrofuran (1:10:40) (2.80 ml, 0.28 mmol) 
was added and after stirring for 10 mm. the solvents were evaporated in vacuo 
and the residue was dissolved in 20 ml of methylene chloride. This was 
washed with 1x20 ml water and the aqueous layer was then extracted with 2x5 
ml methylene chloride. The combined organic layers were washed with 1x20 
ml 10% aqueous sodium thiosulphate solution, 1x20 ml brine, dried over 
sodium sulphate and the solvent was removed in vacuo to give an oil. This 
was purified by dry flash chromatography, eluting with 0-5% methanol in 
methylene chloride to give the title compound as a pale brown oil (0.044g, 
21%); softening point 56 -59°C; tIc Rf(A)  0.7; Umax  (bromoform mull) 2960 (alkyl 
C-H), 1750 (bnpe C=O), 1690 (thymidine C=O's), 1610, 1530 and 1450 (aromatic 
C-C), 1520 and 1350 cm -1 (NO2); 6H  (200 MHz, COd 3) 1.77 (3H, s, 5-CH 3), 2.14 
(1H, m, 2'-H), 2.43 (1H, m, 2'-H), 3.70 (3H, d, 11.3 Hz, -OCH 3), 4.12-4.40 (3H, 
m, 4'-H and 5'-H's), 4.57-4.80 (3H, m, bnpe cz-CH 2 and B-CH), 4.86 (1H, m, 3'-H), 
5.05 (2H, d, PH  9.3 Hz, benzyl -CH 2-), 6.18 (1H, t. JAB  7 Hz, 1'-H), 7.10 (1H, m, 
6-H), 7.25-7.41 (9H, m, bnpe aromatic H's and benzyl aromatic H's), 8.18 (1H, d, 
AB 8.7 Hz, bnpe aromatic H's); 6 (50 MHz, CDCI 3) 12.3 (5-CH 3), 38.1 (2'-C), 49.3 
(bnpe 8-C), 54.4 (d, Jco'  5.7 Hz, -OCH 3), 66.8 (bnpe ce-C), 68.8 (5'-C), 69.8 (d, 
Jcoi' 5.4 Hz, benzyl -CH 2-), 76.5 (3'-C), 82.1 (d, J CCOp 3.1 Hz, 4'-C), 84.8 (1'-C), 
111.1 (5-C), 124.1 (bnpe aromatic 3-C), 126.8-128.9 (bnpe aromatic 2-C and 
benzyl aromatic C's), 134.9 (6-C), 145.9 (benzyl aromatic 1-C), 147.2 (bnpe 
aromatic 4-C), 149.9 (4-C), 154.1 (bnpe aromatic 1-C), 163.3 (2-C); 6p (36 MHz, 




Thymidine (1.939g, 8.01 mmol) was co-evaporated twice from pyridine and 
then dissolved in 20 ml pyridine. 9-Fluorenvlmethyl chioroformate (2.49g, 9.61 
mmol) was added and the reaction was stirred for 6 hours. The pyridine was 
removed in vacuo and the residue was dissolved in 40 ml methylene chloride 
and washed with 2x40 ml water. The combined aqueous layers were extracted 
with 20 ml methylene chloride and the combined organic layers were washed 
with 2x30 ml brine, dried over sodium sulphate, and the methylene chloride 
was evaporated in vacua The oil obtained was crystallised from methylene 
chloride and petroleum ether (bp 40-60 °C) to give the required product as a 
white solid (1.856g. 50%); mp 183-186 °C; tic Rf(A) 0.5; max (bromoform mull) 
3500-3200 (0-1-1), 2960 (alkyl C-H), 1750 (fmoc C=O), 1700 and 1670 (thymidine 
C=O's), 1490-1450 cm -1 (aromatic C-C); SH  (200 MHz, d 6-DMSO) 1.69 (31-1, s, 
5-CH 3), 2.12 (21-1, m, 2'-H), 3.92 (11-1, m, 4'-H), 4.20 (11-1, m, 3'-H), 4.27-4.30 (31-1, 
m, fmoc ct-CH2 and -CH), 4.57 (21-1, m, 5'-H's), 5.52 (11-1, br.s, 3'-OH), 6.19 (11-1, t, 
AB 6.7 Hz, 1'-H), 7.31-7.89 (81-1, m, fmoc aromatic H's), 11.33 (11-1, br.s, amide 
N-H); S C (50 MHz, d- 6 -DMSO) 12.3 (5-CH 3), 38.7 (2'-C), 46:5(fmoc C), 67.6 
and 68.9 (5'-C and fmoc ct-Cl2), 70.2 (3'-C), 83.6 and 84.0 (1'-C and 4'-C), 110.0 
(5-C), 120.4, 125.0, 127.3 and 127.9 (fmoc tertiary aromatic C's), 136.0 (6-C), 
141.0 and 143.4 (fmoc quaternary aromatic C's), 150.6 (4-C), 154.6 (2-C), 163.9 
(C0); m/z (FAB) 465 (MW); HRMS (FAB) found 465.16618 (MW), C 25 1-12 51\1207 
requires 465.16616 (<lppm). 
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.5'_O_(9_FluorenylmethOxyCarbOflyl)-thVmidifle-3' -O-N,Nd1IS0Pr0PVI methyl 
phosphoramidite 
(136) 5'-O-Fmoc-T-3'-O-N.N-'Pr2 Me phosphoramidite 
5'_O_(9_Fluorenylmethoxycarboflyl)-ttlymidifle (1.214g. 2.616 mmol) (129) 
was co-evaporated with 50:50 pyridine : methylene chloride then the flask was 
closed with a septum pierced with a needle and placed in an evacuated 
desiccator overnight. The desiccator was then filled with argon and the needle 
removed. An argon filled balloon was attached to the flask. The nucleoside 
was dissolved in 15 ml tetrahydrofuran (not completely soluble) and 
N,N-diisopropylethylamifle (1.82 ml, 10.47 mmol) and then 
NN_diisoProPY(methVlDhOSPhOflamidVl chloride (104) (2.03 ml, 10.47 mmol) were 
added. The reaction was stirred for 30 mm. before being poured into 100 ml of 
argon saturated ethyl acetate and washed with the following argon saturated 
solutions: 2x100 ml water; lxlOO ml saturated aqueous sodium carbonate; 
2x100 ml brine. The solution was then dried over sodium sulphate, filtered 
under argon, and the solvent removed in vacua to give an oil which was 
dissolved in 6 ml toluene and precipitated into 200 ml hexane at -20 °C. The 
precipitate was filtered off and dried in an evacuated desiccator to give the 
required product as a white solid (1.205g. 74%); softening point 76-81 °C; tic 
Rf(B) 0.5; V max  (bromoform mull) 2980 (alkyl C-H); 1750 (fmoc C=O), 1720-1670 
(thymidine C=O's), 1460-1370 cm -1 (aromatic C-C); 6 (80 MHz, COd 3) 1.17 
(12H, d, JAB 6.8 Hz, 'Pr CH 3), 1.79 (3H, s, 5-CH 3
), 2.15 (11-1, m, 2'-H), 2.44 (11-1, m, 
2'-H), 3.37 (31-1, 2d, POCH 13.3 Hz, P-0-CH3), 3.52-3.73 (21-1, m, 'Pr CH), 
4.17-4.59 (61-1, m, fmoc ci-CH2 and -CH, 3'-H, 4'-H and 5'-H's), 6.33 (11-1, t. JAB 
6.7 Hz, 1'-1-1), 7.17-7.80 (91-1, m, 6-H and fmoc aromatic H's); iS (90 MHz, COd3) 
12.3 (5-CH 3), 24.4 (d, JCCOp 7.5 Hz, 'Pr CH 3), 39.5 (d, J0p 5.5 Hz, 2'C), 42.9 (d, 
12.4 Hz, P-O-CI3), 46.6 (fmoc B-C), 50.3 (2d, ac-N-p 17.4 Hz, 'Pr CH), 66.7 (fmoc 
123 
a-C), 69.8 (5'-C), 72.3 (2d, JCOp 16.8 Hz, 3'-C), 83.3 (2d, J0p 4.6 Hz, 4'C), 84.7 
(2s, 1'-C), 111.1 (5-C), 120.0, 124.7, 127.0 and 127.8 (fmoc tertiary aromatic C's), 
135.0 (6-C), 141.1 and 142.9 (fmoc quaternary aromatic C's), 150.2 (4-C), 154.7 
(2-C), 163.7 (CO3); 6., (36 MHz, COd3) 150.1 and 149.8; m/z (FAB) 626 (MW); 
HRMS (FAB) found 626.26312 (MW), C 32H 41 N 308P requires 626.26311 (<lppm). 
5'_O_[9_FluorenylmethoycarbOflyl] -thymidifle-3'-O-N,NdiiS0Pr0PVt 
8-cyanoethyl phosphoramidite 
(130) 5'-O-Fmoc-T-3'-O-N,N-'Prz-13CNEt phosphoramidite 
5'_O_Eg_FluorenylmethoxVCarbOflVl] -thymidine (129) (0.443g. 0.955 mmol) 
was co-evaporated with 50:50 pyridine : methylene chloride then closed with a 
septum pierced with a needle and placed in an evacuated desiccator overnight. 
The desiccator was then filled with argon and an argon filled balloon was 
attached to the flask. The nucleoside was dissolved in 4 ml tetrahydrofuran 
and N,N-diisopropylethylamine (0.664 ml, 3.82 mmol) then 
N,N--diisopropyl' -cyanoethyl phosphoramidyl chloride (0.612 ml, 3.82 mmol) 
were added. The reaction was stirred for 10 mm. before methanol (0.12 ml, 
2.86 mmol) was added to quench the excess phosphitylating agent. The 
reaction was poured into 25 ml of argon-saturated ethyl acetate and washed 
with the following argon-saturated solutions: 2x20 ml water; 1x20 ml saturated 
aqueous sodium carbonate; 1x20 ml brine. The ethyl acetate solution was dried 
over sodium sulphate and the 'solvent removed in vacua The residue was 
dissolved in 4ml toluene and precipitated into 200 ml of hexane at -78 °C. The 
solid was filtered off and dried in an evacuated desiccator to give the required 
product as a white powder (0.539g. 85%); softening point 46-49 °C; tic Rf(B)  0.5; 
max 
(bromoform mull) 2980 (alkyl C-H), 1750 (fmoc C=O), 1720-1670 
(thymidine C=O's), 1470-1370 cm -1 (aromatic C-C); 6H (200 MHz, CD 3CN) 1.18 
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(12H, m, 'Pr CH 3), 1.76 (3H, 2s, 5-CH 3), 2.10-2.32 (2H, m, 2'-H), 2.65 (2H, m, 'Pr 
CH), 3.28-3.82 (4H, m, B-cyanoehtyl CH2CH2), 3.98-4.35 (4H, m, 3'-H, 4'-H and 
5'-H's), 4.38-4.64 (3H, m, fmoc ct-CH2 and B -CH), 6.17 (1H, t. JAB  5.0 Hz, 1'-H), 
7.25-7.83 (9H, m, fmoc aromatic H's and 6-H); 6 C (50 MHz, CD3CN) 11.1 (5-CH3), 
19.4 (cyanoethyl B-C) 23.3 ('Pr CH3), 37.8 (2'-C), 42.5 (d, Jco'  12.3 Hz, 
P-0-CH2-), 461 (fmoc B-C), 57.7 (fmoc ct-C), 60.9 (5'-C), 72.3 (d, JCop 17.3 Hz, 
3'-C), 84.1 (d, J CCOp 6.9 Hz, 4'-C), 85.9 (2s, 1'-C), 109.7 (5-C), 116.8 (CEN), 119.5, 
124.3, 126.7 and 127.3 (fmoc tertiary C's), 135.1 (6-C), 140.7 and 143.0 (fmoc 
quaternary C's), 149.9 (4-C), 154.1 (2-C), 163.3 (CO3); 6p (36 MHz, CD3CN) 148.2; 
m/z 665 (MW) 447. 
5'-O-[ Bis (4_nitrophenyl)ethoxVcarbonyll-thVmidifle -3'-O-N,N-diiSOPrOPYl. 
B-cvanoethvl phosphoramidite 
(128) 5'-O-Bnpeoc-T-3'-O-N,N-'Pr2713-CNEt phosphoramidite 
5'-O-(Bis (4-nitrophenyl)ethoxycarbonyl] -thymidifle (107) (0.423g. 0.761 
mmol) was co-evaporated twice with 10% pyridine in methylene chloride and 
then the flask was closed with a septum pierced with a needle and placed in an 
evacuated desiccator overnight. The desiccator was filled with argon and the 
needle was removed. An argon filled balloon was attached to the flask and the 
nucleoside was dissolved in 4 ml tetrahydrofuran. N,N-Diisopropylethylamine 
(0.53 ml, 3.04 mmol) and then N,N-diisopropyl 8-cyanoethyl phosphonamidyl 
chloride (0.49 ml, 3.04 mmol) were added and the reaction was stirred for 10 
mm. before being quenched with methanol (0.09 ml, 2.28 mmol) and poured 
into 20 ml of argon-saturated ethyl acetate. This was washed with the 
following argon-saturated solutions: 1x20 ml water; 2x20 ml saturated aqueous 
sodium carbonate; 1x20 ml brine, dried over sodium sulphate and the solvent 
removed in vacuoto give a brown oil. The residue was dissolved in 2 ml ethyl 
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acetate and precipitated into 250 ml of hexane at -20 °C. The solid was filtered 
off and dried in an evacuated desiccator to give the title compound as a grey 
powder (0.515g. 90%); softening point 67-71 °C; tIc Rf(B)  0.5; 'max (bromoform 
mull) 2980 (alkyl C-H), 1750 (bnpe C=O), 1720-1660 (thymidine C=O's), 1610, 
1510 and 1470 (aromatic C-C), 1520 and 1350 cm -1 (NO2); 6H  (200 MHz, CDCI3), 
1.12 (12H, m, 'Pr CH3), 1.74 (3H, s 5-CH 3), 2.16 (1H, m, 2'-H), 2.42 (1H, m, 2'-H), 
2.61 (2H, m, 'Pr CH), 3.48-3.82 (4H, m, NCCH 2CH2-), 4.13 (1H, m, 4'-H), 4.31-4.42 
(3H, m, 3'-H and 5-H's), 6.22 (1H, t, JAB  6.0 Hz, 1'-H), 7.19 (1H, m, 6-H), 7.38 (4H, 
d, JAB 8.7 Hz, bnpe aromatic H's), 8.15 (4H, d, JAB 8.7 Hz, bnpe aromatic H's); 6 
(50 MHz, COd3), 12.2 (5-CH 3), 20.1 (d, J0p 4.3 Hz, cyanoettiyl B-C), 24.3 ('Pr 
CH), 39.0 (2'-C), 43.1 (d, J0p 12.4 Hz, cyanoethyl c&-C), 49.2 (bnpe B-C), 67.0 
(bnpe cL-C), 68.6 (5'-C), 72.6 (2d, J0p 15.4 Hz, 3'-C), 82.9 (d, J0p 12.1 Hz, 
4'-C), 84.9 (1'-C), 110.9 (5-C), 117.5 (-C=N), 124.0 and 129.0 (bnpe aromatic 2-
and 3-C), 135.3 (6-C), 146.1 and 147.1 (bnpe aromatic 1- and 4-C), 150.1 (4-C), 
154.2 (2-C), 163.6 (CO3); 6 (36 MHz, CDCI3) 149.4; m/z (FAB) 757 (MH 1 ) 539; 
HRMS (FAB) found 757.25981 (MH), C 34 H 42N6012P requires 757.25981 (<lppm). 
N_Methyl_N,N-dicyCtOheXvlcarbOdiimidium iodide 
N-Me-DCC iodide 
This compound was prepared by the method of Scheffold and Saladin 132 to 
give a 74% yield of very pale yellow crystals, mp 109-111 °C (lit. 111-113 0C). 
2,2- Bis (4-nitrophenyl)ethyl iodide 
Bnpe I 
2,2-B/s (4-nitrophenyl)ethanOl (1.440g. 5.00 mmol) was dissolved in 50 ml 
tetrahydrofuran 	and N_methy l_N,N_dicyclOheXylcarbOdiimidium iodide (139) 
(3.487g, 10.00 mmol) was added. 	The reaction was stirred for 24 hours under 
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nitrogen at 30 °C. The solvent was removed in vacuo and the residue was 
dissolved in 50 ml methylene chloride and washed with 3x25 ml 50 50 
methanol : water, 2x25 ml 1% aqueous sodium thiosuiphate solution, 2x25 ml 
brine, dried over sodium sulphate and the methylene chloride evaporated in 
vacuo to produce a yellow oil. This was crystallised from chloroform and 
diethyl ether to give the title compound as a yellow solid (1.4059, 71%); mp 
139-140°C; tic Rf ( 0) 0.5; v m,, (methylene chloride solution) 2980 (alkyl C-H), 
1610 and 1540 (aromatic C-C), 1520 and 1350 cm -1 (NO2); A m ,,, 276 nm, E max 
21000; 6H (200 MHz, COd 3) 3.75 (21-1, d, JAB 7 Hz, cx-Cl2), 4.54 (11-1, t. JAB 7 Hz, 
-CH), 7.41 (41-1, d, JAB  8 Hz, aromatic H's), 8.20 (41-1, d, JAB 
8 Hz, aromatic H's); 
S C (50 MHz, CDCI 3) 5.6 (a-C), 53.4 (B-C), 124.1 (aromatic 3-C), 128.5 (aromatic 
2-C), 147.1 and 148.1 (aromatic 1- and 4-C). 
1-Methyl-3--[2,2-B1S (4_nitrophenyl)ethOxyCarbOflYl}imidazolium chloride 
(142) 1-Me-3-Bnpeoc-lm Cl 
Prepared by the method of Pfleiderer 111 
2,2-Bis (4-nitrophenyl)ethyl chloroformate (106) (9.526g. 27.18 mmol) was 
dissolved in 100 ml of methylene chloride and cooled to 0 ° C. 
1-MethylimidazOle (2.16 ml, 27.18 mmol) was added and the reaction was 
stirred under nitrogen for 15 mm. then allowed to reach room temperature. 
The solid was filtered off and washed with methylene chloride then dried to 
give the title compound as a white solid (10.78g. 92%); mp 160-162 °C; 'max 
(bromoform mull) 2960 (alkyl C-H), 1790 (C=O), 1600 (aromatic C-C), 1520 and 
1350 cm -1 (NO2); 5H  (200 MHz, d 6
-OMSO) 3.88 (31-1, s, -CH3), 4.79 (31-1, s, bnpe 
c&-CH2 and B-CH), 7.62 (41-1, d, JAB 8.4 Hz, bnpe aromatic H's), 7.63 (21-1, m, 
imidazole H's), 8.16 (41-1, d, JAB 8.7 Hz, bnpe aromatic H's), 9.13 (11-1, s, imidazole 
H); S C (50 MHz, d 6-DMSO) 36.7 (-CH3), 48.4 (bnpe B-C), 70.8 (bnpe a-C), 119.6 
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and 119.9 (imidazole 4- and 5-C), 124.0 (bnpe aromatic 3-C), 125.1 (imidazole 
2-C), 130.0 (bnpe aromatic 2-C), 146.8 and 147.3 (bnpe aromatic 1- and 4-C); 
m/z (FAB) 433 (MH) 397 (M-Cl) 83; HRMS (FAB) found 397.11479 (MH), 
C 19H 17N406 requires 397.11480 (<lppm). 
3',5'-O-(TetraisopropyldiSilOXafle - 1 ,3-diyl)-2'-deoxyadeflOSifle 
(141) 3',5'-O-'Pr4Si2O-2'-dA 
2'-Deoxyadenosifle (2.803g. 10.42 mmol) was co-evaporated twice with 
pyridine then dissolved in 40 ml of N,N-dimettlylfOrmamide. Imidazole (3.1249, 
45.89 mmol) then 1,3_dichloro_1,1,3,3-tetraiSOPrOPyldiSiloxane (3.70 ml, 10.56 
mmol) were added and the reaction was stirred for 1 hour. The solvent was 
evaporated in vacuo and the residue was dissolved in 50 ml methylene 
chloride. The precipitate of imidazole hydrochloride was filtered off and the 
remaining solution was purified by dry flash chromatography, eluting with 0-2% 
methanol in methylene chloride to give the required compound as a pale 
yellow glass (4.897g. 95%); softening point 44-46 ° C; tic  Rf(A) 0.3; V m ax 
(bromoform mull) 3480 and 3400 (N-H), 2960-2860 (alkyl C-H), 1540 and 1460 
cm -1 (aromatic C-H); 6H  (80 MHz, CDCI3) 0.97 (228H, m, 'Pr CH3 and 'Pr CH), 
2.62 (2H, m, 2'-H's) 3.78-4.00 (31-1, m, 4'-H and 5'-H's), 4.85 (11-1, m, 3'-H), 5.76 
(21-1, br.s, NH2), 6.25 1H, t, JAB  6.3 Hz, 1'-1-1), 7.96 and 8.23 (21-1, 2s, 2-H and 8-H); 
S C  (50 MHz, CDCI3), 12.6 ('Pr CH), 16.9 ('Pr CI-1 3), 39.7 (2'-C),.61.9 (5'-C), 70.1 
(3'-C), 82.3 (4'-C), 84.9 (1'-C), 119.8 (5-C), 138.3 (2-C), 148.5 (6-C), 152.5 (8-C), 
155.8 (4-C); m/z (FAB) 494 (MH). 
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3',5'-O-(TetraiSoprOPVldiSilOXafle - 1,3-diyl)-N6-12,2-  bis (4-nitrophenyl)ethOxr 
carbonyl]-2'-deOxyadeflOSifle 
(143) 3',5'-O-'Pr4Si20-N6-bflpeOC2'dA 
3,5_O_(tetrai sop ropyldisilOXafle1,3_diVl)_2'_de0xVet0sme (141) (0.232g. 
0.47 mmol) was dissolved in 10 ml of carbon tetrachloride and 
1-methyl-3-[2,2- b/s (4_nitrophenyl)ethOXYCarbOflYlFimidaZ0liUm chloride (142) 
(0.404g. 0.94 mmol) was added and the reaction was reftuxed for 3 hours. The 
solvent was then evaporated in vacua and the residue was purified by flash 
silica chromatography, eluting with methylene chloride to give the title 
compound as a white foam (0.075g, 20%); softening point 96-99 °C; Rf(A) 0.7; 
Vmax 
(methylene chloride solution) 3400 (N-H), 3050 (aromatic C-H), 2960 and 
2880 (alkyl C-H), 1760 (C=O), 1610, 1510 and 1460 (aromatic C-C), 1520 and 
1350 cm -1 (NO2); sS (200 MHz, CDCI3) 0.99-1.04 (28H, m, 'Pr CH3 and CH), 2.66 
(2H, m, 2'-H's), 3.87 (1H, m, 4'-H), 4.01 (2H, m, 5'-H's), 4.71 (1H, m, 3'-H), 
4.81-4.91 (3H, m, bnpe ct-CH2 and B-CH), 6.29 (1H, t JAB 6.0 Hz, 1'-H), 7.40 (4H, 
d, JAB 8.7 Hz, bripe p-disubstituted aromatic H's), 8.14 (4H, d, JAB 8.6 Hz, bnpe 
p-disubstituted aromatic H's), 8.14 (1H, s, 2-H), 8.61 (1H, s, 8-H), 9.14 (1H, s, 
amide H); 6c (50 MHz, COd 3) 12.7 ('Pr CH), 17.1 ('Pr CH 3), 39.7 (2'-C), 49.4 (bnpe 
B-C), 61.5 (5'-C), 66.5 (bnpe c&-C), 69.6 (3'-C), 83.3 (4'-C), 85.2 (1'-C), 122.6 
(5-C), 123.9 (bnpe aromatic 3-C), 129.0 bnpe aromatic 2-C), 141.4 (2-C), 146.3 
and 147.1 (bnpe 1- and 4-C), 148.9 (6-C), 150.6 (4-C), 152.2 (8-C); m/z (FAB) 
808 (MW) 494 (M-bripeoc); HRMS (FAB) found 808.31576 (MH), C 37 H 50N 7 010Si2 
requires 808.31575 (<lppm). 
129 
3.3. Stability studies 
Stability of 5'-O-Bnpeoc-ThVmidifle (107) to triethylamifle 
5'-O-Bnpeoc-thymidine (107) (0.015g. 0.027 mmoi) was dissolved in either 1 
ml of a, 10% triethylamine/ 90% methylene chloride or b, 10% triethyiamine/ 
90% acetonitrile. The stability of the protected nucleoside was monitored by 
tic, 5'-O-BnpeOc-thymidifle (Rf(A) 0.4) is converted to thymidine (R f(A) 0.2) and 
1,1_b/.4-nitropheflYl)ethefle (R f (A) 0.8). When methylene chloride (a) was used 
as the solvent the nucleoside remained stable for 24 hours, and showed only 
slight cleavage after 7 days. The acetonitrile solution (b) resulted in a small 
amount of cleavage after 30 mm. and was completely cleaved within 24 hours. 
Stability of 5'-O-Bnpeoc-thymidifle (107) to N,N-diisopropylethYlamifle 
5'-O-Bnpeoc-thyrnidifle (107) (7.7mg, 0.014 mmol) was dissolved in 0.5 ml 
of tetrahydrofuran and N,N_diisopropylethylamifle (9.61i1, 0.056 mmcl) was 
added. The stability of the nucleoside was monitored by tic, 
(5'-O-Bnpeoc-thYmidifle Rf(A) 0.4), but no change was observed after 2 hours. 
Stability of 5'-O-Bnpeoc-thymidifle (107) to 4_N,N_dimethylamifloPyridifle 
5'-O--Bnpeoc-thymidifle (107) (5mg, 0.009 mmol) was dissolved in either lml 
of a, methylene chloride or b, pyridine and N,N-dimethylamiflOPyridifle (1mg, 
0.009 mmol) was added. The stability of the protected nucleoside was 
determined by tic: 5'-O-Bnpeoc-thYmidifle (R f (A) 0.4) is converted to thymidine 
(R f (A) 0.2) and 1,1 _b/.4-nitropheflVl)ethefle (R
f (A) 0.8). 
With both methylene chloride and pyridine as the solvent tic indicated a 
small amount of cleavage after 24 hours. 
130 
Stability of 5'-O-Bnpeoc-thymidifle (107) to tetrazole 
5'-O-Bnpeoc-thymidine (107) (0.0056g, 0.010 mmoi) was dissolved in a 0.5 
M solution of tetrazole in acetonitrile (0.5 ml, 0.025 mmol) and tic showed that 
the protected nucleoside was stable for at least 2 hours. 
Deprotection of 5'-O-Bnpeoc-thymidine (107) with DBU acetate 
5'-O-Bnpeoc-thymidine (107) (0.010g. 0.018 mmol) was dissolved in 1 ml of 
acetonitrile and DBU (3.2 il, 0.022 mmoi) and acetic acid (1.2 Pl, 0.022 mmol) 
were added and the deprotection was followed by tic: 5'-O-Bnpeoc-thymidifle 
(R f(A) 0.4) is converted to thymidine (R f(A)  0.2) and 1,1.-b/.4-nitrophenyl)ethefle 
(R f (A) 0.8). A small degree of cleavage was detected after 3 mm. and after 40 
mm. about 50% of the nucleoside had been deprotected. 
Deprotection of 5'-O-Bnpeoc-thymidine (107) with DBU 
5'-O-Bnpeoc-thymidine (107) (0.310g. 0.558 mmol) was dissolved in 5 ml of 
acetonitriie and DBU (0.83 ml, 5.58 mmol) was added, the pale yellow solution 
turned dark green. After stirring for 10 mm. tic indicated that the deprotectiOn 
was completed. The solvent was removed in vacuo and the residue was 
purified by dry flash chromotography, eluting with 0-10% methanol in 
methyiene chloride. 
A white, crystalline solid, found to be thymidine, was isolated (0.094g. 70%); 
mp 183-185 °C, (thymidine 187-189 °C; tic Rf(A)  0.2; 6H (80 MHz, 0 6-DMSO) 1.77 
(31-1, s, 5-CH 3), 2.07 (21-1, m, 2'-H), 3.59 (21-1, m, 5'-H's), 3.74 (11-1, m, 4'-H), 4.24 
(1H, m, 3'-H), 4.79 (1H, br.s, 5'-OH), 5.16 (11-1, br.s, 3'-OH), 6.16 (11-1, t. JAB 6.5 Hz, 
1'-1-1), 7.67 (11-1, s, 6-H), 11.17 (11-1, br.s, amide H). 
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Deprotection of Bnpebenzyi carbonate (111) with OBU acetate 
Bnpe benzyl carbonate (111) (0.005g, 0.012 mmol) was dissolved in 1 ml of 
acetonitrile and DBU acetate (10 equivalents) was added. The deprotectior% was 
followed by tic: bnpe benzyi carbonate (Rf(c) 0.6) is converted to benzyi alcohol 
(R f(c) 0.4) and 1,1-b/s (4-nitrophenyl)ethefle (R f(c) 0.7). 
After 30 mm. most of the carbonate remained intact. 
Deprotection of bnpe,benzyl carbonate (111) with DBU 
Bnpe.benzyl carbonate (111) (0.010g. 0.024 mmol) was dissolved in 1 ml of 
acetonitrile and DBU (1 equivalent) was added. The deprotection was followed 
by tic: bnpe benzyl carbonate (Rf(c) 0.6) is converted to benzyi alcohol (R f(
c) 0.4) 
and 1,1-b/.4- nitro phenVl)ethene (R f(c) 0.7). The deprotectiOn was monitored 
every minute and was complete after 4 mm. 
The above procedure was repeated using 5 equivalents of DBU and found to 
be complete after 2 mm, and with 25 equivalents of DBU was complete in less 
than 30 seconds. 
DeprotectiOn of 5'_O_Bnpeoc_N 6_BeflZYl2'de0X adenosine (123) with DBU 
5_O_Bn peoc_N 6_BeflZOYl_2'_de0Xyadefbt 	(123) (0.0068g. 0.010 mmol) 
was dissolved in imI of acetonitrile and DBU (1 equivalent) was added. The 
deprotection was monitored by tic: 5'_O_Bnpeoc_N6-2'-deOXyadeflosine (Rf(A) 
0.4) is converted to N 6_ben zoyi_2'-deOXyadeflOsine (Rf(A) 0.2) and 
1,1_b/.4-nitropheflyl)ethefle (R f (A) 0.8). The deprotection was complete after 10 
mm. 
The above procedure was repeated several times using varying amounts of 
DBU and different solvents, see table 2. 
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Table 2 
OBU (equivalents) Solvent Deprotection Time 
1 acetonitrile 10 mm. 
10 acetonitrile 5 mm. 
10 CH 2CH2 >10 mm. 
10 DMF 1 mm. 
100 DMF 15 sec. 
The procedure was also repeated using 10 equivalents of DBU acetate in 
DMF and the deprotection was complete after 8 mm. 
Deprotection of 5._O_Bnpeoc_N6_beflZOVl_2'_deo)(Yadenosme (123) with 
piperidine 
5_O_Bnpeoc_N6_beflZOYi_2'de0xYaden0su (123) was dissolved in 1 ml of 
DMF and piperidine (10 equivalents) was added. The reaction 
was toliowea oy 
tic: 5_O_Bnpeoc_N 6 beflZOYl_2'_de0XYad0 5 me (R f (A ) 	 0.4) 
is 	converted to 
N 6_benzoyl-2'-deOXyadenosifle (R f(A)  0.2) and 1,1_bi.4-nitrophenVl)ethefle (R
f(A ) 
0.8). The deprotection was complete after 12 mm. 
The above procedure was repeated using 100 eqivaients of DBU in DMF and 
the deprotectiori was completed in 5 mm. 
Stability of the SARC linker to DBU in DMF 
5'-O-DMTr-thymidifle bound to controlled pore glass resin by the SARC 
linker (0.004g) was suspended in 0.5 ml of 10% OBU in DMF for 10 mm. The 
resin was removed by filtration and was treated with 1 ml of 60% aqueous 
concentrated hydrochloric acid / 40% ethanol to produce an orange solution. 
When the filtrate was treated with the same acid solution no orange colour 
was observed. 
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Stability of resin bound 1-, 2-. 3- and 4-residue oligonucleotides to OBU in 
DMF 
The polynucleotides dA, dApdA, dApdApdA, and dApdApdApdA were 
prepared on an ABI 380b synthesizer and left bound to the resin via the SARC 
linker. These resin bound polynucleotides were washed with 10% OBU in DMF 
for 5 mm. then cleaved in concentrated aqueous ammonia at 50 °C and the 
amount of oligonucleotide present was determined by measuring the uv 
absorbance at 260 nm. 
The above experiment was repeated without the DBU/DMF as a control. 
When the results were compared the monomer showed 5% cleavage from the 
resin but the dimer, trimer and tetramer appeared stable. 
Stability of 5'-O-Bnpeoc-thymidifle-3'OaCetate (125) to 1 2/1-120 
5'-O-Bnpeoc-thymidifle-3'-OaCetate (125) (0.125g. 0.209 mmol) was 
dissolved in 2 ml of tetrahvdrofuran and a solution of iodine (0.1M) in water 
2,6-lutidine : tetrahydrofuran (1:10:40) (4.18 ml, 0.418 mmol) was added. The 
solution was stirred for one hour then the solvent was removed in vacua The 
residue was dissolved in 50 ml of methylene chloride and washed with 1x40 ml 
water, 2x40 ml 10% aqueous sodium thiosulphate solution, 1x40 ml brine, dried 
over sodium sulphate and the solvent removed in vacua to give a pale yellow 
foam (0.121g, 97%); tic Rf(A)  0.7; 1 1-1 n.m.r. and 13C n.m.r. were identical with the 
starting material. 
Coupling of 5'_O-Bnpeoc-N 3-An-T-3'-0N,N'Pr2JMe phosphoramidite (116) 
with methanol 
5'-O-Bnpeoc-N 3-An-T-3'-0N,N 1 Pr2!Me phosphoramidite (116) (0.010g. 
0.012 mmol) was dissolved in 0.2 ml acetonitrile and methanol (2 p1, 0.051 
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mmol) and tetrazole solution (0.5 M) (0.12 ml, 0.06 mmol) were added. The 
reaction was monitored by tic: 5'_O-BnpeocN 3-3'-0N,N - 'Pr2,Me 
phosphoramidite (Rf(B)  0.7) reacted to give a product of Rf(B) 0.6 within 2 mm. 
Coupling of 5'-O-DMTr-T-3'-O-N,NPr2Me phosphoramidite with methanol 
5'_O-DMTr-T-3'-O-N,NPr2Me phosphoramidite (0.011g, 0.016 mmol) was 
dissolved in 0.2 ml of acetonitrile and methanol (3 III, 0.08 mmol) and tetrazole 
solution (0.5 M) (0.16 ml, 0.08 mmol) were added. The reaction was monitored 
by tic: 5'_O-DMTr-T3'0N,N'Pr2,Me phosphoramidite (Rf ( 6) 0.6) reacted to 
give a product of Rf(B) 0.5 within 2 mm. 
Coupling of 5'O-Bnpeoc-N3-Afl_T_3'N,N7'Pr2)Me phosphoramidite (116) 
with T-3'-OAc (5) 
5'_O_Bnpeoc-N-AflT3'N,N'Pr2Me phosphoramidite (116) (0.065g, 0.076 
mmol) was dissolved in 2 ml of acetonitrile and 3'-O--acetyl-thymidifle (5) 
(0.043g. 0.153 mmol) then tetrazole (0.5M in acetonitrile) (0.76 ml, 0.38 mmol) 
were added and the reaction was monitored by tic: 
5'_O_Bnpeoc-N3-AflT3'N,N'Pr2Me phosphoramidite (R f(B) 0.7) and 
3'-O-acetyl-thYmidine (R f(B)  0.1) reacted to give a product at Rf(8) 0.3. The 
reaction was complete after 20 mm. 
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3.4. Phosphorus N.M.R. Studies 
Coupling of 5'-O-Bnpeoc-T-3'-O-N,N -'Pr2lMe phosphoramidite (108) with 
3'-O-benzoyt-T (131) 
5'-O-Bnpeoc-T-3'-O-N,N - 'Pr2Me phosphoramidite (108) (0.026g, 0.036 
mmol) was dissolved in 0.5 ml of CD3CN, 6,, (36 MHz, CD3CN) 149.2, and 
3'-O-benzoyl-thvmidifle (131) (0.062g, 0.18 mmol) and tetrazole (0.013g, 0.18 
mmol) were added. 6,, (36 MHz, CD 3CN) 139.9 (45%) and 9.3 (55%). Iodine 
(0.05M) in water : 2,6-lutidine : THF (1:10:40) (0.71 ml, 0.036 mmol) was added 
and after 5 mm. the solvents were removed in vacua The residue was 
redissolved in CD 3CN, 6,, (36 MHz, CD 3CN) -1.3 (49%), -1.5 (37%) and -2.7 
(14%). 
Coupling of 5'_O_Bnpeoc_thVmidifle3'ON.NPr2Me phosphoramidite (108) 
with methanol 
5'_O_Bnpeoc_thymidmfle_3'_O_N,NPr2IMe phosphoramidite (e5) (0.033g. 
0.046 mmol) was dissolved in 0.5 ml of CD 3CN, 6,, (36 MHz, CD 3CN) 149.0. 
Methanol (9.3 .il, 0.23 mmol) and tetrazole (0.016g. 0.23 mmol) were added, 6 
(36 MHz, CD 3CN) 140.4. Iodine (0.1M) in water : pyridine : THF (1:10:40) (0.46 
ml, 0.046 mmol) was added and after 10 mm. the solvents were evaporated in 
vacuo and the residue was dissolved in 0.5 ml of CD 3CN, 6,, (36 MHz, CD 3CN) 
-0.4 and -1.5. 
Coupling of 5'_O_Fmoc_thymidifle3'ON,N'Pr2Me phosphoramidite (130) 
with methanol 
5'_O_Fmoc-thymidine-3'-ON,NPr2Me phosphoramidite (130) (0.050g, 0.080 
mmol) was dissolved in 0.5 ml of CD3CN, 6, (36 MHz, CD 3CN) 149.0. Methanol 
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(16 p1, 0.40 mmol) and tetrazole (0.028g. 0.40 mmol) were added, iSp, (36 MHz, 
CD3CN) 140.3. Iodine (0.1M) in water : pyridine : THF (1:10:40) (0.80 ml, 0.080 
mmol) was added and after 10 mm. the solvents were evaporated in vacuo and 
the residue was dissolved in 0.5 ml of CD3CN, 6, (36 MHz, CD 3CN) -0.5 and 
-1.4. 
Coupling of 5'_O_DMTr-thymidifle-3'-O-N,NPr2lMe phosphoramidite with 
methanol 
5'_O_DMTr_thymidine-3'-O-N,N-'Pr2lMe phosphoramidite (0.0499, 0.069 
mmol) was dissolved in 0.5 ml of CD 3CN, Isp (36 MHz, CD 3CN) 148.6. Methanol 
(14 p1, 0.35 mmol) and tetrazole (0.024g. 0.35 mmol) were added, S (36 MHz, 
CD 3CN) 140.1. Iodine (0.1M) in water : pyridine : THF (1:10:40) (0.69 ml, 0.069 
mmol) was added and after 10 mm. the solvents were evaporated in vacua and 
the residue was dissolved in 0.5 ml of CD 3CN, 6 1, (36 MHz, CD 3CN) 0.9, -0.5 and 
-1.3. 
Reaction of PCI 3  with 2,2,2-triphenylethaf101 (119) 
2,2,2-Triphenylethaf101 (0.056g. 0.20 mmol) was dissolved in CDCI3 and 
phosphorus trichloride (0.012 ml, 0.14 mmol) was added, 6l (36 MHz, CD 3CN) 
220 (PCI 3, 41%) and 177 (Ph 3CCH 20PCI2, 59%). 
Reaction of PCI 3  with 2,2,2-triphenylethyl,trimethVlSilYl ether 
2,2,2,-Triphenylethyl,trimethylsilyl ether (prepared as for (120)) (0.32g. 0.93 
mmol) was dissolved in 5 ml of methylene chloride and phosphorus trichioride 
(0.082 ml, 0.93 mmol) was added. The reaction was stirred for 5 mm. then the 
solvents were evaporated in vacua to produce a white foam. 6 1, (36 MHz, 
CD 3CN): 
177 [Ph 3CCH 20PCI2, 6%1; 
137 
165 [(PH 3CCH 20)2PCI 11%1; 
138 [(Ph 3CCH 20)3P 28%1; 
7 [oxidised products 56%]. 
The above procedure was repeated with varying amounts of the silyl ether 
and at various temperatures, to give different proportions of the alcohol 
substituted phosphorus compounds, see table 3. 
Table 3 
Equivalents Temp Mono- Di- Tn- 
Oxidised 
of alcohol °C (%) (%) sub. (%) (%) 
1 20 6 11 28 
56 
4 20 0 0 84 
16 
1 -30 71 17 0 
12 
1 -78 70 0 0 
30 
The 	Reaction 	of 	triethylammoflium 	(5'-O-OMTr-thymidifle3'0 
2-chiorophenyl) phosphate with 2-cvanoethanOl 
TriethylammoniUm (5_O_DMTr_thymidifle3'0_2_Cht0r0P nyI) phosphate 
(0.053g. 0.064 mmol) was co-evaporated twice with pyridine then dissolved in 
0.5 ml of 50:50 pyridine : CD3CN. MesitylenesulPhOflyl_3_n1tr01,2,4thiazote 
(0.094g. 0.32 mmol) was added, 6 p (36 MHz, CD 3CN) -20.5. The sample was 
cooled to -30 °C and 2-cyanoethanol (0.022 ml, 0.32 mmol) was added and the 
reaction was monitored by 31 P n.m.r. at -30 °C, see table 4. 
6, (36 MHz, CD 3CN): 
-7.0 (Starting material) 
-20.1 (Starting material-MSNT complex) 
-8.1 (Product) 
138 
The product is 5._O_DMTr_thVmidifle_3'_020r0P 	8-cyanoethyl 
phosphate. 
Table 4 
Time Starting Material Product 
MSNT Complex 
(min.-sec.) (%) (%) 
(%) 
0 0 0 
100 
1-10 34 15 
50 
4-10 47 18 
35 
8-00 51 23 
26 
11-00 55 24 
21 
16 
13-50 57 27 13 
16-40 58 29 11 
19-30 60 29 9 
22-30 60 31 7 
25-20 62 31 6 
28-20 61 33 0 
31-10 65 35 
The above procedure was repeated adding 1-methylimidaZOle (0.051 ml, 
0.64 mmol) as an accelerating agent with the 2-cyanoethaflol. Monitoring the 
reaction under the same conditions showed that the starting material-MSNT 
complex had been converted to starting material and product within 50 
seconds. 
The procedure was also repeated adding zinc iodide (0.204g, 0.64 mmol) as 
a potential accelerating agent with the 2-cyanoethanOl. Monitoring the 
reaction under the same conditions gave the results shown in table 5. 
6P (36 MHz, CD 3CN): 
-7.1 (Starting material) 




Time Starting Material Product 
MSNT Complex 
(min.-sec.) (%) (%) 
(%) 
0-00 0 0 
100 
1-30 0 53 
47 
4-50 0 71 
29 
8-10 0 78 
22 
11-20 0 81 
19 
25-10 0 90 
10 
28-10 0 93 
7 
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3.5. OligodeoxynuCleOtide Synthesis 
All syntheses were performed on an ABI 380b DNA synthesizer using 10 mg 
of functionaliSed resin. The monomers were dissolved in anhydrous 
acetonitrile, DBU and piperidine were distilled from potassium hydroxide, and all 
other reagents were as supplied by ABI or Cruachem. At the end of the 
synthesis the oligonucleotide was cleaved from the resin by treatment with 
concentrated aqueous ammonia and the benzoyl protection on the exocyclic 
amine function of 2'-deoxyadenOSifle was removed by heating the ammonium 
hydroxide solution to 50 °C for 5 hours. The water and ammonia were removed 
in vacuo and the residue was dissolved in 1 ml of water and analysed by 
reverse phase and/or ion-exchange HPLC. 
5'-O--Protecting groups: 
Bnpeoc = 2,2- b/s (4-n itrophenyl)ethoxYCarboflVl 
Fmoc = 9_fluorenylmethOxycarbOflyl 
DMTr = 4,4'-dimethoXytrityl. 
Phosphorus protecting groups: 
N,N_DiisoproPYlPhOSPhora mid 
 ites were used with either methyl or -cyanoethyl 
protection. At the end of the synthesis the methyl groups were removed with 
thiophenol and the B-cyanoethyl groups were removed by the aqueous 
ammonia treatment. 
Resin: 
Controlled pore glass (CPG) was used as a solid support and the first 
nucleoside was attached to it via the succinyl-SarCOsyl (SARC) linker. 
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5'-DeprotectiOn: 
For the Fmoc and Bnpeoc groups this was mainly performed with a 10% 
solution of DBU in acetoflitrile, DMF or methylene chloride, but piperidine in 
acetonitrile was also used. When using the DMTr group 10% trichloroacetic 
acid in methylene chloride was used. 
The conditions for the syntheses can be seen in table 6. 
Table 6 
Protocol Sequence 5'-Protection P-Protection Deprotection Deprotection 
reagent time (s) 
1 A DMTr B-CNEt TCA/DCM 50 
2 A Bnpeoc Me DBU/MeCN 120 
3 A DMTr Me TCA/DCM 
50 
4 A DMTr Me TCAIDCM 50 
5 A DMTr B-CNEt TCA/DCM 
50 
6 A DMTr -CNEt TCA/DCM 
50 
7 A DMTr Me TCA/DCM 50 
8 B DMTr B-CNEt TCAJDCM 
50 
9 B Bnpeoc Me DBU/DCM 
50 
10 B Bnpeoc Me DBU/DMF 50 
11 B DMTr -CNEt TCAIDCM 50 
12 B Fmoc Me DBU/MeCN 
180 
13 B Bnpeoc Me DBU/MeCN 180 
14 A Bnpeoc B-CNEt DBU/MeCN 50 
15 A Bnpeoc -CNEt Pip./MeCN 
60 
16 A Fmoc B-CNEt DBU/DMF 100 
17 A Bnpeoc B-CNEt DBU/DMF 200 
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Where A=(Tp) 5T and B=(dAp) 7dA, Pip.=piperidine 
The sequences prepared by protocols (1) and (8) were prepared for use in 
comparative HPLC studies. 
(3A) and (5A) were treated with a solution of 10% DBU in acetonitrile for 10 
mm. before the final DMTr deprotection, removal of the methyl groups from 
phosphorus, or cleavage of the oligonucleotide from the resin. 
(4A) and (6A) were treated with a solution of 10% DBU in acetonitrile for 10 
mm. after the final DMTr deprotection and before removal of the methyl groups 
from phosphorus or cleavage of the oligonucleotide from the resin. 
The sequence prepared by protocol (7) was treated with a solution of 10% 
piperidine in acetonitrile for 10 mm. before the final DMTr deprotection, removal 
of the methyl groups from phosphorus or cleavage of the oligonucleotide from 
the resin. 
(118) was treated with a solution of 10% DBU in DMF for 10 mm. after the 
final DMTr deprotection and before removal of the methyl groups from 
phosphorus or cleavage of the oligonucleotide from the resin. 
The monomers used in protocols (12) and (13) were protected on the 
N 3-position of thymidine with the anisoyl group. 
HPLC Analysis of the oligodeoxynucleotide syntheses 
( 	(Standard) 
Reverse phase HPLC Rt(A) 27 mm. 
Reverse phase HPLC Rt(B) 17 mm. 
Ion-exchange HPLC Rt(c)  13 mm. 
Reverse phase HPLC Rt(A)  28 mm. (small broad peak) 
Ion-exchange HPLC Rt(c)  13 min.  
This peak was isolated using preparative ion-exchange HPLC and then 
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re-examined on reverse phase HPLC. 
Reverse phase HPLC Rt(B) 17 mm. 18 mm. and 19 mm. (small peak) 
Reverse phase HPLC R((13) 17 mm. 18 mm. 19 mm. and 21 mm. 
Ion-exchange HPLC Rt(c)  8 mm. 
Reverse phase HPLC Rt(B) 15 mm. 17 mm. 18 mm. 19 mm. 
Ion-exchange HPLC Rt(c)  6 mm. 
Reverse phase HPLC Rt(B) 18 mm. 
Reverse phase HPLC Rt(B) 18 mm. 
Reverse phase HPLC Rt(B) 16 mm. 17 mm. 
JLBJ (Standard) 
Reverse phase HPLC Rt(D) 19 mm. 
Reverse phase HPLC Rt(E) 27 mm. 
Reverse phase HPLC Rt(D) 6 mm. 14 mm. 16 mm. 17 mm. 17.5 mm. 18 
mm. 18.5 mm. 19 mm. (peaks get progressively smaller) 
Ion-exchange HPLC Rt(c) 4 mm. 5 mm. 8 mm. 12 mm. 16 mm. 19 mm. 
22 mm. (peaks get progressively smaller), ((813) Rt(c) 24 mm.) 
(1OBJ 
Reverse phase HPLC Rt(E) 26 mm. 29 mm. 
(11 B) 
Ion-exchange HPLC Rt(c) 7 mm. ((813) Rt(c) 7 mm.) 
(12B) 
Ion-exchange HPLC Rt(F) 15 mm. (small peak), ((1A) 
Rt(F) 14 mm.) 
(13B) 
Ion-exchange HPLC Rt(F) no product 
(14A) 
Reverse phase HPLC Rt(E) 25 mm. 32 mm. 34 mm. 35 mm. 36 mm. 37 
mm. (small peaks), ((1A) Rt(E) 37 mm.) 
Ion-exchange HPLC Rt(F) 3 mm. 3.5 mm. 4 mm. 45 mm. 5 mm. 
((1A) Rt(F)  5 mm.) 
(15A) 
Ion-exchange HPLC Rt(F) 3 mm. 4 mm. 5 mm. 
(16A) 
Reverse phase HPLC Rt(G) 10 mm. 15 mm. 17 mm. 18 mm. 19 mm. 
(small peaks), ((1A) Rt(H)  19 mm.) 
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(1 7B) 
Reverse phase HPLC Rt(G) 11 mm. 16 mm. 17 mm. 18 min. 19 mm. 
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Bnpeoc 2,2-b/s (4-nitrophenyl)ethOxyCarbOflYI 
Cmpt 1 -[(2-chloro-4-methyl)pheflVIF 
4-methoxypiperidifl -4-Yl 
DBN 1 ,5-diazabicyclo[4.3.O]flOfl -5efle 
DBU 1,5-diazabicyclo[5.4.0]UfldeC5efle 




DNA deoxyribonucleic acid 
Fmoc fluoren-9-ylmethOXyCarbOnYl 
HPLC high performance liquid chromatography 
MMTr 4-monomethOxytrityl 
MSNT 1-mesitylenesulphoyl3flitrO 	1 ,2,4-triazole 




NMR nuclear magnetic resonance 
NPE 2-(p-nitrophenyl)ethyl 
p-NBST p-nitrobenzenesulphOflyltriaZOle 
RNA ribonucleic acid 
SARC sarcosyl 
TBAF tetra-t7--butyl ammonium fluoride 
TBDMS t-butyldimethylsilyl 
THP tetra hydropyraflyl 
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A typical synthesis cycle used on an ABI DNA synthesizer (see p.66) 
SYNTHESIS CYCLE 
VERSION 1.34 
CYCLE NAME: 	SSCE103A 
NUMBER OF STEPS: 89 
DATE: 	 .Jul 5, 1988 
TIME: 15:57 
Peg. I 
STEP FUNCTION STEP STEP ACTIVE FOR BASES SAFE 
___AM____ TIME ___q__c___T ---  --- Q..__L STEE 
1 10 £18 To Waste 4 Yes Yes Yes Yes Yes Yes Yes Yes 
2 9 £15 To Column 60 Yes Yes Yes Yes Yes Yes Yes Yes 
3 2 Reverse Flush 20 Yes Yes Yes Yes Yes Yes Yes Yes 
4 1 Block - Flush 4 Yes Yes Yes Yes Yes Yes Yes Yes 
5 28 Phos Prep 3 Yes Yes Yes Yes Yes Yes Yes Yes 
6 +45 Group 1 On 1 Yes Yes Yes Yes Yes Yes Yes Yes 
7 90 TET to column 2 Yes Yes Yes Yes Yes Yes Yes Yes 
8 19 B+TET To Col 1 3 Yes Yes Yes Yes Yes Yes Yes Yes 
9 90 TET to column 2 Yes Yes Yes Yes Yes Yes Yes Yes 
10 19 B+TET To Col 	1 2 Yes Yes Yes Yes Yes Yes Yes Yes 
11 9 £18 To Column 2 Yes Yes Yes Yes Yes Yes Yes Yes 
12 -46 Group 1 Off 1 Yes Yes Yes Yes Yes Yes Yes Yes 
13 +47 Group 2 On 1 Yes Yes Yes Yes Yes Yes Yes Yes 
14 10 £18 To Waste 7 Yes Yes Yes Yes Yes Yes Yes Yes 
15 1 Block Flush 4 Yes Yes Yes Yes Yes Yes Yes Yes 
16 90 TET to column 2 Yes Yes Yes Yes Yes Yes Yes Yes 
17 20 B+TET To Col 2 3 Yes Yes Yes Yes Yes Yes Yes Yes 
18 90 TET to column 2 Yes Yes Yes Yes Yes Yes Yes Yes 
19 20 B+TET To Col 2 2 Yes Yes Yes Yes Yes Yes Yes Yes 
20 9 £18 To Column 2 Yes Yes Yes Yes Yes Yes Yes Ye 
21 -48 Group 2 Off 1 Yes Yes Yes Yes Yes Yes Yes Yes 
22 +49 Group 3 On 1 Yes Yes Yes Yes Yes Yes Yes Yes 
23 10 £18 To Waste 7 Yes Yes Yes Yes Yes Yes Yes Yes 
24 1 Block Flush 4 Yes Yes Yes Yes Yes Yes Yes Yes 
25 90 TET to column 2 Yes Yes Yes Yes Yes Yes Yes Yes 
26 21 B+TET To Col 3 3 Yes Yes Yes Yes Yes Yes Yes Yes 
27 90 TET to column 2 Yes Yes Yes Yes Yes Yes Yes Yes 
28 21 B+TET To Col 3 2 Yes Yes Yes Yes Yes Yes Yes Yes 
29 9 £18 To Column 2 Yes Yes Yes Yes Yes Yes Yes Yes 
30 -50 Group 3 Off 1 Yes Yes Yes Yes Yes Yes Yes Yes 
31 4 Wait 30 Yes Yes Yes Yes Yes Yes Yes Yes 
32 16 Cap "rep 10 Yes Yes Yes Yes Yes Yes Yes Yes 
33 10 £18 To Waste 5 Yes Yes Yes Yes Yes Yes Yes Yes 
34 2 Reverse Flush 5 Yes Yes Yes Yes Yes Yes Yes Yes 
35 1 Block Flush 4 Yes Yes Yes Yes Yes Yes Yes Yes 
36 445 Group I On 1 Yes Yes Yes Yes Yes Yes Yes Yes 
37 22 Cap To Col 1 10 Yes Yes Yes Yes Yes Yes Yes Yes 
36 -46 Group I Off 1 Yes Yes Yes Yes Yes Yes Yes Yes 
39 +47 Group 2 On 1 Yes Yes Yes Yes Yes Yes Yes Yes 
40 23 Cap To Col 2 8 Yes Yes Yes Yes Yes Yes Yes Yes 
41 -48 Group 2 Off 1 Yes Yes Yes Yes Yes Yes Yes Yes 
42 +49 Group 3 On 1 Yes Yes Yes Yes Yes Yes Yes Yes 
43 24 Cap To Col 3 8 Yes Yes Yes Yes Yes Yes Yes Yes 




CYCLE NAME: 	SSCEI03A 
NUMBER OF STEPS: 89 
Page 2 
STEP FUNCTION STEP STEP ACTIVE FOR BASES SAFE 
NUMBER __5_' _ 	 - TIME _&_cc_ ----------- ---- 7_ STEP 
44 -50 Group 3 Off 1 Yes Yes Yes Yes Yes Yes Yes Yes 
45 4 Wait 1 Yes Yes Yes Yes Yes Yes Yes Yes 
46 10 £18 To Waste 7 Yes Yes Yes Yes Yes Yes Yes Yes 
47 2 Reverse Flush 5 Yes Yes Yes Yes Yes Yes Yes Yes 
48 1 Block Flush 4 Yes Yes Yes Yes Yes Yes Yes Yes 
49 81 £15 To Waste 7 Yes Yes Yes Yes Yes Yes Yes Yes 
50 13 £15 To Column 15 Yes Yes Yes Yes Yes Yes Yes Yes 
51 4 Wait 30 Yes Yes Yes Yes Yes Yes Yes Yes 
52 10 £18 To Waste 10 Yes Yes Yes Yes Yes Yes Yes Yes 
53 2 Reverse Flush 20 Yes Yes Yes Yes Yes Yes Yes Yes 
54 1 Block Flush 4 Yes Yes Yes Yes Yes Yes Yes Yes 
55 9 £18 To Column 20 Yes Yes Yes Yes Yes Yes Yes Yes 
56 2 Reverse Flush 5 Yes Yes Yes Yes Yes Yes Yes Yes 
57 9 £18 To Column 10 Yes Yes Yes Yes Yes Yes Yes Yes 
58 2 Reverse Flush 5 Yes Yes Yes Yes Yes Yes Yes Yes 
59 9 £18 To Column 10 Yes Yes Yes Yes Yes Yes Yes Yes 
60 2 Reverse Flush 5 Yes Yes Yes Yes Yes Yes Yes Yes 
61 9 £18 To Column 10 Yes Yes Yes Yes Yes Yes Yes Yes 
62 2 Reverse Flush 5 Yes Yes Yes Yes Yes Yes Yes Yes 
63 1 Block Flush 4 Yes Yes Yes Yes Yes Yes Yes Yes 
64 33 Cycle Entry 1 Yes Yes Yes Yes Yes Yes Yes Yes 
65 10 £18 To Waste 3 Yes Yes Yes Yes Yes Yes Yes Yes 
66 9 £18 To Column 20 Yes Yes Yes Yes Yes Yes Yes Yes 
67 2 Reverse Flush 5 Yes Yes Yes Yes Yes Yes Yes Yes 
68 1 Block Flush 6 Yes Yes Yes Yes Yes Yes Yes Yes 
69 6 Waste-Port 1 Yes Yes Yes Yes Yes Yes Yes Yes 
70 5 Advance FC 1 Yes Yes Yes Yes Yes Yes Yes Yes 
71 82 £14 To Waste 5 Yes Yes Yes Yes Yes Yes Yes Yes 
72 14 £14 To Column 10 Yes Yes Yes Yes Yes Yes Yes No 
73 2 Reverse Flush 1 Yes Yes Yes Yes Yes Yes Yes Yes 
74 14 £14 To Column 10 Yes Yes Yes Yes Yes Yes Yes Yes 
75 2 Reverse Flush 1 Yes Yes Yes Yes Yes Yes Yes Yes 
76 14 £14 To Column 10 Yes Yes Yes Yes Yes Yes Yes Yes 
77 2 Reverse Flush 1 Yes Yes Yes Yes Yes Yes Yes Yes 
78 14 £14 To Column 10 Yes Yes Yes Yes Yes Yes Yes Yes 
79 2 Reverse Flush I Yes Yes Yes Yes Yes Yes Yes Yes 
80 14 £14 To Column 10 Yes Yes Yes Yes Yes Yes Yes Yes 
81 1 Block Flush 4 Yes Yes Yes Yes Yes Yes Yes No 
82 10 £18 To Waste 5 Yes Yes Yes Yes Yes Yes Yes No 
83 9 £18 To Column 30 Yes Yes Yes Yes Yes Yes Yes No 
84 2 Reverse Flush 5 Yes Yes Yes Yes Yes Yes Yes No 
85 10 £18 To Waste 5 Yes Yes Yes Yes Yes Yes Yes Yes 
86 9 fiB To Column 30 Yes Yes Yes Yes Yes Yes Yes Yes 
87 2 Reverse Flush 5 Yes Yes Yes Yes Yes Yes Yes Yes 
88 1 Block Flush 4 Yes Yes Yes Yes Yes Yes Yes Yes 
89 7 Waste-Bottle 1 Yes Yes Yes Yes Yes Yes Yes Yes 
APPENDIX 2 
Preparativeion-exchange HPLC trace of (2A), (see p.67) 
4 	6 	R 	10 	12 	14 	lb 	10 mm. 
155 
156 
Analytical reverse phase HPLC trace of (2A) after 
purification by ion-exchange HPLC (see p.67) 
A 
0 	2 	4 	6 	8 	10 	12 	14 16 	18 20 mm. 
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A NewBase-stable Linker or Solid-phase OOortioceotde Synthesis 
Tom Brown,8 Clare E. Pritchard,8 Gillian Turner, 8 and Stephen A. Salisburyb 
a Department of Chemistry, University of Edinburgh, West Mains Road, Edinburgh EH9 3JJ, Scotland 
b Pharmacia L.K.B. Biochrom Ltd., Science Park, Milton Road, Cambridge CB4 4FJ, England 
The succinyl-sarcosyl linker (ib), which is stable to prolongid contact with 1,8-diazabicyclo[5.4.0]UfldeC -7-efle but 
cleaves rapidly with aqueous ammonia, is of potential value in solid-phase oligonucleotide synthesis. 
The DMTrt group is not ideal for the protection of the 
5'-hydroxy function of deoxyribose in solid-phase DNA 
synthesis' 2  as acidic deprotection at successive cycles gives 
rise to depurination, particularly at deoxyadenosine resi-
dues. 34  This is not a serious problem in small scale synthesis as 
the acidic treatment is very brief (ca. 30 s) but it is a limiting 
factor in large-scale work when a deprotection time of around 
t Abbreviations: DMTr = 4,4'-dimethoxytrityl; FMOC = 9-fluor-
enylmethoxycarbonyl; LCAA = long chain alkylamino; CPG = 
Corning porous glass (controlled pore glass); DBU = 1,8-diazabicy-
clo(5.5.0)undec-7-ene: DMAP = 4-dimethylaminopyridifle dT = 
thymidine: AB, = N6-be nzoyl adenine : THP = tetrahydropyran-2-yl; 
DCCI = dicyclohexylcarbodiimide TCA = trichioroacetic acid. 
3 min is necessary. In addition, some uncommon nucleosides 
such as 2-amino-deoxyadenosine are acutely sensitive to 
acid-catalysed depurination and cannot be used routinely. 3 
When the 5'-DMTr-group is used in RNA synthesis in 
conjunction with acid-labile THP 2'-OH protection, it has 
been shown that repeated TCA treatment leads to significant 
loss of THP and subsequent 3' to 2' phosphoryl migration. 5 
Clearly there is a need for an alternative 5'-hydroxy 
protecting group for certain applications in oligonucleotide 
synthesis. Recent advances 67 indicate that the 5'-FMOC 
group can be removed by brief treatment in a suitable base, 
offering the possibility of a completely acid-free protocol. 
Unfortunately, the linker conventionally used to attach the 
oligonucleotide to the support matrix (la) is unstable to DBU 
and 1% cleavage occurs at each FMOC-deprotection step.6 
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(1) 	 (2) 
R' 	R2 	 R3 
a -CH,CH2- Me LCAACPG 
b -CHICHI- Me CH2CONHLCAACPG 
C 	-C6H4-0- H CH,CO,Et 
d -CH,CH,- H CH2 CO 2Et 
e -CH,CH,- Me CH,CO,Et 
f 	-CH.CH,CH2- H CH.,CO,Et 
Piperidine and morpholine can be used as alternatives, 7 but 
although (la) is more stable to these, FMOC-deprotection is 
much slower. The obvious incompatibility of base-labile 
5'-protecting groups and (la) prompted us to design a 
resin-oligonucleotide linker that is resistant to DBU. We have 
found that the linker (ib) suffers less than 5% cleavage after 
overnight treatment with a 10% solution of DBU in dry 
dichloromethane or toluene.1 Under the same conditions 
scission of (Ia) is complete in less than 1 h, presumably owing 
to a mechanism involving deprotonation of the amide nitrogen 
followed by intramolecular nucleophilic displacement at the 
ester carbonyl group. Although (ib) is stable to DBU, it is 
hydrolysed in less than 1 It at room temperature by concen-
trated aqueous ammonia, the standard reagent for removal of 
an oligonucleotide from the solid support. 
The properties of the linkers were demonstrated using the 
model compounds (id), (le), and (if) where reactions could 
be conveniently monitored by t.l.c. The ester group of (id) is 
cleaved by 10% DBU in dry dichloromethane in 5 mm 
whereas under the same conditions (le) is essentially un-
changed after 24 h and compound (if) is cleaved slowly (5 h). 
Cleavage of (if) can be assumed to proceed by an intramol-
ecular cyclisation and the formation of a 6-mem6ered ring. An 
analogous mechanism for (id) produces a 5-membered ring 
(an N-substituted succinimide) and will therefore take place 
more readily.§ Additional support for this mechanism comes 
from studies on the phthaloyl linker (ic). When the solid 
support is treated with 10% DBU, liberation of the nucleoside 
is extremely fast owing to the rigid conformation imposed by 
the aromatic ring favouring the intramolecular reaction (50% 
cleavage in 3.5 mm). Hydrolysis of the phthaloyl linker with 
concentrated aqueous ammonia is relatively slow (35 mm). 
The resin was functionalised as follows: FMOC-sarcosine (10 
equiv.) and DCCI (5 equiv.) were added to Pierce long-chain 
alkylamino CPG in a mixture of DMF and dichloromethane. Removal 
of the FMOC.group with piperidine in DMF followed by coupling of 
the sarcosine methylamino group to 5'-DMTr thymidine 3'-O-succi-
nate (10 equiv.) in the presence of DCCI (5 equiv.) gave a loading of 
20 mequiv. of 5'-DMTrdt/g of dry resin. (DMTr cation assayed 
colorimetrilly at 490 nm). 
§ Compounds (id). (Ic) and (if) were characterised by f.a.b. mass 
spectrometry, 'H n.m.r., and elemental analysis. 
(b) 
L_ 
Figure 1. Reverse-phase h.p.l.c.: (a) d(A) 8 DMTr: (b) d(A) 8 FMOC. 
Solid-phase DNA synthesis9j was carried out using the 
linker (ib) and 5'-DMTr-3-cyanoethyl phosphoramidite 
monomers. The oligonucleotides produced were indistin-
guishable in terms of purity and yield from those synthesised 
using linker (la) (Partisil-SAX ion-exchange and C8-reverse-
phase h.p.l.c. analysis). 
We have demonstrated the value of the sarcosyl linker in 
conjunction with the 5'-FMOC protected monomer (2) by 
synthesising d(A)8.11 The reverse-phase h.p.l.c. chromato-
grams of the crude product and a sample of d(A) 8 prepared by 
standard methodology (Figure 1) indicate that both methods 
produce excellent qualily DNA. The choice of capping agent 
in the FMOC cycle is crucial, as acetic anhydride and DMAP 
produce some cleavage of the FMOC group. Replacement of 
DMAP with N-methylimidazole gives cleaner synthesis but 
the best results were obtained using trimethylsilyl chloride (1 
mm). 8 A more serious problem occurs when unprotected 
thymidines are exposed to DBU. Deprotonation of the N(3) 
atom occurs, giving rise to a rapid reaction with the adjacent 
phosphotriester and the formation of an N(3)-methyl thymine 
residue. Thus, if d(T)6 is prepared by standard methods using 
the 5'-DMTr-dT methoxy phosphoramidite and the linker 
(ib), and the fully protected resin-bound oligonucleotide is 
treated with 10% DBU in dichloromethane for 10 mm, after 
which time it is liberated from the resin with aqueous 
ammonia, a mixture of several products is obtained. It can be 
shown by reverse-phase h.p.l.c. that authentic d(T) 6 is only a 
minor component. Interestingly, anion-exchange h.p.! .c. 
failed to separate the mixture and the single peak was shown 
to coelute with authentic d(T) 6 . The base-promoted methyla-
tion of thymidine has been reported previously by Jones. 9 
Thymine base protection should clearly be employed in the 
5'-FMOC DNA synthesis protocol. A number of suitable 
protecting groups have been developed.  10 
In conclusion, we suggest that the resin-oligonucleotide 
linker (ib) in combination with 5'-FMOC or similar 
base-labile protecting groups will provide a viable acid-free 
protocol for solid-phase oligonucleotide synthesis. The value 
of this combination in RNA synthesis has recently been 
¶ Solid-phase oligonucleotide synthesis was carried out on an Applied 
Biosystems 380B DNA -synthesiser, using the standard 0.2 p.mol 
li-cyanoethyl or methyl phosphoramidite cycle. The following 
sequences were prepared using oligonucleotide-resin-linkers (ia) and 




10% DBU in dichioromethane was used to replace TCA but 
otherwise the standard methoxy-phosphoramidite cycle was used. 
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